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Osteoporosis (OP) is a common disease, especially among postmenopausal women. OP is regarded as 
the main cause of fragility fractures. Bisphosphonate (BP) medications, approved by the FDA in 1995, 
have been adopted as the most common and frontline treatment to OP. The most obvious positive effect 
of BP is their ability to improve bone mineral density (BMD). However, lots of concerns have been raised 
after BP medications coming into market for about ten years. A new type of hip fractures (atypical 
fractures) has been reported and linked with long-term BP treatment. It is still debatable on the effect of 
BP on bone health. Previous studies have evaluated BP’s effect either by measuring BMD quantitatively 
or following up fracture cases. There are very limit studies from an engineering background investigating 
BP’s effect on bone strength and microstructure, especially on those bones sustaining fractures despite 
BP treatment.  
The femoral heads from trauma patients’ hip replacement operations were collected and worked as a BP 
study group (10 femoral heads) and fracture control group (13 femoral heads) depending on whether or 
not the patient had been treated with BP before fractures. Cadaver samples were collected from an 
elderly control group (5 femoral heads). Five cylindrical sub-samples were cored from the same location 
of each femoral head. All the five cylinder sub-samples were micro-CT scanned for microstructure 
measurements. Two of the five cylinder sub-samples were selected randomly and compressively 
mechanically tested for apparent strength. Another two sub-samples were further synchrotron radiation 
scanned for a sub-micro features study, especially focusing on the trabecular microcracks and fully 
broken trabeculae.  
The apparent strength for BP treated samples is 29% and 48% lower than that of non-treated fracture 
controls and elderly controls, respectively. The density and microstructure parameters for the BP study 
group are slightly higher than or at a similar level as those of non-treated fracture controls. However, 
there are 24% and 55% more microcracks existing in BP treated samples than that of non-treated 
fracture controls and elderly controls, respectively.  
There are a sub-group of patients with whom BP treatment does not work very well, as they still 
fractured even with BP treatment for years. The bone mass density and trabecular microstructure may 
not be the cause of lower apparent strength. Microcracks and fully broken trabeculae can partly explain 
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      Chapter 1.               
Motivation and Structure of Thesis 




1.1.1 Osteoporosis and fragility fractures 
Osteoporosis (OP) is a very common bone disease among elderly people, which causes a reduction in 
bone mineral density (BMD), alters bone microstructure and increase the risk of bone fracture 
(Hooven, Gehlbach et al. 2005). A report published by the US Department of Health and Human 
Services in 2004 shows that more than 30% of women and 20% of men over the age of 50 are 
predicted to suffer a fracture during their life time (Rockville 2004). In current clinical studies, OP is 
thought as the main reason of fragility fracture (Bessho, Ohnishi et al. 2009).  
1.1.2 Bisphosphonates  
Bisphosphonates (BP or BPs), including alendronate, risedronate, ibandronate and zoledronate, 
(McClung 2006, Russell, Xia et al. 2007) have been developed over the past 30 years and adopted as 
the most common and frontline treatment for OP since the 1990s (Bone, Hosking et al. 2004, Reid 
2011, Walsh and Chapman 2011, Aspray and Francis 2012, Diab and Watts 2014). BP can preserve 
bone density, improve bone connectivity and prevent trabecular structure from weakening (Doga, 
Bonadonna et al. 2002, Papapoulos 2005, Civitelli, Napoli et al. 2007, Brown, Morin et al. 2014).  
The positive effects of BP have been investigated by clinical follow-up studies, notably, by Bone’s 
group (Bone, Hosking et al. 2004). This study was based on a 10 years follow-up of 994 
postmenopausal women and showed that BP increased BMD (Figure 1.1). Another study also 
showed that BP increased BMD but observed a decrease in BMD if the treatment was discontinued 
after 5 years (Black 2006). Importantly, fracture incidence was also measured and it was found that 
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discontinuation of BP treatment after 5 years did not increase fracture risk (fracture incidence) other 
than vertebral fractures, compared with the control group (continuous treatment after 5 years). 
 
Figure 1.1 Bone mineral density change in the femoral neck (Bone, Hosking et al. 2004). . The 5-mg 
group (202 patients) was treated with alendronate 5mg daily for 10 years; the 10-mg group (196 
patients) was treated with alendronate 10mg daily for 10 years; the discontinuation group (199 
patients) was treated with alendronate 20mg daily for 2 years, then 5mg daily for 3 years, followed by 
placebo for another 5 years. 
Most of the studies proving BP’s’ positive effect use two criteria: the first is the increase in BMD or 
bone mineral content (Miller 2003, Bone, Hosking et al. 2004); the second is the reduction in 
fracture cases from follow-up studies (Chaiamnuay and Saag 2006, Thomas, Horlait et al. 2013, 
Eriksen, Diez-Perez et al. 2014). The link between bone mineral density and mechanical strength is 
not known from the current literature. In addition, patients who have been identified as having a 
high fracture risk and have been treated with BP tend to be more careful with their activities and this 
is a potential confounder when measuring the reduction in fracture risk. This indicates that BP 
medications may not work as well as currently thought in reducing the incidence of fractures. 
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Concerns in some patients  
There is a concern, especially after the American Food and Drug Agency (FDA) issued a warning, 
subsequently published by BBC (Figure 1.2), that BP may actually cause fractures for some patients.  
Among various BP adverse effects including subtrochanteric or diaphyseal fractures, gastrointestinal 
lesions and neoplasms, atrial fibrillation, and osteoporosis of the jaw, it was the awareness of 
atypical femoral fractures (AFFs) occurring after BP treatment that sparked doubt about the effect 
that BP has on improving bone strength (Giusti, Hamdy et al. 2010, Shane, Burr et al. 2010, Giusti, 
Hamdy et al. 2011). Most of these atypical fractures happened spontaneously and were considered 
as low energy fractures (Brett A. Lenart 2008, Grasko, Herrmann et al. 2009, Nieves and Cosman 
2010). Notably, it was found that 90.1% (Dell, Adams et al. 2012) of the patients sustaining these 
injuries had been treated with BP for a long period before their fractures occurred.  




Figure 1.2 BBC news article about BP. (Journalist 2006, Roberts 2010) 
The first atypical case was published in 2005 (Odvina, Zerwekh et al. 2005). As the fracture features 
failed to meet the classical fragility fractures, they were named as atypical fractures. There are 
mainly three atypical features: Firstly, the fracture location is usually on the subtrochanteric or 
femur shaft; secondly, it happens in a unique fracture pattern, which is usually transverse or slightly 
oblique; finally, also more seriously, it occurs spontaneously in low energy cases, when patients walk 
or fall from standing height or less (Goh 2006, Brett A. Lenart 2008, Lenart, Neviaser et al. 2009, 
Somford, Draijer et al. 2009, Abrahamsen 2010, Nieves and Cosman 2010, Caeirorey 2011, El 
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Rachkidi, Sari-Leret et al. 2011, Gunawardena, Baxter et al. 2011, Ng, Gino et al. 2011). There are 
also no any premonitions before fractures happening, so it is difficult to predict this kind of fracture. 
Some atypical fracture cases in different locations are shown from Figure 1.3 below, from which the 
above three atypical features can be seen.  
          
Figure 1.3 Three main types of atypical fractures. Left: atypical subtrochanteric fracture; middle: 
atypical medio-diaphyseal fracture; right: atypical diaphyseal proximal fracture. (Caeirorey 2011).  
The concerns are not limited to bone atypical fractures, but the effect on bone natural repair 
function. In clinical practice, it is observed that there are still a large number of patients suffering 
typical hip fractures even after they have been on BP treatment. One group of samples used in this 
study are from trauma patient hip replacements operations. It was found that about 15% of the 
typical hip fractures patients included in this study had been treated with BP prior to their fractures. 
It can be concluded that BP does not work well in some patients, either causing potential atypical 
fractures or not preventing typical fractures. The bones of these patients may react in a different 
way to BP compared with most of the patients that BP works effectively in protecting fractures.  
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Possible reasons for BP’s adverse effect on bone strength  
There are two types of cells involved in bone growth: Osteoblasts are active in bone formation, 
healing and growing whereas osteoclasts are active in bone and mineral absorption and resorption. 
Bone remodelling is the continued process of bone resorption and formation (Huston 1937). The 
reason for BP’s adverse effect can be explained from bone biology. After skeletal growth has finished, 
bone remodelling is responsible for removing old bone and forming new bone, which is shown in 
Figure 1.4 (Coxon, Oades et al. 2004). Bone turnover depends on the balance between bone 
resorption and formation. Normal bone remodelling involves repairing  damaged bone and replacing 
old bone with new bone.  
 
Figure 1.4 Bone remodelling process. 1. Resorption: simulated osteoblast precursors release factors 
that stimulate osteoclast differentiation and activity. Osteoclasts remove bone mineral and matrix, 
creating a cone. 2. Reversal: mononuclear cells prepare bone surface for new osteoblasts to begin 
forming bone. 3. Formation: successive waves of osteoblasts synthesize an organic matrix to replace 
resorbed bone and fill the cavity with new bone. 4. Resting: bone surface is covered with flattened 
lining cells (Coxon, Oades et al. 2004).  
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BP is reported to inhibit bone resorption function (Abrahamsen 2010), and suppress bone turnover 
(Brett A. Lenart 2008). Osteoporosis patients or patients with high bone turnover diseases may 
benefit from decreasing bone resorption in the short term. However, these benefits may be lost in 
the long term after accumulation of old, less mechanically competent and microdamaged bone 
(Abrahamsen 2010, Rachkidi, Sari-Leret et al. 2011). The normal process of microcracks being 
repaired is shown in Figure 1.5, but BP may affect this process (Odvina, Zerwekh et al. 2005, Brett A. 
Lenart 2008, Abrahamsen 2010).  
 
Figure 1.5 Microcrack repairing process (Hazenberg, Hentunen et al. 2009). 
.  
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1.2 Statement of the clinical problem 
The integrated effect of BP on bone health and strength improvement has been doubted. There 
have been a number of clinical studies regarding possible adverse effect of BP on bone health and 
strength (Black 2006, Giusti, Hamdy et al. 2011, Gunawardena, Baxter et al. 2011, Ng, Gino et al. 
2011). Some studies reported that a high level of microdamage was found after BP treatment 
(Mashiba, Turner et al. 2001, Allen, Iwata et al. 2006). BP can improve bone strength by increasing 
bone density, but they can also inhibit bone’s self-repairing function leading to the accumulation of 
microcracks. This research aims to investigate the effect of BP on bone mechanical strength, 
microstructure and the possible connection between BP treatment and the accumulations of 
microcracks and fully broken trabeculae.  
1.3 An engineering approach 
Previous work has evaluated the effect of BP by measuring BMD and fracture incidence rates during 
clinical follow-up studies. Such studies suffer from many complicating factors. Notably some patients 
may have fractured simply because they had a particularly unfortunate fall and not because they had, 
or had not, been on BP treatment. A biomechanical study does not suffer from many of these 
complicating factors; if the BP treated bone is found to be mechanically weaker during an in-vitro 
mechanical test it logically represents a bone that has a higher risk of fracture. However, the only 
biomechanical studies of the effect of BP on bone strength are animal studies where bone 
metabolism is much higher than in humans. Also the animals were ovariectomised to simulate the 
bone metabolism of OP in humans. As BP works by affecting metabolism, animal models may 
therefore not be very appropriate. Hence the approach of this Thesis was to carry out a 
biomechanical study of the strength of bone from relevant patient groups (patients who had 
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suffered a femoral fracture and some of whom were on BP while others were not), who are more 
prone to fracture, especially focused on determining the strength of the bone of patients who had 
been treated with BP previously but had still fractured.  
1.4 Aims and objectives 
This study aims to investigate whether long-term treatment with BP medication has any adverse 
effects on the mechanical properties of patients’ bone.  
There are four objectives and they are listed below.  
1. Does the bone from patients treated with BP have lower mechanical (compressive) strength 
relative to the bone from non-treated osteoporotic controls and elderly controls?  
2. Do BP-induced changes of bone density explain the difference in bone mechanical strength 
between BP treated patients and control groups?  
3. Are the differences (if any) in mechanical strength related to the differences (if any) of 
microstructural parameters (bone volume fraction, connectivity density, trabecular thickness and 
space)?  
4. Does BP-treated bone contain more microcracks than non-treated controls? If so, can this explain 
the difference (if any) in mechanical strength?  
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1.5 Set-up of study 
This research is based on femoral head samples from hip replacement operations and cadavers.  
The first part of this research investigates the mechanical strength of human trabecular bone 
samples through mechanically testing the samples. The second part of this research analyses 
microstructure and sub-microstructure with the aid of X-Ray micro-Computed Tomography (CT) and 
synchrotron radiation micro-CT imaging. The strength and structure results are further combined 
and analysed. 
1.6 Structure of the thesis  
The Thesis is divided into six chapters. Chapter One introduces the background, motivation, aims, 
objectives and setup of the Thesis. Chapter Two (Introduction) provides a broader and more detailed 
description of the topics related to bone. Chapter Three investigates the differences in mechanical 
strength among different groups through compressive mechanical testing, and bone apparent 
density was also physically measured. Chapter Four investigates the reasons for this lower strength 
in BP-treated samples at a micro level using standard micro-CT scans and compares the differences 
in microstructure among groups. It also assesses the influence of each individual microstructure 
parameter on trabecular compressive strength. Chapter Five investigates the reasons for this lower 
strength in BP-treated samples at a sub-micro level using synchrotron radiation micro-CT scans. The 
numbers of microcracks and fully broken trabeculae are assessed for different groups. Chapter Six 
synthesises the findings of the study and proposes future work. 
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               Chapter 2.               
Bone Material, Structure and 
Mechanical Properties 
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2.1  Bone 
Bone is a rigid organ in the human body, which is the main part of the vertebral skeleton. Bone 
functions in both mechanical and biological ways. As a structure, bone provides mechanical support 
for the body against gravity, is involved in daily activities and protects other human organs. As an 
organ, bone produces red and white blood cells, stores mineral contents and different kinds of stem 
cells (Cowin 2009).  
Bone is non-uniform solid and connective structure, which contains an outer layer of dense and 
compact bone, and a porous inner core. The outer part of bone is named as cortical bone or 
compact bone. The inner part of bone is named as trabecular or cancellous bone. In this report, the 
terms cortical bone and trabecular bone are used. The elaborate combination of cortical-trabecular 
bone structures minimizes weight whilst maintaining its main structural functions (Gibson and Ashby 
1999). 
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2.2 Bone composition and density 
2.2.1 Bone composition  
Bone tissue consists of both organic and inorganic contents. Bone comprises of three main phases: 
organic, mineral and water. In terms of the volume, adult cortical bone contains approximately 30% 
organic content, 50% mineral content and 20% water (Oyen and Ferguson 2010). In terms of the wet 
weight, the composition of cortical bone and trabecular bone are quite similar, in that they contain 
about 35% organic content, 45% mineral content and 20% water (Gibson and Ashby 1999).  
The flexibility and tensile strength are mainly from the contribution of organic elements, especially 
collagen (Fantner, Birkedal et al. 2004, Currey 2006). The inorganic calcium crystals lie within and 
around the collagen fibres, provideing compression resistance for the bone against external force 
and ensures it remains particularly durable during daily activities (Currey 2006). Figure 2.1 
represents the way collagen fibrils and mineral crystals combine together.  
 
Figure 2.1 Collagen fibril and mineral crystals in the bone (Karunaratne, Esapa et al. 2012). 
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2.2.2 Bone density measurement 
There are three types of bone density defined in the literature: BMD, bone apparent density and 
bone material density.  
BMD is widely used in clinical practice to evaluate bone mineral content quantitatively and predict 
fracture risk non-invasively, especially for OP patients or patients with a previous fracture history. It 
is measured using a Dual Energy X-ray Absorptiometry (DEXA) scanner, which scan a certain area of 
the body and the mass of bone mineral content within the scanning area is thereby estimated. BMD 
is calculated as bone mineral mass within the scanning area divided by the size of the area. Limited 
by the exposure of X-Rays to the human body, the imaging resolution is not high enough to 
characterise trabecular bone microstructure. In addition, DEXA measures the bone mineral mass 
over a 2D area, and is not able to describe the bone actual 3D structure. As a result, more than 44% 
of the incidences of non-vertebral fracture cases in women and more than 21% in men cannot be 
predicted by DEXA scan (Whitmarsh, Humbert et al. 2011). As an alternative to DEXA, BMD can be 
measured by burning the bone at 650 degrees in muffle furnace and weighing the leftover ash 
(Tassani, Ohman et al. 2011). 
In academic research, bone density is often described on both the tissue level and the material level. 
Bone apparent density is defined as the wet mineralised mass of bone including cancellous voids 
over the total volume of the tissue (Zioupos, Cook et al. 2008). Bone apparent density is the most 
common and easiest way to measure bone density. It is calculated as bone weight divided by the 
volume that the tissue occupied, including bone, air, marrow and blood (Zioupos, Cook et al. 2008). 
In practice, a standard shape of bone sample is achieved, and the volume of the sample can be 
calculated with its geometry parameters. The mass can be weighted with a scale. It was found from 
this study that the bone apparent density highly depends on the location from where the specimens 
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are harvested. The apparent density result from different locations within the same bone varies 
considerably. Therefore, a larger specimen size is recommended for bone apparent density 
measurement.  
Bone material density is defined as the bone mass over the volume of bone material itself (Zioupos, 
Cook et al. 2008). The difference between bone apparent density and bone material density is due 
to the porous structure of the bone.  
There are mainly two ways of measuring bone material density. The first method is using a 
submersion liquid whose density is known as      (Zioupos, Cook et al. 2008). In this method, the 
bone mass is weighted in air and recorded as     first. After this, both the bone sample and the 
weight scale are put into the submersion liquid and a lighter weight is measured as      Therefore, 
the volume occupied by the bone material,     , can be calculated with Equation 2.1.  
     
          
    
                                                       Equation 2.1 
The bone material density can be further calculated as Equation 2.2.  
     
          
          
                                                     Equation 2.2 
The second method is using a microCT scanner and relevant software to get the accurate bone 
volume fraction value. Bone volume fraction is calculated as the ratio of bone material volume (BV) 
over total bone tissue volume (TV). The relationship between bone apparent density (     , bone 
material density and bone volume fraction can be demonstrated with Equation 2.3 (Zioupos, Cook et 




    
    
                                                                      Equation 2.3 
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So bone material density can also be calculated as Equation 2.4, in which BV and TV can be achieved 
from microCT scans and relevant software such as BoneJ (Doube, Klosowski et al. 2010). 
     
    
  
  
                                                                     Equation 2.4 
The apparent density for cortical bone ranges from 1.8 to 2.0 g/    (Gibson and Ashby 1999), with 
an average of 1.9 g/    (Oyen and Ferguson 2010). For trabecular bone, the apparent density varies 
a lot with the bone volume fraction. Bone volume fraction can range from 5% to 70% (Gibson and 
Ashby 1999). It is reported by Ashman and Rho that trabecular bone apparent density ranges from 
approximately 0.1 to 1.0 g/    (Ashman and Rho 1988). A similar result was also found for 
trabecular bone apparent density, which is 0.1 to 0.9 g/    (Bonucci 1999). For bone material 
density, there is no difference between cortical bone and trabecular bone (Gibson and Ashby 1999). 
Bone material density and bone mineral content are correlated with a correlation coefficient of 0.77, 
shown in Figure 2.2.  
 
Figure 2.2 Bone material density correlated with bone mineral content for both cortical and trabecular 
samples. Bone mineral content is the ash weight over wet mineralised weight. Those samples with 
apparent density more than 1.3 g/    are denoted as encircled triangles.  
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As shown in Figure 2.3, bone apparent density is positively proportional to bone material density for 
those samples with apparent density more than 1.3 g/   , which are mainly cortical bones. 
However, the opposite tendency is noticed for specimens with apparent density less than 1.3 g/   , 
i.e. trabecular bone (Figure 2.4).  
 
Figure 2.3 Bone apparent density correlated with bone material density for both cortical and 




Figure 2.4 Bone apparent density correlated with material density for trabecular bone.  
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2.3 Bone organisation 
Bone can be resolved into several levels of organisations, from macrostructure to sub-nanostructure. 
Different researchers have slightly different categorisations of this hierarchical structure. Figure 2.5 
shows a standard bone hierarchical structure from the whole bone to molecule level.  
 
Figure 2.5 Bone organisation at different hierarchy levels(Rho, Kuhn-Spearing et al. 1998). 
Different levels of detailed information of bone can be achieved from CT scans with different 
resolutions, which is summarised in Figure 2.6 (Muller 2009, Christen, Webster et al. 2010). Higher 
level resolution CT scans contain more detail information about the sample, but the data size is 
much bigger than normal clinical CT scans. The idea of multiscale modelling is proposed by many 
researchers (Arbenz, van Lenthe et al. 2008, Vaughan, McCarthy et al. 2012), which is demonstrated 
in Figure 2.6. With the multiscale models, the structure-function relationship and bone failure 
mechanism can be studied at the microstructure and ultrastructure scales (Christen, Webster et al. 
2010). The loading transfer through joints between different parts of the skeleton can be studied 
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from the body-level model. Organ-scale model can describe the geometry of the bone organ and 
undertake an Finite Element (FE) analysis accurately. A small cube or cylinder model based on high 
resolution of CT scans can provide detail structure information (Christen, Webster et al. 2010). In 
addition, three 3D models built based on different CT scans resolutions from this study are shown as 
examples in Figure 2.7.  
        
Figure 2.6 Multiscale imaging and modelling. Left: Images at different levels (Muller 2009); Right: 
Multiscale modelling (Christen, Webster et al. 2010).  




Figure 2.7 3D models based on different resolution level of images from this research 
2.3.1 Bone macrostructure 
As introduced previously, there are mainly two types of bone structure in the mature skeleton 
system at macro-level: cortical (compact) bone and trabecular (cancellous) bone. Trabecular bone is 
a network of plates and rods, which make lots of open cells enclosing cavities that contain marrow, 
vasculature and nerves (Cowin 2009). The main difference between cortical bone and trabecular 
bone is the level of the porosity. A bone with volume fraction less than 0.7 is classified as trabecular 
bone (Gibson 1985). 
Macro-level structure of cortical bone can be imaged with clinical CT scans of 0.5mm pixel size 
(Figure 2.8) and a 3D model based on 2D-slice trabecular bone structure can be fully representative 
of bone macrostructure. 




Figure 2.8 Clinical CT images of proximal femur (top left). Images 1-5 are the slices scanned at 
different heights of the femur as shown in the top left figure (Manske, Macdonald et al. 2010).  
Cortical bone models at the macro-level can be used for finite element analysis to study stress 
distribution and predict fracture risk, an example of which is shown in Figure 2.9. The 
macrostructure of bone is usually used for simulating bone joint mechanics and movement, an 
example of which can be found in Figure 2.10.  




Figure 2.9 Finite element analysis of bone macro-level structure for stress analysis and fracture site 
prediction (Yosibash, Padan et al. 2007).  
 
Figure 2.10 Finite element model of the hip built based on clinical CT scans at macro-level (Rudman, 
Aspden et al. 2006).  
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2.3.2 Bone microstructure  
A microCT scan with a pixel size of a few tens of micrometres can show the trabecular 
microstructure (also called as microarchitecture). At the micro-level, trabecular bone is made up of 
interconnected network of rods and plates (Gibson and Ashby 1999). Figure 2.11 shows examples 
from this study: a 2D microCT image with pixel size of 30 µm, and the 3D model built based on these 
microCT scans shows the interconnected network of rods and plates.  
 
Figure 2.11 Trabecular bone microstructure shown in 2D microCT images (left), and the 3D trabecular 
microstructure model built based on the 2D microCT scans (right). The 2D scan is taken from the 
cross-section of a femoral head sample, and the 3D model is a cube shape cropped from the centre of 
the femoral head.  
Not limited to visualise trabecular microstructure qualitatively, quantitative bone morphometry 
provides a solution to study bone microstructure quantitatively (Muller 2009). With this technique, 
the differences in bone at the micro-level between young persons and elder persons or between 
controls and patients with different diseases can be studied.  
Microstructural parameters: bone volume fraction, trabecular length, trabecular thickness and 
trabecular connectivity are used to quantify trabecular microstructure and to assess changes in 
microstructure. In this study these parameters are used to describe microstructural changes due to 
OP and BP treatment and will be introduced in more detail in Chapter 4 (The Effect of BP on 
Trabecular Microstructure). The 2D histology study and morphometry based on 3D microCT models 
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show highly significant correlations for some microstructure parameters (Muller 2009). The further 
understanding of these microstructure parameters can also help develop clinical tools for diagnosing 
disease and for bone strength evaluation.  
The micro-level trabecular bone model also provides a solution for analysing structure-strength 
relationship at each local single trabecular. Figure 2.12 is an example from a sub-study of this Thesis 
(not included with the Thesis) showing finite element analysis on trabecular microstructure. It can 
give detailed information about the stress and strain distribution in each single trabecular, and 
further investigate the stress-concentration part or the weakest strength part of the whole 
microstructure.  
 
Figure 2.12 FE analysis on cubic trabecular model shows the stress distribution on each single 
trabecular microstructure (left), and the cross-section images to show the stress distribution of the 
inner structure (right). 
2.3.3 Bone nanostructure  
With the advance of synchrotron radiation microCT facilities, microCT images with pixel sizes less 
than 1µ or even smaller become accessible (Muller 2009). The most prominent structures observed 
from bone nano-level structure are collagen fibres, which are usually packed together with mineral 
crystals. The three main materials of this structure are crystals, collagens, and other organic proteins 
(Rho, Kuhn-Spearing et al. 1998). A bundle of fibrils is made into a collagen fibre, and merges with 
adjacent fibres to form a matrix network, or fibril arrays. The most common organic component of 
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this matric is Type I collagen (Rho, Kuhn-Spearing et al. 1998, Fratzl 2003). As shown in Figure 2.13, 
Type I collagen is comprised of tropocollagen molecules and each molecule is actually made up of 
three protein triple helix chains (Fratzl 2003). 
 
Figure 2.13 Assembly of collagen fibrils, fibres and mineral crystals (Rho, Kuhn-Spearing et al. 1998). 
The nano-scale imaging after testing can also provide local details of the fracture site and a better 
understanding of bone nano-mechanics. Figure 2.14 shows some uncracked ligament bridges on 
bone crack sites using a scanning electron microscope. 
 
Figure 2.14 Macro-level to Nano-level (Nalla, Stolken et al. 2005) 
 Bone Material, Structure and Mechanical Properties 
27 
 
2.4 Bone mechanical behaviour  
The relationship between load applied to the bone and deformation in response to the load is the 
key information gained from mechanical testing (Figure 2.15). The slope of the load-displacement 
curve can describe the stiffness of the bone and the elastic modulus of the bone, when combined 
with sample geometry parameters. Bone elastic modulus is closely related to the mineralisation of 
the bone. The maximum load of the curve, or ultimate load, represents the force at failure, which 
mainly reflects the integrity of the bone structure. The area under the curve represents the work to 
failure, which is the amount of energy required to break the bone (Cowin 2009).  
 
Figure 2.15 Load-displacement curve for testing the bone 
2.4.1 Mechanical testing  
Mechanical testing methods on bone in general are very similar with those mechanical testing 
methods for other materials. Figure 2.16 shows four standard mechanical testing methods for bone 
samples, which are tensile testing, compression testing, bending testing and torsion testing.  




Figure 2.16 Four main mechanical testing methods on bone: a) tensile test, b) compression test with 
and without correction of misalignment, c) bending test of three points and four points, d) tension 
torsion test (Turner and Burr 1993, Cowin 2009) 
One of the most common mechanical test methods for trabecular bone is compression testing in a 
uniaxial loading machine. The speed is commonly 0.05% compression of the original height per 
second and Young’s module is achieved from stress-strain curve (Stauber, Rapillard et al. 2006). 
Halgrin et al. did compressive testing on the trabecular bone cube and found the mechanical curve 
as shown as in Figure 2.17 (Halgrin, Chaari et al. 2012). Kefalas divided the compression process into 
three stages (Kefalas and Eftaxiopoulos 2012), as shown in Figure 2.18.  




Figure 2.17 Typical compression testing curve of trabecular bone (Halgrin, Chaari et al. 2012).  
 
Figure 2.18 Standard stress-strain curve of trabecular bone under uniaxial compression (Kefalas and 
Eftaxiopoulos 2012).  
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2.4.2 Numerical simulation  
Besides mechanical testing, another widely used method for bone strength testing is FEA. MicroCT-
based FEA is one of the most common research method to study and predict bone strength (Kotha, 
Hsieh et al. 2004, Liebschner, Muller et al. 2005, Nazarian, Stauber et al. 2006, Stauber and Muller 
2006, Fritz, Louis-Plence et al. 2007, Verhulp, van Rietbergen et al. 2008, Verhulp, Van Rietbergen et 
al. 2008, Cohen, Dempster et al. 2010, Mueller, Christen et al. 2011). MicroCT-based FEA can provide 
fine detail of the trabecular microarchitecture (Kabel, van Rietbergen et al. 1999, Kotha, Hsieh et al. 
2004, Shefelbine, Simon et al. 2005, Boyd and Muller 2006, Verhulp, Van Rietbergen et al. 2008, 
Verhulp, van Rietbergen et al. 2008, Cohen, Dempster et al. 2010, Milovanovic, Djonic et al. 2011). In 
most of the studies, trabecular bone volume fraction is used as the key parameter to estimate bone 
quality (Rice, Cowin et al. 1988, Follet, Viguet-Carrin et al. 2011). Meanwhile, it is also concerned 
that one parameter, bone volume fraction, cannot fully describe bone quality, and some other 
parameters should also be used to determine and estimate bone strength. One study has used the 
FEA method to demonstrate the relation between trabecular morphology and trabecular elastic 
properties (Kabel, van Rietbergen et al. 1999). It is found that the model based on stiffness entries 
can explain more than 90% of the variations, which proves the possibility to achieve accurate 
estimates of bone quality based on trabecular bone morphology (Turner, Cowin et al. 1990, 
Homminga, McCreadie et al. 2003).  
The accuracy for linear analysis on micro-FE models is well established. However, the accuracy for 
nonlinear analysis has arisen some concerns. In one study, the trabecular bone specimen was 
compressed beyond the apparent yield point and the results were compared with those from 
mechanical testing (Verhulp, Van Rietbergen et al. 2008). Different element sizes and types were 
applied to the model. It was found that those models with element sizes ranged from 80 to 40 μm 
can predict similar post-yield behaviour. It was also found that both the linear and nonlinear analysis 
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could predict the local deformations well, so geometry linear model can be used to simulate the 
trabecular bone post-yield behaviour (Verhulp, Van Rietbergen et al. 2008). Another study based on 
bovine trabecular samples also showed accurate post-yield location predicted by micro-finite 
element method compared with mechanical testing, which can be seen from Figure 2.19. 
 
Figure 2.19 Comparison between mechanical testing and FEA. Left: Reconstruction based on the CT 
scans of the original sample; Middle: reconstruction based on the CT scans of the sample after 
mechanical compression loading; Right: the FE analysis result under the same load case of mechanical 
testing (Verhulp, van Rietbergen et al. 2008).  
Nagaraja (2005) has undertaken mechanical testing and FE analysis on a cylinder specimen from 
bovine tibia trabecular (Nagaraja, Couse et al. 2005). In this study, microcracks formed by 
mechanical loading were labelled by sequential chelating agents. It was found that the labelled area 
matched very well with the failure area predicted based on von Mises stress by FE analysis. It was 
also found that the trabecular bone failure mode observed by micro-CT of the deformed sample 
matched well with the distribution of von Mises stress from FE analysis (Nagaraja, Couse et al. 2005), 
which can be seen from Figure 2.20.  
 
Figure 2.20 Microstructural failure analysis of trabecular bone (Nagaraja, Couse et al. 2005).  
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2.4.3 Mechanical properties  
At the tissue level, trabecular and cortical bone have large differences in mechanical properties, 
especially the elastic moduli. However, the study from material level shows no obvious differences in 
elastic moduli between cortical bone and single trabecular bone (Turner, Rho et al. 1999, Oyen 
2005). 
The elastic modulus is the slope of stress-strain curve, which describes the resistance of bone being 
deformed elastically. Table 2.1 show the elastic modulus for trabecular bone at the material level 
tested by mechanical testing or FEA. Another study using acoustic and nano-indentation methods 
shows higher results for the elastic modulus of trabecular bone, which can be seen from Table 2.2. 
Table 2.1 Elastic modulus of trabecular bone reported by different researchers using mechanical testing 
and finite element analysis  
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Table 2.2 Elastic modulus of cortical bone and trabecular bone. Elastic modulus (Young’s modulus) were 
measured by acoustic microscope and nano-indentation respectively (Turner, Rho et al. 1999).  
 
Elastic modulus is strongly related to bone density for both cortical bone and trabecular bone based 
on previous research. For trabecular bone, it is reported that the elastic modulus is proportional to 
between the square and the cube of the density. (Carter and Hayes 1977, Gibson and Ashby 1997, 
Muller and Hayes 1997). Density has different influence on elastic modulus with different trabecular 
structure. Figure 2.21 plots the elastic modulus (and relative elastic modulus) against density (and 
relative density) for both unspecified oriented trabecular bone and prismatic oriented trabecular 
bone. It shows the elastic modulus of unspecified orientated trabecular bone is more sensitive to 
density than prismatic oriented trabecular bone.  
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Figure 2.21 Elastic modulus for trabecular bone against apparent density. Left: trabecular bone with 
unspecified orientation; Right: trabecular bone with prismatic structure.  
Compressive strength and tensile strength are achieved from compression and tension tests 
respectively. The compressive strength for trabecular bone has a large range based on different 
locations of the sample. Figure 2.22 shows the plot of compressive strength against apparent density. 
It can be found that the compressive strengths of most of the trabecular samples fall in the range 
between 1MPa and 10MPa. 
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Figure 2.22 Compressive strength for trabecular bone against apparent density. Left: trabecular bone 
with unspecified orientation; Right: trabecular bone with prismatic structure. 
Bone fracture toughness is a parameter used to estimate the energy required to break the bone. It is 
related to the area below the stress-strain curve. The elastic modulus of mineralised materials, 
including cancellous and longitudinal cortical bone, is correlated with fracture toughness. A chart 
created by Dr Oyen (2008) based on the tissue and biomaterial database of Granta Design’s CES 
Selector system can be found in Figure 2.23. It shows the fracture toughness and elastic modulus 
correlations for low-density cancellous bone, high-density cancellous bone, and longitudinal cortical 
bone.  




Figure 2.23 The relationship between fracture toughness and elastic modulus for mineralized 
biological materials (Oyen 2008).   
2.4.4 Bone strength determinant  
Lots of studies have been done to find trabecular bone strength determinants. Many studies found 
that trabecular bone volume fraction (BV/TV) was the strongest strength determinant (Nazarian, 
Stauber et al. 2006, Nazarian, von Stechow et al. 2008, Cory, Nazarian et al. 2010). A study on elderly 
human vertebral trabecular strength determinants combined mechanical tests and microstructure 
measurements (Follet, Viguet-Carrin et al. 2011). Compression tests were done on 10mm cube 
samples with two end caps. The elastic modulus, the ultimate stress and the ultimate stress energy 
were achieved. Considering trabecular microstructure measurement results, it was found that the 
volume fraction was the strongest determinant of elastic modulus and ultimate strength (Follet, 
Viguet-Carrin et al. 2011). Another study tested cylindrical samples, 5.40 ± 0.31 mm in diameter and 
10.31 ± 0.28 mm in height, using the mechanical testing device shown in Figure 2.24. It was found 
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that fracture usually happens in the segment with the minimum volume fraction, which can account 
for about 84% of the variation in bone stiffness and strength (Nazarian, von Stechow et al. 2008). 
 
Figure 2.24 Mechanical test device. LVDT:  linear variable differential transformer. The size of brass 
end caps was 9mm in diameter and 1.2mm in thickness. The brass end caps were glued (American 
Glue, Taylor, MI) to both sides of the specimen. The specimen coring process was finished by diamond 
coring tool (Starlite Industries, Rosemont, PA). After coring, both ends of the specimens were cut 
perpendicular to the longitudinal axis of the cylinder by two parallel diamond watering blades running 
on a low-speed saw (Isomet; Buehler,Lake Bluff, IL) (Nazarian, von Stechow et al. 2008).  
Besides volume fraction, trabecular BMD is also considered as a main strength determinant (Boivin, 
Bala et al. 2008, Bala, Depalle et al. 2011, Follet, Viguet-Carrin et al. 2011). However, some studies 
have argued that the BMD cannot resolve the variation in trabecular density and microstructure, so 
it cannot predict trabecular strength accurately (Nazarian, Muller et al. 2007, Nazarian, 
Bauernschmitt et al. 2008, Nazarian, Snyder et al. 2008, Nazarian, Cory et al. 2009). The idea of 
combining BMD and microstructure was proposed (Nazarian, Muller et al. 2007). Nazarian tested 
specimens from seven discrete regions in the mechanical testing device shown in Figure 2.25. It was 
found that the mechanical properties were very dependent on the trabecular microstructure of each 
sub-region. The BMD measured from each sub-region only explained 37% of the variation in bone 
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mechanical properties while the bone volume fraction explained 74%. Nazarin, Muller et al. (2007) 
found a strong correlation between bone volume fraction and elastic moduli (Figure 2.26). 
         
Figure 2.25 Testing Sample and device. Left: the location of each sub-region from one femur sample; 
Middle: Specimen fixed by two brass end-caps; Right: mechanical testing device. Sample size: 
4.57±0.15 mm in diameter and 9.85±0.80 mm in height. The ratio between length and diameter is 2:1. 
Micro-CT resolution: 20 micro meters (Nazarian, Muller et al. 2007).  
 
          
Figure 2.26 Bone volume fractions and elastic moduli of specimens (Nazarian, Muller et al. 2007).  
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2.5 Bone microcracks  
The accumulation of bone microcracks has a strong influence on bone mechanical properties, both 
bone strength and toughness (Kosmopoulos, Schizas et al. 2008). It will further effect bone fracture 
resistance (Reilly and Currey 2000, Launey, Buehler et al. 2010, Christen, Levchuk et al. 2012). The 
resistance to microcracks forming and developing is an important ability for bone so that it can 
withstand different types of loads and protect the bone from fracturing (Christen, Levchuk et al. 
2012). 
There are very few studies regarding synchrotron radiation scanning trabecular bone nanostructure. 
A study based on synchrotron radiation micro-CT scans reported the average microcrack length was 
between 164 to 209 µm, and the average microcrack width was between 100 to 120 µm (Larrue, 
Rattner et al. 2011). The crack length and width measurement method can be seen from Figure 2.27. 
3D microcrack density ranged from 3.1 to 9.4 microcracks per unit volume (Larrue, Rattner et al. 
2011).  
  
Figure 2.27 Microcracks in 3D and 2D. Left: microcrack length and width in 3D; Right: microcracks 
shown in 2D synchrotron radiation CT scans (Larrue, Rattner et al. 2011).  
Another study involved re-scanning the sample after mechanical compression testing. The slice of 
the scan was compared with the corresponding slice of the original sample. Figure 2.28.shows some 
new microcracks found in the sample, which were derived from the compressive loading.  




Figure 2.28 Micro-CT scans before and after compression testing. Left: A slice of micro-CT scan of the 
original specimen; Right: the corresponding slice of the specimen in the deformed state (Verhulp, Van 
Rietbergen et al. 2008).  
It was found that all the observed microcracks were oriented along the bone’s longest axis. In the 
transverse plane, the microcracks were oriented in the direction of the osteocyte lacunae (Christen, 
Levchuk et al. 2012). In some studies, it was found that the microcracks were parallel to the load 
direction in the compressive load case (Diab and Vashishth 2005, Diab and Vashishth 2007, Christen, 
Levchuk et al. 2012). Figure 2.29 shows the microcrack pattern together with canals and osteocytes 
in the same sample.  
                            
Figure 2.29 Microcracks (green), canals (red) and osteocyte (yellow) in the transverse plane (Christen, 
Levchuk et al. 2012).  
The study of microcrack initiation and development can prompt the understanding of trabecular 
failure mechanism and establishing trabecular local failure criteria. Kosmopoulos tested the 
influence of microcracks on the whole high-density trabecular structure strength (Kosmopoulos, 
Schizas et al. 2008). To find the yield stress and strain of trabecular bone, the original sample was 
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subjected to compressive loading, which increased from 2.4 to 60 MPa. A cyclic stress with constant 
amplitude equal to one third of the yield stress was applied to the 2D trabecular bone FE model. It 
was observed that microcracks accumulated rapidly around small local areas, where sample 
geometry changed frequently due to the cycle loading. Figure 2.30 shows microcrack accumulation 
and propagation under cycle loading. It was found that the elastic modulus reduced by 50% after 
969 loading cycles. This study demonstrated that microcrack propagation was the main mechanism 
for high-density trabecular failure, which happened before the whole specimen failure 
(Kosmopoulos, Schizas et al. 2008). 
   
Figure 2.30 Microcrack accumulation after 969 cycles. Left: undamaged trabecular structure; Middle: 
the diffuse microdamage accumulation after 969 loading cycles; Right: trabecular bone strain density 
(Kosmopoulos, Schizas et al. 2008). 
 
 The Effect of BP on Trabecular Density and Strength 
42 
 
                  Chapter 3.               
The Effect of BP on Trabecular 
Density and Strength 
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3.1 Introduction  
This chapter aims to determine if BP treatment is associated with reduced bone strength, and 
further investigates if the difference in bone strength has any associations with the difference in 
bone densities between BP-treated and untreated control groups. Specifically, it was tested if 
patients who had suffered a typical fracture of the femoral neck after taking BP (alendronate 70mg 
weekly for 1-9 years, ALN group) had reduced bone strength in comparison to naïve fragility 
fractured controls (FC group) and non-fractured elderly controls (ELD group). As a traditional method 
of studying material properties, mechanical testing has been widely used to determine bone 
strength and other mechanical properties. In this study, samples were mechanically tested in 
compression to evaluate the mechanical properties and make comparison among groups.  
Besides bone mechanical properties, bone density is also a crucial parameter of predicting fracture 
risk in the current clinical setup. Many studies have shown that BP medications improve BMD, which 
is one of the main reasons for prescribing BP to patients (Müller and Recker 2007, O'Neal, Diab et al. 
2010, Hollick and Reid 2011). This gives clinicians confidence in continuing to treat patients with BP 
medications (Komatsubara, Mori et al.). Most of these studies are based on DEXA scans to evaluate 
the BMD. However, BMD is different from bone mass density and there are very few studies that 
physically measure bone mass density to evaluate BPs’ improvement on bone. This study also 
measures the mass density by physically weighing the bone tissue after mechanical testing. The 
results from mechanical testing and densities were further combined and discussed.  
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3.2 Samples preparation  
3.2.1 Samples grouping 
There are mainly three collection resources for the samples studied in this study. The first resource is 
hip replacement operations for trauma patients from St Mary’s Hospital, London. The second 
resource is hip replacement operations for osteoarthritis patients from Charing Cross Hospital, 
London. The third source is cadaver samples with full medical records. All the samples were 
collected in the time after the operations and stored at -80 degrees. These collections were 
approved by Imperial Tissue Bank (R13004).  
These samples were grouped into four based on the sources and medical conditions, which was 
introduced in Figure 3.1. For patients identified as high-risk for fractures, some had been treated 
with BP, and some had not for reasons that could not be established. Some patients had been 
misidentified as high-risk fractures and therefore no further treatment was provided. The samples 
from patients who had been treated with BP but still fractured are regarded as the study group, 
which is named as the alendronate (ALN) group as all of these patients had been treated with 
alendronate (one type of BP medication). These are the sub-group patients in which BP medication 
did not work very well. Some hip fracture patients had been identified as at high-risk of fracture but 
had not been treated with BP, and some hip fracture patients had not been identified as high risk of 
fracture. All these patients were classified as high-risk of fracture but without BP treatment patients.  




Figure 3.1 Samples grouping method based on their sources and medical conditions. All the samples are classified into four groups of ALN group, FC group, OA group and ELD group. 
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The samples used for the mechanical testing in this chapter and for all the following chapters in this 
report, were cored from femoral heads. The four samples groups in Figure 3.1 are introduced in 
more detail below.  
 FC group 
The samples for this group were from trauma patients who had undergone hip replacement 
operations. A questionnaire was sent to GPs asking for confirmation if the patient was OP, 
osteoarthritis (OA) and any BP treatment history. The samples without BP treatments were 
classified into this FC group.  
Femoral heads in this group were usually removed based on the fracture site during the 
operation, so they usually only contained the femoral head with minimal bone from the femoral 
neck. Figure 3.2 shows an example of the FC samples.  
 
Figure 3.2 Example FC sample. 
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 ALN group 
After reviewing the questionnaires, the samples confirmed as OP and with BP treatment prior to 
the hip replacement operations were selected. As all these BP treated samples were treated 
with alendronate (ALN), this group is named as ALN group. Alendronate treatment history 
ranged from 1 year to 8 years. The weekly doses were all 70mg. Figure 3.3 shows an example of 
the ALN samples.  
                 
Figure 3.3 Example of ALN sample. 
One of the biggest challenges for this study was to get enough ALN samples. Very few of the 
collected samples had BP treatment history. There are two main reasons for this. Firstly, for the 
OP patients, the patient’s General Practitioner (GP) would evaluate the fracture risk based on 
the level of OP and the patient’s previous fracture history. Those with high fracture risk would be 
treated with BP. These persons may have become more careful with outdoor and other activities, 
which made them less prone to falling and breaking their hips. Secondly, as BP does probably 
reduce fracture risk for the majority of patients, there will be relatively few such fracture 
patients. 
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During the three-year sample collection period, only 10 ALN samples were collected. Details of 
these patients are summarized in Table 3.1. 
Table 3.1 ALN samples information. 





Sample 1 79 F Alendronic Acid 70 5 
Sample 2 61 F Alendronic Acid 70 5.5 
Sample 3 82 F Alendronic Acid 70 5 
Sample 4 68 F Alendronic Acid 70 1 
Sample 5 88 F Alendronic Acid 70 9 
Sample 6 81 F Alendronic Acid 70 2 
Sample 7 80 M Alendronic Acid 70 1 
Sample 8 66 M Alendronic Acid 70 1 
Sample 9 79 F Alendronic Acid 70 1 
Sample 10 94 M Alendronic Acid 70 3 
 Elderly control group 
Besides fractured samples, some non-fractured cadaver samples were also included with this 
study. The current available medical records shown these samples were not OP and OA, and had 
not been treated with BP. These samples were classified into the elderly control group (ELD). 
However, while these donors had not been diagnosed with OP or OA it may be relevant to 
emphasize that it does not necessarily follow they did not have OP or OA. An example of the ELD 
sample can be found from Figure 3.4.   
 





Figure 3.4 Example of ELD sample. 
 OA group 
The samples of osteoarthritis (OA) group were from OA patients’ hip replacement operations.   A 
questionnaire was sent to GPs asking for confirmation if the patient was OP and any BP 
treatment history. The samples without BP treatment were classified into this OA group  
The OA group is included with this study as the additional backup group for ELD group for two 
reasons. Firstly, the number of elderly control group samples was small. The OA group works as 
an additional group to allow comparison with ALN group and FC group. Secondly, as the elderly 
 The Effect of BP on Trabecular Density and Strength 
50 
 
control samples were from cadavers, they were stored for a long time and transported from the 
United States of America. These samples might have not been preserved as well as the samples 
from the ALN and FC groups. The OA samples were collected from the hip replacement 
operations and treated and stored in the same conditions as ALN and FC groups in this Thesis. 
Because of the clinical surgery procedures, the femoral heads samples in this group were usually 
with a big part of femoral neck. Figure 3.5 shows an example of the OA samples. 
 
Figure 3.5 Example of OA sample. 
The gender and age information for all the samples in each group are summarised in Table 3.2.  
Table 3.2 Samples sex and age summary. 
  Median Average Min Max Male Female  Total 
FC 82 82.9 74 95 6 8 13 
OA 72 70.4 53 88 6 4 10 
ALN 79 77.3 61 94 3 7 10 
ELD 82 78.8 73 84 1 4 5 
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3.2.2 Sample processing  
A review of the literature has been performed to determine the suitable sample size and shape. 
There are two types of sample shapes used in previous studies. The first type is cylindrical samples. 
The diameter ranged from 4.6mm to 8mm and the height of cylinders ranged from 6mm to 11mm 
(Nazarian, Stauber et al. 2006, Nazarian, Muller et al. 2007, Nazarian, von Stechow et al. 2008). 
Figure 3.6 is an example of the cylinder samples.  
 
Figure 3.6 Spatial decomposition of trabecular bone (Stauber, Rapillard et al. 2006). 
Besides cylinder samples, some studies also used cube samples. The dimension ranged from 5mm to 
9.12mm (Cohen, Dempster et al. 2010, Rubin, Dempster et al. 2010). Figure 3.7 shows an example of 
cube samples.  




Figure 3.7 Cube sample (Cohen, Dempster et al. 2010). 
For this study, the cylinder was decided as the sample shape based on two reasons. Firstly, the 
cylinder shape is more suitable for compression testing compared with the cubic shape. All the 
particles on one circumference are the same radius to the loading axis and can expand averagely. 
Secondly, cylinder shape sub-samples can be cored by a drill bit, which is easy to process and can 
maintain the uniform sub-sample shape and size. The dimension of 7mm in diameter and 10mm in 
height was decided considering the actual femoral head size that had been collected. It is well 
known that bone adapts to external loading, known as Wollf’s law (Wolff 1892, Jang and Kim 2008). 
Bone develops so that some areas are well adapted to sustain compressive load and other areas 
tensile load respectively, which can be seen from Figure 3.8 (Wolff 1892, Wehrli, Hopkins et al. 2000, 
Jang and Kim 2008). Considering the compression test would be taken, it was better to core the 
subsamples from the section that sustain compression loading.  
 





Figure 3.8 Compressive group and tensile group within the femur (Wehrli, Hopkins et al. 2000). 
Four procedures were designed to process a femoral head for getting standard size and shape 
samples, which were described summarily from Figure 3.9.  
 
Figure 3.9 A summary of samples processing procedures. 
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 Step 1 Sawing a flat surface 
Based on the specific size of each femoral head sample, the sample was cut first to remove 
about one third of the femoral head from the top (Figure 3.10). A flat surface was achieved, on 
which five cores would be drilled out (Figure 3.11). Some tissue paper was used to twine around 
the samples for two reasons. Firstly, it can fix the sample firmly during the sawing process. 
Secondly, the cartilage on the femoral head is protected for other PhD’s research on cartilage 
samples.  
 
Figure 3.10 Saw used for cutting two flat surfaces on the samples. 




Figure 3.11 Processed samples after step 1. 
 Step 2 Drilling five holes 
Five cores were drilled by a diamond drill bit (DK Holdings, UK). The drill bit was actually 8mm for 
the outer diameter, which would leave a 6.8mm in diameter cylindrical sub-sample. A sub-
sample in the centre and four around it were cored, which can be seen from Figure 3.12. 
 
Figure 3.12 Five cylindrical subsamples were cored from one femoral head. The subsamples locations 
were one in the centre and four others around the centre one. 
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The drill platform can be seen from Figure 3.13. A flexible sample fixture was made by modifying 
a lathe clap. The fixture was fixed on an XY two degrees mobile platform, which made it easy to 
move to five different locations. As the required sample length was 10mm, the drill bit went 
down about 13-15mm in depth to get a cylinder with enough length (height) first. A flexible 
sample holding system was designed to ensure the femoral head samples staying stability while 
the drill bit forces acting on. The samples fixture was set upon a two degrees system. The system 
allowed movement of the samples easily in a 2D plane normal to the drill bit for coring five 
cylinder samples in different locations.  




Figure 3.13 Drilling system. 
 Step 3: Saw the second flat plane 
After drilling five cores (Figure 3.14), the sample was sawed again on the second plane, which 
was 12mm offset from the first cutting. The cores were drilled to a depth of 13-15mm, so the 
five cores seperated from the femoral head automatically. No any other external forces were 
needed to avoid causing other damage.  




Figure 3.14 Five cores were separated from the femoral head. 
 Step 4: Accurate cut of 10mm in height using a module  
The cylinder sample was put into a precise mould which had been manufactured with a hole of 
exactly 7mm in diameter and the thickness is exactly 10m (Figure 3.15). The cylinder sub-
samples were put into the hole and two ends that beyond the mould were sawn off. Therefore, 
the 10mm height was achieved for all the sub-samples (Figure 3.16).  
 
Figure 3.15 10mm length standard mould. 




Figure 3.16 An example of the sub-samples with standard size. 
All the cylinder sub-samples were processed following the above procedures efficiently and 
accurately. All the sub-samples were labelled and stored in samples boxes for different studies. 
Two out of five sub-samples were selected randomly for mechanical testing study, which were 
the samples marked as a green colour in Figure 3.17.  
 
Figure 3.17 Samples randomly chosen for different studies. The sub-samples marked in green were 
used for mechanical testing; the sub-samples marked in red were from the centre of the femoral head 
and reserved for future study; the sub-samples without any marks were used for synchrotron 
scanning.  
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3.3 Methodology  
In this chapter, the sample mass and volume have been measured for comparing the apparent 
density among groups. The apparent density, which was defined by dividing the mass with the 
volume that the tissue occupied (Zioupos, Cook et al. 2008), was used to compare the difference 
among groups. Material density was also studied in this chapter. 
3.3.1 Mechanical testing  
A uniaxial compression testing was used to test these trabecular cylinder sub-samples. The two ends 
of the cylinder samples were unrestricted. An Instron 5866 (Figure 3.18, Instron Engineering 
Cooperation, US) was used for the testing. A load cell (Serial Number 83169; Instron Engineering 
Cooperation, US) with maximum load of 10KN was used for compressive loading. 




Figure 3.18 Instron system used for mechanical testing. 
Figure 3.19 shows an example of the testing process. The samples were gradually compressed to 50% 
of the original height. Apparent strength and elastic modulus can be achieved for the very beginning 
part of compression process. The sample is over-deformed to 50% for providing not only the 
necessary information (during the beginning 10% deformation), but also some extra information in 
case of future study. There was no obvious horizontal sliding being found between the sample and 
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metal base. Fat and marrow extruded out while testing provided friction reduction between the 
sample and metal bases. Based on the above observation, no friction oil needed to be added to the 
two ends to reduce end effects.  
 
Figure 3.19 Example of a sample testing. 
The displacement control was chosen for testing, which had been used by many other studies 
(Nazarian, von Stechow et al. 2008, Topolinski, Cichanski et al. 2011, Halgrin, Chaari et al. 2012). For 
the displacement control testing, two main parameters need to be set, which were loading rate and 
testing period. Loading rate was a key parameter, as some studies (Pithioux, Subit et al. 2004, Kulin, 
Jiang et al. 2011, Ural, Zioupos et al. 2011) have shown, loading rate has an influence on bone 
mechanical properties. However, a study done by Szabo (Szabo, Taylor et al. 2011) has found that 
strain rate had no influence on trabecular bone mechanical properties through three points bending 
on bovine single trabecular bone. To compare the influence of different loading rates, fast loading 
and slow loading, samples were tested at five different loading rates, the information of which can 
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be found from Table 3.3. The tests were undertaken on sawbones (Pacific Research Laboratories, 
Inc., Washington, USA), which were a type of artificial bones with foam structure, for two reasons. 
Firstly, the real bone samples were very valuable; secondly, every real bone sample had a different 
structure but the sawbones samples had a uniform structure, which allowed the loading rate to be 
the main variable parameter.  
Table 3.3 Different loading rates. 




Option 1 0.5 25 0.02 
Option 2 0.5 50 0.01 
Option 3 0.5 100 0.005 
Option 4 0.5 200 0.0025 
Option 5 0.5 400 0.00125 
 
The mechanical curves of sawbone samples tested at different loading rate can be seen from Figure 
3.20. At the beginning, all these mechanical curves for five different loading rates were mixed 
together and no clear pattern was found. However, at the end these five mechanical testing curves 
were ranked as the same order as loading rates (from fast to slow) downwards. The sample tested at 
high (fast) loading rate required higher load to break (blue curve in Figure 3.20) and the sample 
tested at low (slow) loading rate required lower load to break (green curve in Figure 3.20).  




Figure 3.20 Mechanical behaviour of sawbones tested at different loading rates. 
The above tests were undertaken on sawbones. When it came to real bones, five cylinder samples 
from the same femoral heads were tested under the same testing setup as sawbones. The 
mechanical testing curves for these five samples were plotted in Figure 3.21. The loading curves had 
three stages. The first stage is elastic deformation, in which the weakest layer of trabecular 
microstructure was compressed gradually until almost fractured. After this, the sample came into a 
very short plastic deformation stage until a layer of trabecular microstructure was fully fractured. In 
this stage, a maximum load was found. In the third stage, more layers of trabecular microstructures 
were broken down and the samples were continually compressed. Similar results were also found 
for the first and second phases compared with those from saw bones. However, the opposite results 
were found in the third stage. Even though the pattern was not so clear as that from sawbones, it 
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can be found that higher load was required when the samples when loaded at lower loading rate. 
Based on the pilot study, the loading rate of 0.05 mm/s was chosen for the mechanical testing.  
 
  
Figure 3.21 Mechanical behaviour of five cylinder bone samples. These five cylinder samples from the 
same femoral head tested at different loading rates. Three stages are classified based on the purple 
colour testing curve at loading rate 0.025mm/s.  
Apparent strength and the elastic modulus at tissue level are measured for each cylinder sample 
based on the results form mechanical testing. As trabecular bone has the components of bone, 
porous space and marrow, the compression test on the cylinder sample is actually testing the whole 
tissue structure instead of the bone material itself. The strength result is much lower than the 
compressive strength from a single trabecula sample, which is pure bone material. Therefore, 
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apparent strength is defined here at the tissue level, which is actually the compressive strength for 
the whole cylindrical structure. Similarly, bone elastic modulus at tissue level is also defined to 
distinguish it from the result of testing a single trabecula sample.  
3.3.2 Bone apparent density measurement  
As trabecular bone is a porous structure, the volume of bone tissue occupied in the space is larger 
than the bone material volume itself. Based on different types of volume, bone apparent density and 
bone material density are used for the density measurement in this chapter. Bone apparent density 
is defined as the mass of bone over the total volume of the tissue occupied, which included the 
material volume and the porous space (Zioupos, Cook et al. 2008). Bone material density is defined 
as the mass of bone over the volume of the bone material occupied, excluded the porous space.  
Bone apparent density is based on the total cylindrical volume of the sample, which is roughly 7mm 
in diameter and 10mm in height. The percentage of solid pure bone material within a cylinder can be 
calculated through dividing bone apparent density by bone volume fraction (Kabel, van Rietbergen 
et al. 1999). Based on the above two parameters, bone material density was calculated for each 
sample as Equation 3.1. The method of calculating bone volume fraction and the results are 
introduced in the following Chapter of bone microstructure.  
                    
                   
                   
                                                    Equation 3.1 
The height and diameter of each cylinder sub-sample was measured using calipers three times, 
respectively. The volume of each cylinder sub-sample was calculated. Meanwhile, all the cylinder 
samples were weighed (AB204-S Analytical Balance, Mettler Toledo, Greifensee, Switzerland; 
Readability: 0.1mg, linearity: ±0.2mg) before the test and after the test. Following the mechanical 
tests the samples were kept in a fuming cupboard and the weight was measured every week until 
the change between two measurements was less than 1%. The last measurement was considered as 
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the weight of the sample. The bone apparent density was calculated as the volume of the sample 
divided by the dried out sample weight (the last weight measurement). To validate this procedure 
for removing all the marrow and water from the samples, 10 additional samples were chemically 
‘dried’. Subsequent to the above procedure, these samples were put into 70% ethanol, and then 100% 
ethanol to remove all the water. After that, these samples were put into 100% xylene. Finally, the 
samples were put into 100% ethanol again to make sure all the water was removed and leave the 
sample along for enough time till still. Following this chemical drying procedure the samples were 
weighed again and showed that the chemical process had resulted in less than 1% further reduction 
in weight proving that all the water and marrow had been removed by the previous procedure.  
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3.4 Results  
There are five parameters reported and compared among groups in this section: two mechanical 
properties of apparent strength and elastic modulus, as well as bone apparent density, volume 
fraction and bone material density.  
3.4.1 Bone apparent strength  
The apparent strength results for four groups are presented in Figure 3.22. A one-way ANOVA was 
conducted to determine if the apparent mechanical strength was different for different groups. 
There were no outliers, as assessed by boxplot; data was normally distributed for each group, as 
assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as assessed by 
Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± standard deviation. 
The apparent mechanical strength was statistically significantly different among different groups, F(3, 
72) = 35.848,p< 0.0005,  = 0.60. The apparent mechanical strengths were 4.6 ± 1.1 MPa for the 
ALN group, 6.5 ± 1.5MPa for the FC group, 10.6 ± 2.8 MPa for the OA group and 7.4 ± 3.0 MPa for 
the ELD group. Tukey’s post hoc analysis was also conducted and the results were shown in Figure 
3.22. The mean apparent strength for the ALN group was statistically weaker (p<0.05) than that of 
the FC group. Both the ALN group and the FC group were found statistically significantly weaker 
(p<0.001) bone strength compared with the OA group.  
It shows the ALN group and the FC group are obviously weaker than OA and ELD groups. The 
apparent strength for the ALN group is 29% lower than the FC group. 




Figure 3.22 Bone apparent strength for each group. Tukey’s post hoc analysis was done to find if the 
result of every two groups were significantly different. The same letter marked on two groups 
indicates that the result was significantly different between them with a p value of less than 0.05. The 
same letter with the symbol of one star marked on two groups indicates that the result was 
significantly different between them with a p value of less than 0.001.  
3.4.2 Bone apparent elastic modulus at the tissue level 
As the data was not normally distributed for all groups assessed by Shapiro-Wilk test (p< 0.05), a 
Kruskal-Wallis test was conducted to determine if there were differences in bone apparent elastic 
modulus among groups. Distributions of bone apparent elastic modulus were similar for all groups, 
as assessed by visual inspection of a boxplot. Medians of bone apparent mechanical strength were 
statistically significantly different among groups,   (3) =26.958, p<0.0005. Subsequently, pairwise 
comparisons were performed using certain procedures(Dunn 1964) with a Bonferroni correction for 
multiple comparisons. This post hoc analysis was also conducted to determine if there were 
statistically differences in the medians for different group combinations and the results are shown in 
Figure 3.23.  





Figure 3.23 Bone apparent elastic modulus for each group. Tukey’s post hoc analysis was done to find if 
the result of every two groups were significantly different. The same letter marked on two groups 
indicates that the result was significantly different between them with a p value of less than 0.05. The 
same letter with the symbol of one star marked on two groups indicates that the result was significantly 
different between them with a p value of less than 0.001.  
3.4.3 Bone apparent density 
The normal distribution test has been undertaken for bone apparent density parameter. Assessed by 
Shapiro-Wilk test (p> 0.05), the data is normally distributed. A boxplot (Figure 3.24) was presented 
respectively for the apparent density data. As the data sets for each groups were all normally 
distributed, a one-way ANOVA test was performed for apparent density and no statistically 
significantly differences were found across groups.  
The mean apparent density for the ALN group was found to be 2.0 % higher than that of the FC 
group, and 4.5% and 2.5% lower than those of the OA and the ELD group, respectively.  





Figure 3.24 Bone apparent density for each group. There was no statistically significant difference 
between any groups. 
3.4.4 Bone volume fraction 
The bone volume fraction is normally categorised as one of the trabecular microstructural 
parameters. However, it is introduced in this Chapter instead of Chapter 4, as bone material density, 
which is reported later in this chapter, was calculated based on bone volume fraction.  
A one-way ANOVA was conducted to determine if bone volume fraction was different for different 
groups. There were two outliers, as assessed by boxplot; data was normally distributed for each 
group, as assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as 
assessed by Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± 
standard deviation. The bone volume fraction was statistically significantly different among different 
groups, F(3, 63) = 15.1 ,p< 0.0005,  = 0.39. The bone volume fractions were 0.261 ± 0.05 for ALN 
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group, 0.264 ± 0.04 for FC group, 0.378± 0.09 for OA group and 0.330 ± 0.51 for ELD group, in that 
order. Tukey’s post hoc analysis was also conducted and the results were shown in Figure 3.25.  
 
 
Figure 3.25  Bone volume fraction for different groups. Tukey’s post hoc analysis was done to find if the 
result of every two groups were significantly different. The same letter marked on two groups indicates 
that the result was significantly different between them with a p value of less than 0.05. The same letter 
with the symbol of one star marked on two groups indicates that the result was significantly different 
between them with a p value of less than 0.001.  
3.4.5 Bone material density  
As the data was not all normally distributed when assessed by a Shapiro-Wilk test (p< 0.05), A 
Kruskal-Wallis test was conducted to determine if there were differences in bone material density 
among groups. Distributions of bone material density were similar for all groups, as assessed by 
visual inspection of a boxplot. Medians of bone material density were statistically significantly 
different among groups,   (3) = 20.5, p<0.0005. Subsequently, pairwise comparisons were 
performed using certain procedures (Dunn 1964) with a Bonferroni correction for multiple 
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comparisons. This post hoc analysis revealed statistically significant differences in some group 
combinations, which are shown in Figure 3.26.  
 
 
Figure 3.26 Bone material density for different groups. Tukey’s post hoc analysis was done to find if 
the result of every two groups were significantly different. The same letter marked on two groups 
indicates that the result was significantly different between them with a p value of less than 0.05. The 
same letter with the symbol of one star marked on two groups indicates that the result was 
significantly different between them with a p value of less than 0.001. 
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3.5 Discussion  
3.5.1 Mechanical properties 
The most important finding was that the BP-treated bones (ALN group) had lower apparent 
(compressive) strength compared to non-BP treated (FC group) and non-fracture control bones (OA 
and ELD groups). 
Not many studies were found in the current literatures that have physically tested human trabecular 
bones with BP treatment history (no studies were found) and fractured OP bones (very few studies 
were found). This is probably due to the limited availability of samples.  
The load-displacement (or stress-strain) curve from this study is compared with the literature in 
terms of the shape before comparing the results. Figure 3.27 is an example of a load-displacement 
curve from mechanical testing in this study, which clearly shows three stages: load increase from 
zero to maximum until fracturing the first layer of trabeculae, approximately horizontal curve until 
two trabecular cells meet and touch, higher load required again for compressing more trabeculae. It 
matches well with the results from literatures shown in Figure 2.17 and Figure 2.18 introduced in the 
previous chapter (Halgrin, Chaari et al. 2012, Kefalas and Eftaxiopoulos 2012).  
 




Figure 3.27 An example of load-displacement curve of trabecular cylinder sample. 
The average apparent strengths are 4.6MPa for the ALN group, 6.5MPa for the FC group, 7.4MPa for 
the ELD group and 10.6MPa for the OA group. Lv et al. (2015) using similar shape of cylinder samples 
from OP patients found the apparent strength was 6.7±2.8 MPa (n=18) (Lv, Zhang et al. 2015). The 
apparent strength reported by Topolinski et al. (2011) was between 1MPa to 12MPa (Topolinski, 
Cichanski et al. 2011). The apparent strength results of this study matched well with the current 
literature, especially the findings from Lv et al. in 2015 (Lv, Zhang et al. 2015).  
In contrast, other studies have reported different results to this Thesis. Zhang (Zhang, Li et al. 2010) 
tested cylinder cores from femoral heads achieved from hip replacement operations. The apparent 
strength from compressive mechanical testing was reported as 3.27±1.24 MPa for OA bones and 
2.55±1.22 MPa for OP bones (Zhang, Li et al. 2010). The apparent strength found in this Thesis is 
quite high compared with Zhang’s study for two reasons. Firstly, the samples used in Zhang’s study 
were from the trabecular part under the subchondral bones in the femoral head, from where the 
bones were usually more porous based on the observation of samples in this study. Secondly, the OA 
samples were from serious OA patients (Grade IV) with cartilage erosion. The trabecular bones for 
these patients may have been damaged and affect the mechanical properties. Secondly, all the 
samples were from female group with an elder average age. The ultimate stress for trabecular can 
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reduce from 8 MPa (average of 60 year old group) to 6 MPa (average age of 80 years old group) 
(Cowin 2009). 
The ALN group was found to have 29% lower apparent strength than the FC group, and 38% lower 
than the ELD control group. Both comparisons were found to be significantly different. This is the 
key finding from this research and the first result on human BP-treated samples that has ever been 
reported. Therefore, no similar findings from other literature are available for comparison. Some 
studies have been done on animals and also reported the difference in strength between BP-treated 
samples and controls. Allen and Burr (Allen and Burr 2008) treated beagle dogs with BP. Firstly, they 
found that the density-strength relationships were consistent for BP-treated and non-treated control 
groups. Secondly, the BMD increase was noticed for BP-treated group. However, a lower BMD 
normalised strength was found for BP-treated group compared with non-treated control group.  
It is also reported that BP’s improvement on bone strength mainly lasts for the first one to three 
years of treatment because of the benefit from the increased bone mineral density. After 1 to 3 
years, there is identical strength between BP-treated groups and controls, which is shown in Figure 
3.28 (Allen and Burr 2007, Allen and Burr 2008). The average BP-treatment for the samples in this 
study is 3.35 years. BP-treated bone begins to lose its advantage gained from the increased bone 
mineral density in term of the strength. The BP-treated samples used in this Thesis were all from 
trauma patients. The fact that these patients still fractured when they were on BP treatment means 
these persons’ bones react more adversely than others to BP. Based on the above discussion, it is 
understood that apparent strength for BP-treated samples was lower than controls in this Thesis.  




Figure 3.28 Strength-density relationship for BP-treated beagles and controls. Beagles were treated 
for 1 year before the mechanical testing. The strength-density relationships were similar for treated 
and untreated (Allen and Burr 2008).  
However, other studies have reported BP to improve bone apparent strength or ultimate load 
(Ohnishi, Nakamura et al. 1997, Wang, Allen et al. 2008, Zimmermann, Schaible et al. 2016). Firstly, 
these studies were all on young healthy animals. The reaction to BP may be different between young 
bones and aged bones. Secondly, they were treated with BP for a short term, which was from 1 to 12 
months. The treatment period was too short to show BP’s adverse effect, or when the positive 
effects of BP treatment on bone strength surpass any adverse effects. Thirdly, BP is reported to 
suppress bone turnover and further effect bones’ self-repair of microcracks and other artifacts 
(Mashiba, Turner et al. 2001). These microcracks occur as a result of daily activities. The animals in 
these studies were kept in the lab and there were almost no daily activities that would stimulate 
microcrack initiation and development. The above discussions can partly explain why higher strength 
was found in BP-treated groups compared with controls.  
Patients treated with BP (ALN group) had significantly lower strength than all other groups. It is 
argued that the low apparent strength of ALN group was therefore probably not simply due to low 
apparent density or bone volume fraction, but also because the bone was of lower quality than even 
the FC group. Following this, bone apparent strength was normalised with apparent density and 
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bone volume fraction to isolate the effect of bone apparent density and bone volume fraction on 
bone strength. The results are shown in Figure 3.29. It was found that the apparent density 
normalised strength ALN group were still weaker than other groups.  
As the data was not normally distributed for all groups assessed by Shapiro-Wilk test (p< 0.05), A 
Kruskal-Wallis test was conducted to determine if there were differences in bone apparent strength 
normalized with apparent density among groups. Medians of apparent strength normalised with 
apparent density were statistically significantly different among groups,   (3) = 45.5, p<0.0005 
Subsequently, pairwise comparisons were performed using certain procedures (Dunn 1964) with a 
Bonferroni correction for multiple comparisons. This post hoc analysis was also conducted to 
determine if there were statistically differences in median for different group combinations and the 
results were shown in Figure 3.29.  
 
Figure 3.29 Bone apparent strength normalized with bone apparent density. Tukey’s post hoc analysis 
was done to find if the result of every two groups were significantly different. The same letter marked 
on two groups indicates that the result was significantly different between them with a p value of less 
than 0.05. The same letter with the symbol of one star marked on two groups indicates that the result 
was significantly different between them with a p value of less than 0.001.  
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The apparent strength was still lower when normalized with bone apparent density. It suggests low 
density is not the cause for low strength for BP treated samples.  
Based on a similar consideration as bone apparent density, bone apparent strength was normalised 
with bone volume fraction to isolate the influence from the porosity of bone.  
A one-way ANOVA was conducted to determine if apparent strength normalised with bone volume 
fraction was different for different groups. There were a few outliers for the ALN group, as assessed 
by boxplot; data was normally distributed for each group, as assessed by Shapiro-Wilk test (p> 0.05); 
and there was homogeneity of variances, as assessed by Levene's test of homogeneity of variances 
(p>0.05). Data is presented as mean ± standard deviation. The apparent strength normalised with 
bone volume fraction was statistically significantly different among different groups, F(3, 61) = 
15.995,p< 0.0005,  = 0.41.  
The apparent mechanical strengths were 17.2 ± 3.6 MPa for the ALN group, 24.0 ± 4.8 for the FC 
group, 28.3 ± 5.9 for the  OA group and 27.9 ± 8.2 for the ELD group, in that order. Tukey’s post hoc 
analysis was also conducted and the results are shown in Figure 3.30. 




Figure 3.30 Bone apparent strength normalized with bone volume fraction. Tukey’s post hoc analysis 
was done to find if the result of every two groups were significantly different. The same letter marked 
on two groups indicates that the result was significantly different between them with a p value less 
than 0.05. The same letter with the symbol of one star marked on two groups indicates that the result 
was significantly different between them with a p value of less than 0.001. 
It was also found the apparent strength of the ALN group was significantly different from other 
groups when normalised with bone volume fraction. It is suggested that low bone volume fraction 
was not the cause for low strength for the ALN group. Further study has been done to evaluate bone 
quality at the micro- and sub-micro- levels, and this is presented and discussed in the following two 
chapters of this Thesis. 
It was found that the elastic modulus at the apparent level was 169MPa for the ALN group, 194MPa 
for the FC group, 449MPa for the OA group and 288MPa for the ELD group. The elastic modulus was 
reported as 17GPa for cortical bone and 0.76-11.3GPa for trabecular bone (single trabecular full 
bone sample) (Gibson and Ashby 1999). However, the trabecular structure at the tissue level has a 
much lower elastic modulus. Based on the tissue and biomaterial database of Granta Design’s CES 
Selector system, trabecular bone elastic modulus heavily depends on density (Oyen et al., 2008). For 
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low-density trabecular bone, elastic modulus varies from 80MPa to 300MPa, but for high-density 
trabecular bone the elastic modulus can vary from 700MPa to 1050 MPa. Odgaard reported that 
elastic modulus measured from cylinder trabecular samples ranged from 170MPa to 1637MPa and 
averaged at 689MPa (Odgaard and Linde 1991). The elastic modulus was also reported as 482 MPa 
for compression testing and 479 MPa for tensile testing (Røhl, Larsen et al. 1991). The apparent 
elastic modulus measured from this study ranged from 100MPa to 900MPa. This matches well with 
the results from the literature. However, the average elastic modulus for the ALN, FC and ELD groups 
are lower than the results reported from Røhl (Røhl, Larsen et al. 1991) and other studies. The result 
from the OA group supports the result reported by Røhl. The ALN and FC group samples were both 
from OP patients and were in the low-density group. Therefore, the average elastic modulus for 
these two groups was lower than findings from other research based on healthy bones. The result 
from the ELD group is close to the literature reported results but slightly lower. The ELD samples 
from cadavers had been chemically treated for safety reasons and transported a long distance. All 
these process may have affected the bone mechanical behaviour. This will be discussed in more 
detail in the limitations section of this Thesis.  
The elastic modulus for the ALN group was 13% lower than that of FC group and 41% lower than the 
ELD group. The difference in apparent strength between the ALN group and the FC group was 29%. 
There was no significant difference between the ALN and FC groups. It shows that ALN samples have 
lower resistance than the FC group (not significantly different) and ELD group (significantly different) 
to being deformed elastically. The results also show the elastic modulus of fractured (ALN and FC) 
groups are lower than non-fractured (OA and ELD) groups. Even though there are no previous 
studies of mechanical properties on human bone, some studies on animals have shown BPs’ adverse 
effects on bone material properties, especially elastic modulus. Shahnazari (Shahnazari, Yao et al. 
2010) treated two groups of aged rats with BP for 4 months at doses of 30 and 90 µg/kg monthly 
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respectively and compared with sham controls. Lower elastic modulus was found in the BP-treated 
groups compared with un-treated controls.  
The elastic moduli measured in this Thesis have a large range. The reason is due to the very small-
scale deformation in this test and the large variety of microstructure among different samples. 
When each sample is subjected to load, the layer with the lowest strength breaks first. This has 
already been demonstrated in Nazarian’s study (Nazarian, von Stechow et al. 2008). Once this layer 
is broken, the load can deform the sample to a certain length relating to the height of this layer 
along the direction of the loading. As the testing process is within a small scale of deformation 
before reaching the maximum load, the process of breaking the first layer of microstructure has a 
crucial influence on the elastic modulus result.  
To avoid the above problem, tensile testing on single trabeculae is highly recommended. As the 
sample is a single trabecula, it is the material level elastic modulus being tested and can isolate the 
disruption from microstructure. There are two types of samples that can be chosen for the test. The 
first type is a single trabecular sample with the original shape, without any machining process. There 
are two main shortcomings for this type of sample. Firstly, the sample is usually with a curved shape, 
which is not very suitable for either tensile or compressive testing. Secondly, samples are usually of 
various cross-sectional areas and this affects the accuracy of the final result. The second type of 
sample is a single trabecula that is machined to a standard shape, such as a rectangle bar. This 
solution can solve the two shortcomings of the first type of samples. However, the machining 
process may damage the sample.  
Apart from the mechanical property results, the ALN sample also behaved differently compared with 
other samples during the mechanical testing. Figure 3.31 shows the compression fracturing 
processing of the ALN sample and ELD sample, respectively. ALN samples were more elastic and had 
spring-like behaviour at the beginning of the compression stage and were easily compressed in 
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height without much energy (and lower maximum load) absorbed and there was much less 
destruction of the trabecular structure at the two ends. However, the OA and ELD samples usually 
had obvious destruction on either end of the cylinder samples or in the middle of the fracture site. 
This process usually needs higher energy (and load) to gain further shortening in the height. The last 
figure in Figure 3.31 shows obvious destruction at the top of the cylinder sample. 
 
Figure 3.31 Compression fracturing process of an ALN sample (above) and ELD sample (below). 
3.5.2 Bone densities  
The most important finding for the bone density study is that no significant differences between BP-
treated samples and non-treated OP controls were found, which further prove that the lower 
strength of the BP-treated samples was not due to lower density (less bone).  
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Early in 1937, bone density was studied and reported. The mass density for cortical bone was 1.8-1.9 
g/    , and the trabecular bone mass density ranged from 5% to 70% of the density of cortical bone 
based on the variance of its porosity (Huston 1937). A study (Morgan, Bayraktar et al. 2003) found 
the apparent density was 0.26-0.75 g/    and averaged at 0.56 g/   . The bone apparent density 
results from this study were 0.73 g/    for the ALN group, 0.72 for the FC group, 0.77 for the OA 
group and 0.75 for the ELD group. This agrees with Huston’s study and partly agrees with Morgan’s 
study.  
It was found that the ALN group showed 2% higher density compared with the FC group, but the 
difference was not significant. There are no any studies physically measuring BP-treated bone 
density using human samples. However, some studies on animal models have demonstrated similar 
results on the function of BP in maintaining or even improving bone density (Allen and Burr 2008, 
Shahnazari, Yao et al. 2010). For short term BP treatment, the improvement in bone apparent 
density by BP is not very significant. A study followed the trabecular microstructure changes in 
postmenopausal women in the first 12 months period of BP treatment found no significant changes 
in the BMD of the spine (no improvement), femoral head (with a reduction of about 0.55) and 
femoral neck (about 1% improvement) (Greenspan, Perera et al. 2010). Most BP samples from this 
study were from a short period (1-2 years) of treatment, so the improvement in bone apparent 
density was still not obvious. 
There was also no significant difference found between the FC samples and the ELD samples. The 
apparent density for the FC group was 4% lower than that of the ELD control group. This may conflict 
with normal knowledge, as OP is thought to reduce bone density more than this. However, this 
finding is supported by Nazarian’s study (Nazarian, von Stechow et al. 2008) on cadaveric samples. In 
their study they physically measured trabecular bone density for healthy persons and OP patients 
and found almost no difference on the density. It is noticed that the difference between OP samples 
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and non-OP samples (ELD and OA groups) in density is not as large as that reported from BMD 
studies (Kanis, McCloskey et al. 2008). There are two reasons that can explain this. Firstly, all the 
samples are from femoral heads, which are very dense part of the bones. The bone mass shows a 
larger reduction in the femoral shaft than femoral head compared with healthy bone. Secondly, the 
effect of OP is not homogenous but affects some areas more than others and the sample used in this 
study may be too small and may not be an area affected significantly by OP. To demonstrate this 
visually using the photos of samples in this study, one sample from each group was chosen as an 
example to represent the group. All four samples are listed below in Figure 3.32. As the ELD samples 
were from cadavers and had been chemically treated for safety reasons, it is quite different in 
appearance. The samples from the other three groups were from fresh tissue obtained from hip 
replacement surgery and had not been chemically treated. It can be seen that OP samples (ALN and 
FC groups) are more porous in certain areas. However, in the central part of the femoral head the 
porosity appears similar across groups. 
 
Figure 3.32 Cross-sections of femoral head samples from four groups, respectively. From left to right: 
ALN group, FC group, OA group and ELD group. 
The trabecular bone material density was found to be 2.72 g/    for the ALN group, 2.71 g/    for 
the FC group and 2.3 g/    for the ELD group. Nazarian (Nazarian, von Stechow et al. 2008) 
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measured trabecular bone material density for healthy persons and OP patients, and found 
1.82±0.12 g/    (n=61) for healthy normal persons and 1.81±0.11 g/    (n=35) for OP patients. 
Bone material density averaged at 2.1 g/    for OA group, which matches with the literature. The 
results of the other three groups show higher material density compared with Nazarian’s study. 
Zioupos et al. (2008) found that bone with higher apparent density tended to have lower bone 
material density (Zioupos, Cook et al. 2008). The ALN and FC groups in this study had lower apparent 
density than ELD group, and the material density for the ALN and FC groups was indeed found to be 
lower, which is consistent with Zioupos et al. (2008). Bone material density is calculated as Equation 
3.1, which is the bone apparent density divided by bone volume fraction. Both apparent density and 
bone volume fraction have errors and the operation process causes error accumulation and further 
enlarges the error for the final result of bone material density.  
The apparent strength for all the samples (n=76) were correlated with bone apparent density (Figure 
3.33) and a very low correlation factor of 0.12 was found between the above two parameters. 
However, when it comes to the ALN and the FC groups, there were no correlation found between 
apparent strength and apparent density for the ALN group (  =0) and the FC group (  =0.09).  




Figure 3.33 Apparent strength correlated with apparent density for all groups. 
However, for non-fractured groups (OA and ELD groups), much higher correlation were found as 
shown in Figure 3.34 and Figure 3.35. It was found that apparent strength was correlated with 
apparent density at R² = 0.33 and R² = 0.44 respectively for OA and ELD groups.  
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Figure 3.35  Apparent strength correlated with apparent density for the ELD group. 
This shows that apparent density had less influence on bone strength for the ALN and FC groups 
than it did for the ELD control and OA groups. In other words, some other mechanisms are at work in 
the bone of the fracture patients that overshadows the effect of differences in apparent density 
within the group. The lower correlation coefficients for ALN and FC groups reduce the overall 
correlation coefficient for all the samples. The results for the ELD and OA groups were reasonable. It 
can be concluded that bone apparent density has a large influence on bone apparent strength for 
healthy bones, but the influence on OP bones is limited.  
3.5.3 Bone volume fraction  
Bone volume fraction is a microstructural parameter and therefore it might seem more 
appropriately investigated in Chapter 4 which addresses all the other microstructural parameters. 
However, it is reported and discussed in this chapter for two reasons: Firstly, the calculation of bone 
material density in this chapter requires the bone volume fraction to be known. Secondly, bone 
volume fraction, apparent density and BMD are all very closely related and often used for the same 
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purpose of describing the difference between the ‘amount’, ‘quality’, porosity or density of bone 
between groups such as osteoporotic patients and healthy controls. In this chapter it is necessary to 
be able to describe this differentiation when discussing the bone strengths of the different patient 
groups. 
Bone volume fraction is 26.1% for the ALN group, 26.4% for the FC group, 33.0% for the ELD group 
and 37.8 for the OA group. Many studies on healthy human femoral head have reported bone 
volume fraction results. Tassani (Tassani, Particelli et al. 2011) found 29% for healthy bones. Zhang 
(Zhang, Li et al. 2010) reported the bone volume fraction result as 20% for OP bones and 35% for OA 
bones. Comparing between the BP-treated and untreated FC controls, there is no significant 
difference observed between the ALN group (26.1%) and the FC group (26.4%). The samples with the 
highest and lowest volume fraction for the ALN, FC and ELD groups were selected and two 3D 
reconstruction models were made to compare the differences in bone volume fraction in Figure 3.36.  
 
Figure 3.36 3D reconstruction of cylinder samples mechanically tested. Two samples from the same 
column are from the same group: A and B are from non-fractured control ELD group, C and D are from 
non-treated fractured control FC group; E and F are from BP-treated ALN group. The upper row of 
samples (A, C and E) represents samples with the highest bone volume fraction of each group. The 
lower row of samples (B, D and F) represents samples with the lowest bone volume fraction of each 
group.  
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No other studies have measured bone volume fraction on human samples treated with BP. There are 
several studies on BP-treated animals. Most of these studies found BP can increase the bone volume 
fraction by 2% to 10% (Ding, Day et al. 2003, Shahnazari, Yao et al. 2010, Wu, Adeeb et al. 2013). In 
Ding’s (Ding, Day et al. 2003) study, a pair of 3D reconstruction models has been made to compare 
the bone volume fraction difference between BP-treated animal and non-treated controls. It was 
found that bone volume fraction was 22.4% for control groups, but 25.6% for BP-treated animals. 
Figure 3.37 shows a clear improvement in bone volume fraction after BP treatment for these two 
groups.  
 
Figure 3.37 3D reconstructions of trabecular bone samples based on samples with median value of 
bone volume fraction from BP-treated and control group. The sample from the control group beagle 
dog had a lower volume fraction (mean=22.4%), made up of a combination of plate- and rod-like 
structures. The sample from the BP-treated group had higher volume fraction (mean=25.6%), made 
up of more plate-like structures.  
The bone volume fraction averaged at 26.3% for the fracture groups (ALN and FC), and 35.4% for the 
non-fracture groups (OA and ELD), i.e. the fractured groups were more porous. Figure 3.38 shows a 
group of cylinder samples that have been scanned at the same setup. Two of these were OA samples, 
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and all others were trauma samples. It shows clear differences in term of the microstructure, 
especially porosity. Figure 3.39 shows two CT slices from samples with high and low bone volume 
fractions respectively. Besides bone volume fraction, a significant difference was also found in bone 
apparent strength. The correlation between bone apparent strength and bone volume fraction is 
therefore further studied in this chapter.  
 
Figure 3.38 A comparison between OA sample and trauma samples on bone volume fraction on the 
same micro-CT scanning setup. Two samples were from OA patients (blue arrow) and all other 
samples were from trauma patients.  
 
Figure 3.39 High and low bone volume fraction comparison. Left: BVF=38%; Right: BVF=19%. 
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As other studies have proved (Nazarian, von Stechow et al. 2008, Tassani, Particelli et al. 2011), bone 
volume fraction is a major factor that effects bone strength. Similar results were also found from this 
study. Figure 3.40 shows the correlation relation between apparent strength and bone volume 
fraction for all samples (n=76) of the four groups. It was found that bone apparent strength is 
correlated with bone volume fraction with a factor of 0.59. Similar results were also reported by 
other studies. Melton (Melton, Riggs et al. 2011) tested healthy human wrist samples and reported 
the strength was correlated with bone volume fraction at the factor of 0.49. Topolinski (Topolinski, 
Cichanski et al. 2011) tested human femoral head samples and reported the correlation factor as 
0.68 between strength and bone volume fraction. 
 
Figure 3.40 Apparent strength correlated with bone volume fraction for all groups. 
Similarly, when the apparent strength was correlated with bone volume fraction for each group 
(Figure 3.41 to Figure 3.43), it was also found that bone volume fraction was a main determinant for 
the ALN, FC and OA groups. Ding (Ding, Day et al. 2003) showed bone volume fraction strongly 
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Figure 3.41 Apparent strength correlated with bone volume fraction in the ALN group. 
 
 
Figure 3.42  Apparent strength correlated with bone volume fraction in the FC group. 
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Figure 3.43  Apparent strength correlated with bone volume fraction in the OA group. 
In the ELD group, there was no correlation between apparent strength and bone volume fraction. 
The ELD group samples behaved different here compared with other groups and the literature 
results. The limitations of ELD group samples will be discussed in 3.5.4. 
3.5.4 Limitations 
The limitations of the studies in this chapter are summarized below. 
There are two main limitations in the samples. Firstly, the strength of the BP patients’ bone before 
BP treatment started was clearly impossible to establish. As these patients were identified for BP 
treatment their bones were perceived weak but it was unknown how weak they were. Hence, it was 
unknown whether the reduction of strength in the BP-treated samples (relative to the non-treated 
samples) occurred as a result of, or during, BP treatment or was a result of these bones being 
weaker than non-treated bones even prior to BP treatment. Secondly, the ELD group samples were 
from cadavers. The cadaver samples have been chemically treated for safety reasons prior to the 
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mechanical testing. Samples from other group in this study were stored at -86 degrees before the 
testing. The different samplers storing conditions made the ELD group not very comparable with 
other three groups.  
There are three main limitations from samples processing and mechanical testing setup. The first 
limitation is the damage on samples during the samples preparation process, which is unable to 
evaluate and its potential effect on bone mechanical properties is also very difficult to investigate.  
The second limitation is that several factors could have affected the accuracy of elastic modulus 
measurement. Elastic modulus measurement is sensitive to the accuracy of sample geometry from 
the machining, the contact surface of samples and the testing rig. Elastic moduli results reported in 
this study were lower than the findings from some of the literature. There were mainly four sources 
that could have affected the accuracy of the elastic modulus measurement. Firstly, it was the 
slippage between the sample and the two ends. Secondly, stress concentration in parts of the 
samples, especially the contact part between samples and testing rig, also could have affected the 
elastic modulus. Thirdly, the two flat surfaces at the two ends of the cylinder were not machined 
perfectly flat, or two surfaces were not parallel to each other. A gap might exist between the sample 
and testing rig, which might cause error in the displacement and load measurements, further 
affecting the inaccuracy of the elastic modulus calculation. Finally, the interfacial friction at the two 
end surfaces of the samples was reported to lower the measured elastic modulus by 20% to 70% 
compared with the real value (Gibson and Ashby 1999). 
The third limitation is in measurement of the density. As samples were weighed after mechanical 
testing, some small particles broke out of the cylinder samples during compression. Although, 
attempts were made to include all the parts for weighing, there may have still been some very small 
particles missing leading to bone mass loss. 
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3.6 Conclusions  
This study found no significant difference in the apparent density between groups. This was 
surprising as it was expected that many of the fractured samples (ALN and FC) would be 
osteoporotic (the reason they fractured in the first place). This was even more surprising in light of 
the fact that the fracture samples were found to be significantly more porous (lower bone volume 
fraction) as would be expected if they were more osteoporotic. While the material density of 
osteoporotic samples was reported to be relatively high due to increased mineral-to-collagen 
content it can probably partly explain the unexpected apparent density results found in this study.  
The apparent strength of the ALN group was significantly weaker than all other groups including the 
non-treated fracture control group (FC). This could not be explained as simply an effect of higher 
porosity of possibly more osteoporotic ALN-bone as the bone volume fraction normalised strength 
of BP-treated bone was also significantly weaker than all other groups. In fact, the mean porosity of 
ALN and FC samples was almost identical but the strength of FC samples was almost 40% higher than 
ALN samples. Thus, it appears that BP caused the bone to be weaker through a mechanism different 
from, and counteracting, BP’s accepted positive effect on porosity. This led to the hypothesis that BP 
may have a detrimental effect on bone microstructure and microcracking which will be investigated 
in the following chapters. 
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                  Chapter 4.               
The Effect of BP on Trabecular 
Microstructure 
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4.1 Introduction  
Many previous studies have demonstrated the ability of BP to increase BMD and reduce fracture 
risks in women with OP (Liberman, Weiss et al. 1995, Black, Thompson et al. 2000, Bone, Hosking et 
al. 2004, Müller and Recker 2007, Russell, Xia et al. 2007, Hollick and Reid 2011). Risedronate, 
alendronate (Watkins, Norris et al. 2012) and ibandronate (Shahnazari, Yao et al. 2010) improved 
trabecular bone mass in mice and rats. In these studies of mice and rats, the trabecular 
microarchitecture (thickness, number and connectivity) was found to increase with BP usage, which 
was associated with improved compressive strength. Similarly in beagles, BP was found to increase 
trabecular thickness (and mass) with an associated increase in strength (Komatsubara, Mori et al. 
2003). However in humans, it is not known how BP improves microstructure and how such changes 
in microstructure might affect bone strength (Nalla, Kinney et al. 2003).  
In the previous chapter, it was found that BP treated human bones had lower mechanical strength. It 
was also found that the differences in bone density and bone volume fraction (normalised strength), 
between BP-treated and control groups, could only partly explain this lower strength. These findings 
led to queries about the role of the microstructure of bone and the overall hypothesis of this chapter: 
does BP-treated bone have poorer trabecular microstructure and, if so, is this associated with the 
lower mechanical strength found in Chapter 3? To address these hypotheses, this chapter will 
evaluate the differences between BP-treated samples and controls.  
Mostly, trabecular bone microstructure morphology and measurements have been studied from 
three aspects: geometry, volume distribution and material distribution (Karlsson, Sernbo et al. 1996) 
The samples described in Chapter 3 were micro-CT scanned before the mechanical testing and 3D 
reconstructed (examples shown in Figure 4.1). This chapter aims to determine what effect (if any) BP 
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has on trabecular microstructure, through measuring and comparing BP treated fractured bones 
against controls (non-treated fractured controls, OA controls and bones from elderly cadavers). Any 
BP induced changes in these microstructural parameters will be correlated with the strength results 
from Chapter 3 to identify any links between BP-treated bone’s reduction in mechanical strength 
and BP-treated bone’s changes in microstructural parameters. 
            
Figure 4.1 Left: 3D reconstruction of cylindrical trabecular sample used for mechanical testing; Right; 
3D reconstruction of the femoral head as received post arthroplasty surgery. 
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4.2 Methodology  
4.2.1 Samples 
The work in this chapter was based on micro-CT scans of the same samples described in the previous 
chapters. The scans were performed prior to the mechanical testing described in Chapter 3.  
4.2.2 Micro-CT scanning 
All the samples were micro-CT scanned at resolution of 30 µm using the scanner (Nikon X-Tek 
HMXST-225, Japan) shown in Figure 4.2. 
 
Figure 4.2 Micro-CT scanner. 
Two sample holders were made (Figure 4.3). With these holders, 26 cylinder samples can be scanned 
at the same time. Samples were numbered anticlockwise. Small holes were drilled into the sample 
holder to distinguish between the upper and lower layers. An example micro-CT scan slice is shown 
in Figure 4.4. The scan for each cylinder sample was cropped from the whole scan slices set.  




Figure 4.3 Samples holders for micro-CT scanning. 
 
Figure 4.4 An example showing one slice from a micro-CT scan. 
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4.2.3 Image processing  
Make binary  
All the micro-CT imagers were first changed into binary format for further processing. A comparison 
of the images before and after this process is shown in Figure 4.5.  
  
Figure 4.5 Binary process. 
Purify operation 
A so-called ‘purify’ operation prepares the images for connectivity analysis. Connectivity 
measurement assumes the image has only one connected (Odgaard and Gundersen 1993) region. 
The purify operation removes all regions (including regions caused by background noise) except the 
largest one. 
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4.2.4 Microstructure measurements  
Measurements of microstructural parameters were performed using bone J, which is a plug-in for 
ImageJ (Doube, Klosowski et al. 2010). The theories and measurement methods for each parameter 
are introduced below.  
 Connectivity density 4.2.4.1
Connectivity was defined by Odgaard and Gundersen (1993) as the number of redundant trabeculae 
in trabecular bone (Odgaard and Gundersen 1993). A redundant trabecula is a trabecula that can be 
cut without separating the original bone structure. In other words, the connectivity of the 
‘networked’ structure is sufficient to prevent the structure from disintegrating into multiple parts. 
The more cuts that can be carried out without the structure disintegrating reflects how well the 
network is connected, hence the term ‘connectivity’. The definition is easiest to understand in 2D. 
Figure 4.6 shows three different structures. In (a), AB is a single trabecula, which is not possible to 
cut without separating the structure into two parts. The connectivity of this structure is recorded as 
0. In (b), a branch CD is added on the original structure of AB. If the CD branch is cut, the whole 
structure is still in one piece, and the connectivity is recorded as 1. Similarly with the structure in (c), 
two branches, CD and EF, are added to the original structure of AB. Two cuts can be done in this 
structure, one on CD and one on EF, without separating the whole structure into two pieces, hence, 
the connectivity is recorded as 2.  




Figure 4.6 Connectivity illustrated in 2D. (a) a single trabecular branch of AB; (b) another branch of CD 
added to the original branch of AB; (c) additional branches of CD and EF to the original branch of AB 
(Cowin 2009) 
Another model, in a topological sense, is used to further illustrate the connectivity of trabecular 
bone. Trabecular bone is simplified as a rod-branch network, which is shown in Figure 4.7. This is a 
network containing only rods and branches. Different branches are connected with rods. A structure 
is classified as a simply connected structure if only one path can be made between two rods. In 
Figure 4.7 (a), only one path can be made between P and Q. A structure is classified into a multiply 
connected structure if some nodes are connected with more than one path. In Figure 4.7 (b), node P 
and Q are connected with two paths.  
 




Figure 4.7 Trabecular structure is simplified as a rod-branch network in 2D. (a) Simply connected 
network. Only on path can be made from two nodes of P and Q. (b) multiply connected network, 
made based on (a) by adding a new branch. Two paths can be made between P and Q. (Odgaard and 
Gundersen 1993) 
The key parameter when determining connectivity is the Euler number χ, which is also known as the 
Euler Characteristic (Cowin 2009). The Euler characteristic, , is a standard mathematical concept 
(for which Euler developed many of the concepts, hence the name) that describes a particular aspect 
of the geometry of a shape or structure. Generally speaking the Euler characteristic of a structure (a 
triangle, square etc) is a function of the number of vertices (V), edges (E) and faces (F) of the 
structure (e.g. the  of a cuboid is = V – E + F = 8–12 +6 =2). The theory behind the Euler 
characteristic for complicated structures such as a cancellous ‘network’ is very involved but is a long-
standing and accepted concept. It is beyond the scope of this Thesis to describe the mathematical 
details of the Euler characteristic for complicated structures but the issues relevant to this Thesis will 
be highlighted.  
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The  of a structure made of many smaller structures can be shown to be a combination (a modified 
‘summation’) of the individual  of the smaller structures (Odgaard and Gundersen, 1993). Thus a 
stack of micro-CT slices may be considered a structure consisting of the many cuboids (all the voxels) 
of the 3D image and the  of this structure being a combination of the  of all the individual cuboid 
shaped voxels. To get the  of the cancellous structure within this 3D image stack, the contribution 
from all the voxels from marrow spaces are simply discounted (Odgaard and Gundersen, 1993). For 
this reason the 3D image is made binary and each voxel is in effect assigned to either the bone 
region or the marrow region. As the  for the image stack is ‘summed up’, the contribution from the 
‘marrow voxels’ is simply given a value of zero and in effect the resulting  is the Euler characteristic 
of the cancellous structure. 
In 3D, the Euler Characteristic for trabecular bone can also be shown to be a combination of 0, 1, 
and2 (Odgaard and Gundersen, 1993):  
                                                                 Equation 4.1 
where  0 is the number of unconnected parts of the structure (in trabecular bone, it is assumed that 
all the bones are connected within one region, so           is the number of redundant 
trabeculae, or connectivity as defined by Odgaard and Gundersen (1993), and    is the number of 
fully enclosed marrow pores that do not connect with the main marrow space (in trabecular bone it 
is assumed that there are no completely enclosed marrow cavities, so      ). Hence with these 
simplifications Equation 4.1 can be written with particular reference to cancellous bone as: 
                                                                  Equation 4.2  
Connectivity defined as number of redundant trabeculae, or 1, can then be calculated as: 
                                                                  Equation 4.3 
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Where  is the Euler characteristic of the cancellous structure calculated based on the micro-CT 
voxels as described above. 
The connectivity density is calculated by dividing the estimated connectivity by the total volume of 
the sample (Equation 4.4).  




   
 
                                          Equation 4.4 
In this research, the imaging analysis software BoneJ (Doube, Klosowski et al. 2010) is used to 
calculate connectivity density. BoneJ uses the following procedures: 
1. The image stacks are purified resulting in just one bone region and one non-bone region (the 
marrow phase). All the noise and other isolated regions are removed. Subsequently BoneJ treats all 
the trabecular structures as one connected region when calculating the connectivity and 
connectivity density.  
2. The Euler Characteristic is calculated for each voxel and recorded as δχ. The calculation is done for 
all the images slices.  
3. All the δχ are summed to give the Euler Characteristic value for the whole bone (χ=∑ δχ). The 
bone sample is assumed as though it is floating in the space and has no connections with the 
surroundings (it is not cut from a larger piece of bone). 
4. In this study, as in other similar studies, the sample under investigation (the cylinder sample) is 
taken from a bigger sample (the femoral head). In other words the trabecular structures of the 
cylinder sample were originally connected to other parts of the femoral head and by removing the 
sample from the femoral head, the sample’s connectivity has been artificially changed. This is a so-
called edge-effect and is a common feature in connectivity studies (Odgaard and Gundersen, 1993). 
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Without going into the details of the mathematical approach to address this issue, conceptually, the 
approach is to estimate bounds of the solution between the faces of the cylinder sample being fully 
connected, and not-connected, to the surrounding bone and leading to a modified Euler 
characteristic . In this Thesis, this operation is carried out using BoneJ.  
5. Finally, the connectivity is calculated using the below equation.  
                                                              Equation 4.5 
6. Connectivity density is calculated as the below equation.  
                     
  
           
                              Equation 4.6 
 Anisotropy 4.2.4.2
As early as 1892, Wolff (Wolff 1892) suggested that trabecular bone grows in response to external 
load. Trabecular bone varies its orientation depending on the mechanical loading it is subjected to 
and this results in bone being an anisotropic structure. The trabecular microarchitecture is 
anisotropic in respect to both elastic modulus (Keaveny 2001) and strength (Mosekilde, Mosekilde et 
al. 1987). The structural anisotropy measures how highly trabecular substructures (trabecular 
branches) are oriented within the sample. If the value is 0, the sample is totally isotropic; if the result 
is 1, the sample is totally anisotropic.  
 Fractal dimension 4.2.4.3
Boxes with a certain size were scanned through the images stack (Figure 4.8) and the number of 
boxes that contained foreground (trabecular bone) was counted. When the box size equals the size 
of the image slice, i.e. only one box, this must contain some outlines of the trabecular bone. This box 
size was recorded, and the count was 1. When the box size was reduced to half of the image size, 
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there were 4 boxes existing. These are counted and recorded as 4 as all of these four boxes were big 
enough to contain some parts of the trabecular outline. As the box size was further reduced, at 
some point some boxes did not contain any part of the trabecular outline, such as the first box on 
the fifth row in Figure 4.8. The log(size of box) is plotted against the log(counting of number of boxes 
containing trabecular outlines), an example of which is shown in Figure 4.9. It was found that the 
slope of this graph has an approximately constant value for the same sample (Parkinson and 
Fazzalari 2000).  
 
Figure 4.8 Example of a slice of trabecular bone (Parkinson and Fazzalari 2000) 
 




Figure 4.9 Scatter plot of log (box size) vs log (number of boxes) for one sample. Number of boxes is 
counted for the box that contains the outline of trabecular bone sample. (Parkinson and Fazzalari 
2000) 
This study used BoneJ (Doube, Klosowski et al. 2010) to calculate the fractal dimension parameter. In 
the programme, the log (box count that contains trabecular outlines) is negatively plotted against 
log (box size) as seen on Figure 4.10. The gradient of the curve is positive and recorded as the fractal 
dimension of each sample. When the size of box is decreasing, the proportion of boxes that contains 
trabecular bone outline increases.  
 
Figure 4.10 Fractal dimension plot. 
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 Trabecular thickness and space 4.2.4.4
Trabecular thickness and trabecular space are two key parameters of the 3D structure of trabecular 
bone.  
In 2D, trabecular thickness at a point is defined as the diameter of the largest enclosing circle. 
Example points of A, B and C are shown in Figure 4.11. The largest enclosing circles of these three 
points are shown respectively.  
 
Figure 4.11 Illustrating of local trabecular thickness measurement in 2D (Cowin 2009) 
The trabecular thickness of a single trabecula is the average of different diameters of the enclosing 
circles on the single trabecular branch. Figure 4.12 shows a series of enclosing circles on a single 
trabecular branch. The circlers are fitted along the trabecular branch and an average diameter of 
these circles is calculated and recorded as the trabecular thickness of this branch. The thickness of 
each single trabecula within the structure is further averaged for the trabecular thickness of the 
bone.  
 




Figure 4.12 The largest circles are fitted at three different points  (Darabi, Chandelier et al. 2007) 
When it comes to 3D trabecular structure, trabecular thickness is defined as the diameter of the 
maximal sphere that can fully within the structure. Figure 4.13 shows an example of 3D trabecular 
structure that has been fitted with different spheres. The regions with bright yellow colour are 
thicker than those regions with blue or red colours.  
 
Figure 4.13 Trabecular thickness measured in 3D. Yellow regions are thicker than blue and red regions 
(Doube, Klosowski et al. 2010). 
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Trabecular space is the average separation of the trabecular branches. It is defined very similar with 
trabecular thickness in 3D. Figure 4.14 shows an example of trabecular branches and its filling 
“trabecular space”. The largest spheres are fitted throughout the structure for calculating average 
trabecular space.  
 
Figure 4.14 3D illustration of trabecular space (microCT world, year unknown) 
In this study, BoneJ was used to calculate trabecular thickness and trabecular marrow space in 3D. A 
group of 2D images (Figure 4.15) is used here to illustrate the principles of the process. First the 
micro-CT slices of the cylindrical samples were processed into binary format (Figure 4.15 Left). Then 
the process of fitting the biggest spheres within the trabecular branches and marrow spaces was 
carried out (Figure 4.15, middle and right).  




Figure 4.15 Trabecular thickness and trabecular space. Left: CT scans binary image; Middle: trabecular 
part plot; Right: trabecular marrow space plot. Colours in the plots show the sizes of the fitted spheres 
which in turn indicates the thickness of the trabecular struts (middle) and the marrow spaces (right). 
 Structure model index 4.2.4.5
On the micro-scale, trabecular structure can be simplified as a mixture of many plates and rods (van 
Lenthe, Stauber et al. 2006, Liu, Wang et al. 2013). Gibson (Gibson and Ashby 1997) studied 
trabecular structure as cell structure. Two graphs (Figure 4.16) were made to represent cell 
structures which were fully made up of rod-like structures and plate-like structures, respectively. The 
real trabecular bone is a mixture and combination of these two structures.  
                       
Figure 4.16 Trabecular bone made up of rod-like and plate-like structures. Two models, fully made of 
rods and plates respectively, are used to demonstrate trabecular bone structures. The real trabecular 
bone structure is a combination of these two idealisations (Gibson and Ashby 1997). 
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When it comes to the actual trabecular bone, Figure 4.17 shows the trabecular structure is coloured 
in different colours to distinguish rod-like and plate-like substructures. Plate-like substructures are 
marked in red and rod-like structures are marked in green (Left figure of Figure 4.17). Every plate-
like and rod-like substructure can be distinguished for further calculation and marked in different 
colours (Right figure of Figure 4.17).  
 
Figure 4.17 Femoral neck volumetric decomposition. Left: femur neck trabecular bone structure 
labelled with trabecular type, plate voxels were shown in red and rod voxels were shown in green; 
Right: completely decomposed trabecular bone structure was labelled with a different colour for each 
voxel (Liu, Sajda et al. 2008).  
Structure model index is a parameter to describe weather the trabecular structure is more plate-like 
or more rod-like. In BoneJ, different structure model index values are assigned to different units. A 
plate is recorded as 0, a rod is recorded 3, the structure model index of the trabecular bone should 
be between 0 and 3, and closer to 3 (Table 4.1).  
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4.3 Results  
4.3.1 Connectivity density 
The section reports the measurements of connectivity and connectivity density. As introduced 
previously, connectivity is calculated as the total number of abundant trabeculae in the sample. 
Connectivity density is calculated by dividing the connectivity by the volume of the cylinder sample.  
A one-way ANOVA was conducted to determine if connectivity density was different for different 
groups. There were no outliers, as assessed by boxplot; data was normally distributed for each group, 
as assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as assessed by 
Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± standard deviation. 
The connectivity density was statistically significantly different among different groups, F(3, 63) = 
7.644,p< 0.0005, ω
 
= 0.23. The connectivity density was 4.8 ± 1.5     for the ALN group, 5.4± 1.5 
     for the FC group, 6.6 ± 2.1     for the OA group and 7.7 ± 1.2     for the ELD group 
shown as a bar chart in Figure 4.18. Tukey’s post hoc analysis was also conducted and the results are 
also shown in Figure 4.18.  




Figure 4.18 Trabecular connectivity density. Tukey’s post hoc analysis was done to find if the result of 
every two groups were significantly different. The same letter marked on two groups indicates that the 
result was significantly different between them with a p value of less than 0.05. The same letter with the 
symbol of one star marked on two groups indicates that the result was significantly different between 
them with a p value of less than 0.001.  
4.3.2 Anisotropy 
A one-way ANOVA was conducted to determine if the degree of anisotropy was different for the 
different groups. There were no outliers, as assessed by boxplot; data was normally distributed for 
each group, as assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as 
assessed by Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± 
standard deviation. There were no significant differences found among different groups, F(3, 63) = 
2.152 ,p=0.103. 
The anisotropy results were 0.59 ± 0.11 for the ALN group, 0.62 ± 0.08 for the FC group, 0.54 ± 0.11 
for the OA group and 0.58 ± 0.05 for the ELD group, which is shown in Figure 4.19. 
 




Figure 4.19 Anisotropy of each group. There were no significant differences found between any two 
groups.  
4.3.3 Fractal dimension  
A one-way ANOVA was conducted to determine if fractal dimension was different for different 
groups. There was one outlier, as assessed by boxplot; data was normally distributed for each group, 
as assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as assessed by 
Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± standard deviation. 
The fractal dimension was statistically significantly different among different groups, F(3, 62) 
=10.100,p< 0.0005,  = 0.29. The fractal dimensions were 2.61 ± 0.08 for the ALN group, 2.64 ± 0.05 
for the FC group, 2.70 ±0.04 for the OA group and 2.66 ± 0.06 for the ELD group, in that order. 
Tukey’s post hoc analysis was also conducted and the results are shown in Figure 4.20.  
 




Figure 4.20 Fractal dimension results. Tukey’s post hoc analysis was done to find if the result of every two 
groups were significantly different. The same letter marked on two groups indicates that the result was 
significantly different between them with a p value less than 0.05. The same letter with the symbol of one 
star marked on two groups indicates that the result was significantly different between them with a p 
value less than 0.001. 
4.3.4 Trabecular thickness and space 
A one-way ANOVA was conducted to determine if trabecular thickness was different for different 
groups. There were three outliers, as assessed by boxplot; data was normally distributed for each 
group, as assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as 
assessed by Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± 
standard deviation. The trabecular thickness was significantly different among different groups, F(3, 
63) = 15.503,p< 0.0005,  = 0.39. The trabecular thickness was 210.6 ± 24. µm for the ALN group, 
208.5 ± 20.8 µm for the FC group, 261.6 ± 37.4 µm for the OA group and 226.6 ± 35.8 µm for the ELD 
group. Tukey’s post hoc analysis was also conducted and the results are shown in Figure 4.21.  
 




Figure 4.21 Mean trabecular thickness. Tukey’s post hoc analysis was done to find if the result of every 
two groups were significantly different. The same letter marked on two groups indicates that the result 
was significantly different between them with a p value of less than 0.05. The same letter with the symbol 
of one star marked on two groups indicates that the result was significantly different between them with 
a p value of less than 0.001.  
A one-way ANOVA was conducted to determine if trabecular space was different for different groups. 
There were two outliers, as assessed by boxplot; data was normally distributed for each group, as 
assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as assessed by 
Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± standard deviation. 
The trabecular space was significantly different among different groups, F(3, 62) = 8.673,p< 0.0005, 
  = 0.26. The trabecular space was 1185.8 ± 91.8 µm for the ALN group, 1135.1 ± 69.7 µm for the 
FC group, 1103.0 ± 57.9 µm for the OA group and 1050.8 ± 33.8 µm for the ELD group, in that order. 
Tukey’s post hoc analysis was also conducted and the results were shown in Figure 4.22.  
 




Figure 4.22 Trabecular space. Tukey’s post hoc analysis was done to find if the result of every two groups 
were significantly different. The same letter marked on two groups indicates that the result was 
significantly different between them with a p value of less than 0.05. The same letter with the symbol of 
one star marked on two groups indicates that the result was significantly different between them with a p 
value less than 0.001.  
4.3.5 Structure model index 
A one-way ANOVA was conducted to determine if structure model index was different for different 
groups. There were two outliers, as assessed by boxplot; data was normally distributed for each 
group, as assessed by Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as 
assessed by Levene's test of homogeneity of variances (p>0.05). Data is presented as mean ± 
standard deviation. The structure model index was significantly different among different groups, 
F(3, 59) = 13.566,p< 0.0005,  = 0.37. The structure model index was 2.51 ± 0.54 for the ALN 
group,2.43± 0.46 for the FC group, 1.45 ± 0.71 for the OA group and 1.88 ± 0.44 for the ELD group, in 
that order. Tukey’s post hoc analysis was also conducted and the results were shown in Figure 4.23. 




Figure 4.23 Structure model index. Tukey’s post hoc analysis was done to find if the result of every two 
groups were significantly different. The same letter marked on two groups indicates that the result was 
significantly different between them with p value less than 0.05. The same letter with the symbol of one 
star marked on two groups indicates that the result was significantly different between them with a p 
value less than 0.001.  
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4.4 Discussions  
4.4.1 Connectivity density 
The most important finding of the connectivity study is that lower connectivity was found in the ALN 
group compared with FC control group, and the parameter of connectivity density has a larger 
influence on bone strength for the ALN group compared with other groups.  
The connectivity density was 4.8     for the ALN group, which was 11% lower than that of the FC 
group. There was no significant difference between the ALN and FC groups. The highest connectivity 
density of 7.7     was found in the ELD group, which was significantly higher than the ALN and FC 
groups. Lower connectivity was a common feature for the fractured groups.  
The average connectivity densities from this study ranged from 4.8 to 7.7     for different groups. 
The literature results are summarised and listed in Table 4.2 and Table 4.3. It is noticed that 
connectivity density was reported to range from 2.04 to 20    . The connectivity density results 
from this study match well with the literatures. However, it was also noticed that the connectivity 
density varied a lot among different samples in this study. Kabel, Odgaard et. al. (Kabel, Odgaard et 
al. 1999) tested two groups of samples and reported the average connectivity densities as 6.59 mm-3 
and 3.36 mm-3, respectively. The first group of samples were collected from a 79 year-old male 
cadaver. The second group of samples were collected from 55 different cadavers (38 male and 17 
female, age range from 14 to 91 years old) and reported that the connectivity density of the first 
group was almost two times that of the second group.  
There were no studies that reported the connectivity density for BP-treated bone in humans. A few 
studies have investigated the connectivity in animals treated with BP. In a canine study Ding (Ding, 
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Day et al. 2003) used a high-dose (0.5 mg/kg daily) of BP for one year and the specimens were taken 
from the first lumbar vertebrae of each dog. The same levels of connectivity density were found 
between BP-treated samples and non-treated control samples. It showed that even high doses of BP 
didn’t improve the connectivity density in dogs. Shahnazari (Shahnazari, Yao et al. 2010) tested 
trabecular bone samples from rats. Samples were randomly divided into different groups: a group 
without any treatment, a group that had been ovariectomised and treated with saline, and another 
ovariectomised group treated with different doses of BP (30 or 90 mg/kg). It was found that BP could 
only improve the connectivity density for ovariectomised rats, but the connectivity density of BP-
treated ovariectomised rat was still lower than that of without ovariectomys surgery.  
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Table 4.2 Literature summary: trabecular microstructure measurements. 
Study Sample and site 
Conn.D 
(    ) 
Anisotropy Tb.Th (mm) Tb.Sp (mm) BV/TV SMI 
(Topolinski, Cichanski et al. 2011) Human, femoral head, healthy 2.56 1.73 0.17 0.72 0.25 0.83 
(Liu, Sajda et al. 2008) Human, femoral neck, healthy 7.23 - 0.18 0.63 0.23 0.48 
(Cohen, Dempster et al. 2011) Human, spine or hip, healthy 20 - 0.16 0.62 0.21 -0.1 
(Cohen, Dempster et al. 2011) Human, spine or hip, idiopathic osteoporosis 10 - 0.16 0.65 0.18 0.15 
(Tassani, Particelli et al. 2011) Human, femoral head, healthy - - 0.26 0.74 0.29 0.29 
(Tassani, Particelli et al. 2011) Human, femoral head, osteoarthritis  - - 0.26 0.86 0.24 0.65 
(Zhang, Li et al. 2010) Human, femoral head, osteoarthritis 3.83 1.84 0.26 0.58 0.35 0.6 
(Zhang, Li et al. 2010) Human, femoral head, osteoporosis  3.90 1.86 0.17 0.66 0.20 1.33 
(Milovanovic, Djonic et al. 2011) Human, femoral neck, healthy 11.2 2.00 0.23 0.83 0.11 2.44 
(Milovanovic, Djonic et al. 2011) Human, femoral neck, hip fracture 6.3 2.13 0.21 0.87 0.06 2.61 
(Stauber, Rapillard et al. 2006) Human, spine, healthy - 1.47 0.14 0.95 0.12 0.99 
(Follet, Viguet-Carrin et al. 2011) Human, vertebra, healthy 2.04 1.68 0.13 1.17 0.08 1.79 
(Kabel, Odgaard et al. 1999) 
Human, 79 years old male, six different 
locations * 
6.59    0.17  
(Kabel, Odgaard et al. 1999) Human, 55 different individuals (age range 3.36    0.16  
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from 14 to 91 years) , six different locations * 
(Muller and Ruegsegger 1997) Human, femur cancellous bones, healthy  1.3 0.12 0.36 0.26  
(Muller and Ruegsegger 1997) Human, lumbar cancellous bones, healthy  1.21 0.06 0.65 0.08  
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Table 4.3 Literature summary: determinant coefficient of each parameter on apparent strength. 
 
Study Sample and site 
Conn.D 







(Topolinski, Cichanski et al. 2011) Human, femoral head 0.15 0.04 - 0.47 0.45 0.68 0.55 
(Tassani, Particelli et al. 2011) Human, femoral head, healthy - - - 0.72 0.53 - 0.89 
(Tassani, Particelli et al. 2011) Human, femoral head, osteoarthritis  - - - 0.77 0.34 - 0.86 
(Melton, Riggs et al. 2011) Human, wrist, healthy  0.74 - - 0.52 0.51 0.49 0.72 
(Stauber, Rapillard et al. 2006) Human, spine, healthy - - - 0.09 0.62 0.89 0.74 
(Follet, Viguet-Carrin et al. 2011) Human, vertebra, healthy 0.51 0.37 - 0.13 0.60 0.74 0.64 
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The microstructure measurement data of this chapter was combined with the mechanical strength 
data from the previous chapter. The influence of each microstructure parameter on mechanical 
strength was studied through isolating each single parameter. Accounting for all the samples, 
mechanical strength correlated with trabecular connectivity density with a factor of 0.26 (Figure 
4.24). However, when it came to each group, it was found that connectivity density had a much 
higher influence on the ALN group (           Figure 4.25) than on other groups (        , 
which means the ALN samples’ apparent strength is very sensitive to connectivity density. 
Connectivity density was not so strongly (        correlated with apparent strength for the other 
three groups. Considering the fact that ALN samples have a 12% weaker connectivity density, it can 
be concluded that the microstructure of the ALN group was not well connected and this caused a 
lower mechanical strength. Even though the bone volume fraction of ALN samples did not show a 
significant difference compared with the FC group samples, the trabecular bones of ALN samples 
were not well connected. In this chapter, connectivity is a parameter describing the degree to which 
a trabecular bone structure is multiply connected. It makes no difference between thick and thin 
bones, and also no difference between rod –like and plate-like structures. All the single trabeculae 
can be imagined as a line and connected through a junction point (Odgaard and Gundersen 1993). It 
can be understood that connectivity is a parameter about how well single trabeculae are connected 
to each other, but not how strongly they are connected together.  
 




Figure 4.24 Apparent strength correlated with connectivity density for all groups. 
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It might be argued that the strong correlation between bone apparent strength and connectivity is 
due to the bone volume fraction, as lower connectivity density bone is usually linked with lower 
bone volume fraction. A sample with a lower bone volume fraction means it has less bone available 
to be connected through a single trabecula, so it is suggested that it should have a lower 
connectivity density. If so, the strong correlation between strength and connectivity may just be the 
strong correlation between strength and bone volume fraction that has been reported in the 
previous chapter. To test this, the connectivity density is plotted against bone volume fraction in 
Figure 4.26. It can be found that bone connectivity density is correlated with bone volume fraction 
with a factor of 0.23 for the ALN group. Kabel (Kabel, Odgaard et al. 1999) also reported that no 
strong correlation was found between connectivity density and bone volume fraction using human 
samples from six different locations. In an earlier paper, Odgaard (Odgaard and Gundersen 1993) 
reported the correlation between connectivity density and bone volume fraction as shown in Figure 
4.27. It was reported that no strong correlation was found between bone volume fraction and 
trabecular connectivity density. Based on the results from this study and the literature findings, it 
can be concluded that trabecular connectivity density has a larger influence on bone strength for the 
ALN group than other groups. The influence is not due to the lower bone volume fraction for BP 
bones, but due to the poorly connected trabecular structures. 
 




Figure 4.26  Connectivity density correlated with bone volume fraction. 
 
 
Figure 4.27 Connectivity density correlated with volume fraction. Whilst there was a clear relationship 
the correlation was low (Odgaard and Gundersen 1993) 
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The anisotropy results were 0.59 for the ALN group, 0.62 for the FC group, 0.54 for the OA group and 
0.58 for the ELD group. Statistical analysis revealed no significant differences in anisotropy results 
across groups. Some previous studies in Table 4.2 used an alternative way to calculate the degree of 
anisotropy, which is why the results are greater than 1. The results found in this study were 
transferred to the same calculation method as the literature. It was found that the degree of 
anisotropy was 1.69 for the ALN group, 1.61 for the FC group, 1.85 for the OA group and 1.74 for the 
ELD group, which matches with the literature findings. The anisotropy results were further 
correlated with bone strength from the previous chapter. No obvious correlations have been noticed 
for either all the samples as a group or each individual group. This result matched well with 
Topolinski’s result of 0.04 (Topolinski, Cichanski et al. 2011), also investigating human femoral head 
samples. Follet (Follet, Viguet-Carrin et al. 2011) found a slightly stronger correlation between the 
degree of anisotropy and bone strength compared with the results reported from this Thesis. Follet 
(2011) researched on vertebral samples instead of femoral head samples. Vertebral trabecular 
bones are required to support the load from one direction, along the spine, much more than other 
directions, which may be the reason that bone strength has stronger correlation with the degree of 
anisotropy in vertebral trabecular bones.  
In summary, there were no significant differences found between the BP-treated group and non-
treated control groups. It means both BP treatment has no influence on the orientation of each 
single trabecula.  
 The Effect of BP on Trabecular Microstructure 
133 
 
4.4.3 Fractal dimension 
The fractal dimensions were 2.61 for the ALN group, 2.64 for the FC group, 2.70 for the OA group 
and 2.66 for the ELD group (less than 5% difference between groups). Follet (2005) tested calcaneus 
trabecular samples from 17 cadavers and reported the fractal dimension ranged from 2.2 to 3.0 
(Follet, Bruyere-Garnier et al. 2005), which is consistent with the findings from this study. Higher 
fractal dimension means the trabecular bone is more homogeneous (Milovanovic, Djuric et al. 2012). 
Figure 4.28 shows the fractal dimension results for samples from different age groups. It was found 
that younger bones had a higher fractal dimension than bone from older individuals. The average 
age of the patients of this Thesis was 77 years old, a relatively older group, with respect to Figure 
4.28.  
 
Figure 4.28 Fractal dimensions for different age distributions measured from human femoral neck 
trabeculae (Milovanovic, Djuric et al. 2012).  
The small difference (1%) between the BP-treated group and the non-treated fracture control group 
was not significant. Thus, the ALN group did not have an inferior microstructure in term of fractal 
dimension. However, it was found that the fractal dimensions of bone from fracture patients were 
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marginally but significantly lower than those from non-fracture groups. The mechanical strength for 
the fractured group (ALN and FC groups) was also significantly lower than non-fractured (ELD and OA) 
groups. Some studies have reported that the fractal dimension is a key parameter to evaluate bone 
quality and diagnose OP (Benhamou, Harba et al. 1994, Lespessailles, Lespessailles et al. 2002). 
Follet also reported a strong correlation between maximum compressive stress and fractal 
dimension, which is shown in Figure 4.29.  
 
Figure 4.29 Strong correlation found between maximum compressive stress and fractal dimension 
(Follet, Bruyere-Garnier et al. 2005).  
As in previous studies, fractal dimension results were further correlated with bone strength results. 
The correlation study shows fractal dimension has a strong influence on the apparent strength, 
especially for the ALN group. The overall correlation factor between apparent strength and fractal 
dimension is 0.51 based on all the samples (Figure 4.30). For the ALN group, it was 0.55 (Figure 4.31), 
decreasing to 0.21 for the FC group (Figure 4.32). The correlation factors for the OA control and ELD 
control groups were 0.34 and 0.32 respectively.  




Figure 4.30 Apparent strength correlated with fractal dimension for all groups. 
 
 




























































R² = 0.51 




Figure 4.32 Apparent strength correlated with fractal dimension for the FC group. 
All of these three figures (Figure 4.30 to Figure 4.32) show bone strength increases with trabecular 
fractal dimension. This can be analysed and understood from the definition of fractal dimension. 
Figure 4.33 shows two curves represented Sample A and Sample B respectively. Sample A has a 
larger fractal dimension (gradient of the curve) than Sample B. When these two samples are scanned 
by the same size of box, the trabecular structure of Sample A is always more homogeneously 
distributed and there are more boxes contain the outlines of the trabeculae compared with Sample 
B. In terms of the trabecular microstructure, larger fractal dimension can partly suggest less 
structure artefact (big holes) within the sample or more narrowly spaced trabecular structure, so it 
can withstand larger load, especially the compressive load.  


































Figure 4.33 Illustration of two samples with different fractal dimension (slope of the graph). The 
sample represented by the dashed line (Sample A) has larger fractal dimension than the sample 
represented by the solid line (Sample B). When the same size of box scan through two samples, 
different number of box containing trabecular outlines are counted. The black dot and red dot are 
counted when the box size is 1000. More boxes containing the trabecular outlines are shown in 
Sample A compared with Sample B, which means the trabecular structure is more uniformly and 
homogeneously distributed in Sample A. 
Fractal dimension also has a strong correlation with bone volume fraction (Figure 4.34) and the 
number of trabeculae (Figure 4.35) (Fazzalari and Parkinson 1996). The number of trabeculae is a 
parameter that is closely related to trabecular connectivity. It supports the previous findings that 
both bone volume fraction and connectivity density are strong determinants of bone strength. 
However, the inter-relationships between bone volume fraction, connectivity density and fractal 
dimension need to be further studied. 




Figure 4.34 Bone volume fraction plotted against fractal dimension. These two parameters are 
strongly correlated with a factor of 0.85. (Fazzalari and Parkinson 1996) 
 
Figure 4.35 Number of trabeculae plotted against fractal dimension. These two parameters are 
strongly correlated with a factor of 0.76. (Fazzalari and Parkinson 1996) 
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4.4.4  Trabecular thickness and trabecular space 
There was no significant difference found between the BP-treated and non-treated fractured groups 
in respect to trabecular thickness and trabecular space. However, the fractured (ALN and FC) groups 
showed significantly worse and weaker trabecular microstructure compared with non-fractured (OA 
and ELD) groups. The trabecular thickness was 211 µm for the ALN group, 209 µm for the FC group, 
262 µm for the OA group and 227 µm for the ELD group. The trabecular space was 1186 µm for the 
ALN group, 1135 µm for the FC group, 1103 µm for the OA group and 1051 µm for the ELD group. 
Several studies have measured trabecular thickness and space using human femoral head or femoral 
neck samples from both OP patients and healthy people. For OP disease patients, trabecular 
thickness was reported as 170 to 210 µm, and trabecular space was reported as 660 to 870 µm For 
healthy people, trabecular thickness was reported as 170 to 260 µm, and trabecular space was 
reported as 720 to 830 µm. (Zhang, Li et al. 2010, Cohen, Dempster et al. 2011, Milovanovic, Djonic 
et al. 2011, Tassani, Particelli et al. 2011, Topolinski, Cichanski et al. 2011). The trabecular thickness 
results measured from this study support the literature findings. However, the trabecular space 
result is slightly higher than the literature findings.  
The ALN group has slightly thicker (1%) trabeculae compared with the FC group. The data from bone 
volume fraction also shows that the ALN group had a higher (1%) bone volume fraction than the FC 
group. Trabecular thickness measures the trabecular geometry size in 3D, especially the diameter of 
the cross-section of the single trabeculae branch, and the bone volume fraction measure the total 
volume of bone taking up the whole structure. The results for these two parameters are highly 
consistent with each other.  
There are no other studies that have physically measured trabecular thickness and trabecular space 
in BP-treated human bones but there are animal studies. Such studies on rats and dogs are 
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summarized as follows. Several studies using ovariectomised rats treated with BP studied the 
microstructural change and both positive and negative effects of BP were reported. One of the early 
studies was done by Bourrin et al. (Bourrin, Ammann et al. 2002), who found that BP-treated rats 
had thinner trabeculae than both non-treated ovariectomised rats (32% thinner) and non-
ovariectomised controls (27% thinner). In Muller’s study (Müller and Recker 2007), a thinner 
trabecular thickness was also found in rats after BP treatment (Figure 4.36). In terms of the dose of 
treatment, it was found higher doses rats had thinner trabeculae than rats receiving lower doses 
(Figure 4.37). In Camargos’s (Camargos, Bhattacharya et al. 2015) very recent study, it was also 
found that BP-treated bones had thinner trabeculae than those of both non-treated ovariectomised 
and non-ovariectomised controls. In terms of trabecular space, BP-treated bones were associated 
with larger trabecular spaces than both the non-treated ovariectomised rat bones and non-
ovariectomised rat bones.  
 
Figure 4.36 Trabecular thickness comparison between BP treated and non-treated controls after 22 
months and 33 months of 2.5mg daily treatments, respectively (Müller and Recker 2007).  





Figure 4.37 Trabecular thickness comparison between different doses of treatment (Müller and 
Recker 2007).  
However, there were several studies reporting a slight increase of trabecular thickness after BP 
treatment. While trabeculae become thinner after rats were ovariectomized compared with non-
operated rats, BP increased the trabecular thickness and reduced the trabecular space to a level 
similar to those of sham treatment (i.e. not ovariectomised) rats (Wu, Adeeb et al. 2013). Similar 
results were also found in Brouwers’ study (Brouwers, Lambers et al. 2008). Shahnazari (Shahnazari, 
Yao et al. 2010) proved that BP can significantly increase the trabecular thickness and reduce 
trabecular space for ovariectomised rats. It was found that the trabecular thickness for BP-treated 
ovariectomised rats was 33% thicker than that of non-treated ovariectomised rats, and 20% thicker 
than that of non-ovariectomised rats. The effect on the improvement of trabecular thickness was 
also found to be more obvious with the increase of the dose of BP treatment.  
As well as rat models, canine models are frequently used to model BP’s effect on bones. Ding (Ding, 
Day et al. 2003) reported that high dose BP treatment on canines slightly increased (6%) trabecular 
thickness. Allen (Allen, Iwata et al. 2006) also reported canine vertebral bones showing thicker 
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cortical thickness after BP treatment, but no obvious difference was found when investigating 
different doses of the treatment. 
Trabecular thickness is a key parameter that affects apparent strength. The apparent strength-
trabecular thickness plot for all the samples can be seen from Figure 4.38. The determinant 
coefficient of 0.39 was found between apparent strength and trabecular thickness. Other studies 
have reported different levels of influence of trabecular thickness on bone strength, which are 
summarized and listed in Table 4.3.  
The data from this study shows apparent strength is more sensitive to trabecular thickness for 
fractured samples (ALN group in Figure 4.39 and FC group in Figure 4.40) than non-fractured samples 
(OA and ELD groups); the correlation factors are almost twice as high (0.23 and 0.28 versus 0.15 and 
0.12). 
 


































R² = 0.39 




Figure 4.39 Apparent strength correlated with average trabecular thickness for ALN group. 
 
Figure 4.40 Apparent strength correlated with average trabecular thickness for FC group. 
Trabecular thickness and trabecular space are two parameters that are closely related. The samples 
with thinner trabecular space tend to have more and thicker trabecular spaces, so the correlations of 
strength and trabecular space are expected to be very similar with those of trabecular thickness. 
Bone strength is positively correlated with trabecular thickness, but inversely correlated with 
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trabecular space. The data for all the samples are plotted in Figure 4.41. Apparent strength had a 
higher correlation with trabecular space for the ALN group (        Figure 4.42), and the FC group 
(       , Figure 4.43). The correlation factor for the OA group was 0.27, but very little correlation 
was found for the ELD group.  
 
Figure 4.41 Apparent strength correlated with average trabecular space for all groups. 
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Figure 4.43 Apparent strength correlated with average trabecular space for FC group. 
The correlation studies for trabecular thickness and trabecular space both suggest that thinner 
trabecular thickness and a more porous trabecular structure are common features among trauma 
patients. As a key parameter affecting bone strength, these two parameters should be paid 
attention to when developing diagnostic tools for predicting fracture risk. 
4.4.5 Structure model index 
The structure model index was 2.51 for the ALN group, 2.43 for the FC group, 1.45 for the OA group 
and 1.88 for the ELD group. The structure model index varies greatly between different patients, as 
reported in the literature (Table 4.2). Milovanovic (Milovanovic, Djonic et al. 2011) measured the 
structure model index for hip fracture patients and found an average value of 2.61. The findings 
based on the ALN group and the FC group, which were both from hip fractures bones, support the 
literature findings. For healthy femoral bones, the structure model index is reported as from 0.48 to 
2.44. Some studies have reported very low values, such as -0.1 and 0.15 from Cohen’s (Cohen, 
Dempster et al. 2011) study. Little information can be found in Cohen’s study about the 
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measurement criteria and method to explain the difference to the results of this Thesis. Figure 4.44 
simplifies the trabecular structures and illustrates the meaning of the structural model index (SMI) 
using basic models. SMI cannot be a negative value. Based on the observation of the fractured bones 
in this study, they are closer to a rod-like structure rather than a plate-like structure, so the SMI is 
expected to be between 1.5 and 3. For non-fractured bones (OA and ELD groups), the trabecular 
structures are approximately an average mixture of plates and rods elements based on visual 
observation of the samples, so the structure model index is expected to be around 1.5.  
 
Figure 4.44 Illustration of plate-rod structure. (a) a structure fully made of rods. Structure model 
index=3.This model consists of four basic elements: A thin inner rod, B thick inner rod, C thick outer 
rod. D thin outer rod. (b) a structure mixes with rods and plates. Structure model index=0-3. This 
model consists of three basic elements: a outer plate, B inner plate, C interconnecting rod for the 
mixed model. (c) a structure fully made of plates. Structure model index=0. This model consists of 
three basic elements: A outer plate, B inner plate, C interconnecting plate (Stauber and Muller 2006).  
Comparing BP-treated fractured bones and non-treated fractured controls, the structure model 
index of the ALN group is 3% higher than that of the FC group, which means the BP-treated bones 
are slightly more rod-like in structure compared with the non-treated controls. However, the 
difference is very little and not significantly different. There are no previous studies that have 
measured the SMI for BP-treated human trabecular bones. Several studies tested BP-treated rat 
models. Brouwers (Brouwers, Lambers et al. 2008) treated ovariectomised rats investigating the 
effect of different intervals of BP treatment and found, consistent with the results of this Thesis, no 
significant effect, or a slight reduction in SMI, with BP treatment (the small difference being an effect 
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of the treatment interval). Camargos (Camargos, Bhattacharya et al. 2015) found a higher SMI in the 
BP-treated group compared with controls. 
The structure model index for the fractured groups (ALN and FC) was higher than the non-fractured 
groups (OA and ELD). In OP disease trabecular bone, some plate elements become thinner gradually 
and are classified as rod elements. The whole structure turns from a more plate-like structure to a 
more rod-like structure, so the structure model index value of non-OP patients should be higher 
than that of OP patients. Figure 4.45 shows the comparison of OA and OP bones to demonstrate the 
difference between more plate-like trabecular structure and more rod-like trabecular structure.  
 
Figure 4.45 3D reconstruction of OP and OA bones. Left: plate-like structure with structure model 
index value 0.1, samples achieved from OA patients; Right: rod-like structure with structure model 
index value 1.54, samples achieved from OP patients (Zhang, Li et al. 2010).  
The determinant coefficient of the structure model index for apparent strength was 0.55 for all the 
samples (Figure 4.46), which matches well with the results from Topolinski (Topolinski, Cichanski et 
al. 2011), and is similar to the results from other studies listed in Table 4.3. The structure model 
index is between 1 and 3 for most of the samples in this Thesis. It can be seen that apparent strength 
is adversely correlated with the structure model index, which means the plate-like microstructure 
has a higher mechanical strength than the rod-like microstructure.  
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The structure model index is a parameter that largely affects mechanical strength, just second to 
bone volume fraction. For the ALN group and the FC group, the correlation can be found from Figure 
4.47 and Figure 4.48. The correlation factor for the OA group was 0.44, but very little influence was 
found for the ELD group.  
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Figure 4.47 Apparent strength correlated with structure model index for ALN group. 
 
 
Figure 4.48 Apparent strength correlated with structure model index for FC group. 
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4.4.6 Limitations  
There are mainly two limitations in the methods in this chapter. Firstly, the measurement accuracy is 
highly affected by the quality of micro-CT images. All the trabecular samples were scanned at a pixel 
size of 30 µm. This level of resolution can present the outline of trabecular structure effectively and 
clearly in 2D. However, some detail information may not be fully captured. A special samples holder 
was made to scan 26 samples at one scanning. The effect of this sample holder on the image quality 
is still unknown. Secondly, the software BoneJ (Doube, Klosowski et al. 2010) used in this study for 
measuring trabecular parameters has some assumptions in its algorithm, which may bring some 
potential inaccuracy to the final results.  
In term of the samples, the cadaver samples showed a difference in microstructure and correlation 
results, so there was very little correlation between bone strength and the structure model index for 
the ELD group, compared with literature findings.  
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4.5 Conclusions  
Similar to the bone volume fraction results reported in the previous chapter, there were no large 
(less than 5%) differences found between BP-treated and non-treated controls for all the 
microstructural parameters besides connectivity density. The BP-treated group was reported to have 
a similar trabecular thickness and trabecular space compared with the non-treated control group, 
which matches with the fact that both groups had a similar bone volume fraction level.  
It was found that the connectivity density for the BP-treated group was 11% lower than that of the 
non-treated control group. Moreover, it was also found that trabecular connectivity density had a 
larger influence on bone strength for the ALN group compared with other groups.  
In conclusion, although no large differences were found in microstructural parameters such as bone 
volume fraction, trabecular thickness and structure model index, trabecular bone microstructure for 
the BP-treated group was poorly connected and further reduced the bone mechanical strength.  
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                  Chapter 5.               
The Effect of BP on Trabecular 
Microcracks and Broken 
Trabeculae 
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5.1 Introduction  
Daily activities generate cyclic loading on bones and cause an accumulation of microcracks 
(Hazenberg, Hentunen et al. 2009). Bone has a natural ability to reconstruct and repair these 
microcracks and microdamages (Colopy, Benz-Dean et al. 2004, Hazenberg, Hentunen et al. 2009). 
Investigation of microcracks’ influence on bone strength is fundamentally important to understand 
the behaviour and function of bone and is also important for clinical applications. The microcracking 
behaviour is closely related to the nonlinear mechanical behaviour of bone which in turn affects 
bone’s toughness and ability to resist fracture. The accumulation of microcracks is a crucial 
consideration in predicting fracture risk (Cowin 2009). It is now well established in animal models 
that BP inhibits bone turnover and the activity of repairing the bone from microcrack damage is 
reduced (Chaiamnuay and Saag 2006, Rizzoli, Akesson et al. 2011, Teitelbaum, Seton et al. 2011). 
However, there are very few quantitative studies proving that BP-treated bones have more 
microcracks and contain more damage than non-treated control bones.  
The previous chapter studied the trabecular microstructure at a resolution of 30 µm and 
investigated the difference between BP-treated bones and controls. However, during those studies it 
became clear that this resolution was not sufficient to identify or quantify microcracks; higher 
resolution images were needed for a study aimed at investigating differences in microcrack 
accumulation. Histological sectioning has been used in other microcrack studies. However, this 
technique destroys the sample preventing subsequent mechanical testing of the same sample. As 
the work of this Thesis aims to investigate how the strength is related to the level of microcracks, 
this was viewed as a significant disadvantage. Instead, non-destructive synchrotron radiation micro-
CT scanning with a resolution of 1.3 µm was adopted for this study. Two specimens from the same 
patient were selected across BP-treated (ALN), non-treated control (FC) and elderly control (ELD) 
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groups. One of the two specimens was pre-loaded before the scanning. The comparison among the 
non-preloaded specimens was to find the difference between the existing microcracks and other 
damage. The pre-loaded processing was expected to cause some new microcracks and damage, and 
therefore the difference in the quantity of microcracks was further compared across groups.  
It was noticed, especially in the pre-loaded specimens, that some trabeculae were fully disconnected 
and such damage was termed ‘broken trabeculae’. These broken trabeculae may have a different, 
and possibly more severe, influence on bone strength than small microcracks. Hence, in the 
quantification, broken trabeculae were distinguished from microcracks and counted separately for 
each group and compared across groups.  
There have been no previous studies linking microcracks with fracture risk. The combination of 
mechanical properties and microcracks will further help understand this link.  




5.2.1 Sample preparation  
Because of the limited availability of synchrotron beam line scanning time, the OA control group was 
excluded from the microcrack study of this Chapter. Six femoral heads, matched for age and gender, 
were chosen from each of the ALN, FC and ELD groups. Two specimens (cylinder cores) were 
selected from each femoral head to represent the patients. There were in total 6 patients and 12 
specimens representing each group. 
One of the two specimens from the same femoral head was mechanically tested prior to scanning 
while the other specimen was not tested prior to scanning. The testing consisted of uniaxially 
compressing the cylindrical core specimen by 10% of its original height, i.e. from 10 mm to 9 mm 
(O'Neal, Diab et al. 2010). There were in total 36 cylinder cores scanned, of which 18 cores were 
mechanically tested prior to scanning while the other 18 were not tested prior to scanning.  
During the synchrotron scanning process, high energy from the beam is absorbed by the sample and 
the samples will expand because of the resulting change in temperature. Considering the small size 
of the sample and the high energy density, this expansion would affect the accuracy of image 
reconstruction. To avoid this problem, any water and marrow within the samples needs to be 
removed. All the samples were put into 70% ethanol for half an hour, then into 100% ethanol for 
another half-an-hour, into 100% xylene for a further half an hour and, finally, into 100% ethanol 
again for half-an-hour to make sure all the water was removed. The samples were kept in the fume 
cupboard for enough time for all the chemicals to evaporate until no obvious difference was shown 
in weight measurements, taken over two separated days. All these procedures followed the 
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laboratory manual at Imperial College London. Figure 5.1 shows the samples during chemical 
treatment and Figure 5.2 compares the same sample before and after the chemical treatment.  
 
Figure 5.1 Samples treated in ethanol or xylene. A bottle labelled with sample ID was prepared for 
each specimen.  
 
Figure 5.2 Cylinder specimen before (left) and after (right) the chemical treatments.  
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It was a concern that the above chemical treatment might cause new microcracks. To investigate 
this, a sample without any chemical treatment was scanned prior to the main scanning to compare 
for the effect of chemical treatment. However, as expected, the water and marrow expanded 
because of the very intense beam energy and prevented imaging reconstruction because the sample 
moved during the scanning. The potential hidden damage of the trabecular structure from the 
drying process is one of the limitations of the study and has been further discussed in the Discussion 
section of this chapter. 
5.2.2 Synchrotron radiation scanning 
The synchrotron radiation scanning was undertaken at Diamond Light Source, Oxfordshire, UK. In 
synchrotron, electrons are accelerated to near light speed. As the path of the electrons are bent 
(using magnets) to follow the circular path around the synchrotron, the energy level of the electrons 
are changed; the difference in energy given off as light is 10 billion times brighter than the sun and 
includes very high energy x-rays. As high energy x-rays have a very small wavelength, use of such 
light allows investigation of very small structural features, i.e. high resolution CT scanning. The x-ray 
photons pass through the object and are received by the detector. High resolution of images is 
achieved (Diamond Light Source 2014). Figure 5.3 represents the basic principles of synchrotron 
scanning.  
 




Figure 5.3 Synchrotron scanning main principles. Electrons are accelerated and a very high-intensity X-
ray beam is generated. The electron is kept being accelerated when moving in a circling motion at the 
increased diameter until more than 100 meters. Electrons are accelerated to near light speed so that 
they can give off a light 10 billion times brighter than the sun. The bright beam then passes through a 
monochromator device for quasi-monoenergetic X-rays. X-ray has very limit divergence, so the 
photons can be assumed to impinge in a parallel way passing through the object and on the detector.  
(Cowin 2009) 
Figure 5.4 shows the locations of the beam line, specimen and detector in the whole system. The 
beam passed through the sample. An area of 3.28×2.76 mm was scanned and imaged at pixel size of 
1.3 µm. 6400 projections were taken for a 180 degree rotation. Ring energy is 3.1281J, and ring 
current is 301.5mA. Wiggler readback is 4.2 Tesla. For each scanning, the data consisted of about 
6400 projection slices as raw data. There were about 2000 image slices achieved through 3D 
reconstruction based on the raw data.  
 
Figure 5.4 Detector (camera, the red box on the below left of the figure), specimen and the beamline 
located in the whole system. 
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5.2.3 Microcracks and fully broken trabeculae counting 
There are no standard definitions for microcracks in the literature. Lee (Lee, Mohsin et al. 2003) 
summarized the key characters of microcracks based on the findings from Frost (HM 1960) and Burr 
(Burr and Stafford 1990), and this is reproduced in Table 5.1. The most obvious character used for 
distinguishing microcracks is the size, which is larger than canaliculi and smaller than vascular 
channels. Microcracks have sharp boarders (Figure 5.5 and Figure 5.6) compared with vascular 
channels.  
Table 5.1 A list of criteria in identifying microcracks summarized by Lee (Lee, Mohsin et al. 2003) based 
on the findings of Burr and Stafford (Burr and Stafford 1990) and Frost (HM 1960) 
 
 
Figure 5.5 Microcrack stained by fuchsin. The scale bar shown in the figure is 50 µm (Lee, Mohsin et al. 
2003).  




Figure 5.6 3D reconstruction demonstrating the difference in size among microcracks, canal network, 
and lacunae. (a) a 2D nano CT scan slice; (b) 3D representation of the canal network (red) and lacunae 
(yellow) (c) an example of microcrack (black arrow), lacunae (yellow arrow) and canal network (red 
arrow) (d) an example of a large microcrack, but still smaller than the canal network (Mueller 2009).  
The main criterion in determining a microcrack in the synchrotron radiation scans of this study is the 
difference in the size. Based on the orientation of the microcrack in the single trabecula, two types 
of microcracks were observed. Type 1 microcracks orientate along with the single trabeculae or with 
a small angle, examples of which are shown in (a) and (b) of Figure 5.7. There are some other 
microcracks orientated across or transverse to the single trabecula, examples of which are shown in 
(c) and (d) of Figure 5.7. This type of microcrack is highlighted, as it may develop to cause the single 
trabecular branch to break into two parts and may therefore be more serious in terms of the 
strength of the bone. Similar observations were also reported by Thurner et al.’s study (Thurner, 
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Wyss et al. 2006) and are shown in Figure 5.8. Both of these two types were counted as microcracks 
in this study and reported in the results section.  
 
Figure 5.7 Two main types of microcracks classified based on the orientation of the microcracks with 
the single trabeculae. (a) and (b): microcracks along the single trabecula or with a small angle. (c) and 
(d): microcracks across the single trabecula.  
 




Figure 5.8 Two types of microcracks appearing after the loading (Thurner, Wyss et al. 2006). Small 
angle microcracks indicated by white arrows and transverse microcracks indicated by black arrows. 
Some transverse microcracks, examples of which are shown in Figure 5.9, spanned the entire 
trabecular branch and had separated the single trabecula into two parts. This kind of damage was 
distinguished from microcracks for two reasons. Firstly, it changes the connectivity density, and it 
was viewed as important to try to distinguish the effects of damage on strength from the effect of 
microstructure on strength. Secondly, it seems that a fully broken trabecula, no longer able to 
support tensile or compressive loading, may have a more serious reduction on bone strength and 
that it may be worthwhile investigating this separately. Hence, the number of fully broken single 
trabeculae was counted separately and recorded using the term “number of broken trabeculae”. 
Muller used the term “microfracture” for big microcracks in cortical bone (Muller 2009). This may be 
not a suitable term for this Thesis, as the trabecular thickness measured from previous chapters is 
more than 0.2 cm, which is not at micro level. Besides high resolution microCT scanning, histological 
studies have also indicated that bone damages occurs at the microstructural level as microcracks, 
and also at the ultrastructural level presenting as diffuse damages and fully broken trabeculae 
(Cowin 2009).  
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There are no software packages or programmes currently available that can count the number of 
microcracks automatically and it was not practically feasible to write a programme for this task 
during the PhD. The plan of manually counting microcracks and fully broken trabeculae was adopted 
for two reasons. Firstly, the sample size (36 specimens) of this study was not large. Secondly, the 
specimen was scanned over a small field, which is small enough to fit on the computer screen clearly; 
microcracks were easily distinguishable enabling relatively straightforward quantification (counting) 
of microcracks and fully broken trabeculae. There were about 2200 slices for one cylinder sample, 
which is about 60 gigabytes of data in total. Limited by available computing resources, it was not 
feasible to reconstruct a 3D model for each specimen and count the number of microcracks and fully 
broken trabeculae in 3D. Therefore, the counting of microcracks and broken trabeculae were based 
on observations from 2D synchrotron images.  
Therefore, manual counting in 2D was carried out on BP-treated bones and controls. However, there 
were still two main problems to be solved before undertaking the counting on all the samples. The 
first problem was to decide how many slices should be selected from all the 2200 slices for each 
specimen. The second problem was how to prove the results were independent of observation bias.  
The number of slices to be counted  
There were two solutions designed to address the first problem, which were numerical calculation 
and validation.  
The specimen scan field was 2.76 mm in height and there were about 2200 slices representing this 
2.76 mm of height. The distance between two slices was 1.25 µm, which means 100 slices cover a 
height of 125 µm. It is not a good solution to count too many slices. This is not only due to low 
efficiency, but also due to potential re-counting of microcracks, as a microcrack may appear in many 
adjacent slices. Larrue (Larrue, Rattner et al. 2011) also imaged human trabecular bone using 
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synchrotron radiation microCT scanner and reported the average length of microcracks was around 
200 µm. Considering there were 2200 slices in total, the whole slice set was divided into 11 sections 
(Figure 5.10), so there were 200 slices in each section covering a height of 250 µm. Based on this 
division method, the slices numbered from 1 to 200 sit on Layer 1, 201 to 400 sit on Layer 2, and 
2001 to 2200 for Layer 11. If more than one slice was selected from the same section, the same 
microcrack may appear on all these slices and further cause repeated counting.  
 
Figure 5.10 Illustration of microcracks (yellow) distributed within the scanning field of the specimen. 
The slice set was divided into 11 sections first and each section represents a height of 250 µm.  
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Based on the division in Figure 5.10, the height of each section was slightly more than the average 
length of microcracks. A random number generator was made to generate randomly a number 
between 1 and 200 for each section. Therefore, 11 different slices were chosen from 11 different 
sections for reducing repeated counting.  
Besides the numerical calculation, a validation test was undertaken. A BP-treated sample was used 
for convergence testing. As calculated above, the whole 2200 slices set was divided into 11 sections 
first and one slice was chosen from each section randomly. There were 11 slices counted for 
microcracks. After this, an increased number of slices were counted through increasing the division 
section, as it was not useful to count two very adjacent slices as illustrated previously. The whole 
slice set was divided into 22 sections (100 slices in each section to represent a height of 125 µm) and 
one slice from each section was chosen randomly again. In total, 22 slices were chosen for the 
microcracks counting in this case. Similarly, these 2200 slices were divided into 44 sections (50 slices 
in each section to represent a height of 63µm) and there were 44 slices used for averaging the 
microcracks per slice. The average number of microcracks per slice during these three counts is 
summarized in Figure 5.11. It was found that the results were quite consistent (1.1% difference) 
across three counts with different numbers of slices. As it is efficient to count 11 slices for each 
specimen, no further counting was undertaken and validated the reduced number of slices.  




Figure 5.11 Convergence testing on the number of slices to be counted. The same microcrack may 
appear in more than one slice, especially the 22 slices and 44 slices counting. All the microcracks were 
tracked when do the counting and would not be counted repeatedly.  
In conclusion, all 2200 slices were divided into 11 sections from the top to the bottom. There were 
200 slices in each section to be studied as a sub-group. A random generator was made to generate a 
number between 0 and 200 randomly for each section, so 11 slices were chosen randomly for the 
study in this chapter.  
11 slices was shown to be a sufficient number of slices to achieve consistent results for the large 
data set. Moreover, it may be argued that it is the difference, rather than absolute values, in crack 
levels between the BP and non-BP groups that is important and hence the focus was on applying a 
consistent method to all the groups as opposed to developing a method that can capture all 
microcracks in a specimen.  
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 The Effect of BP on Trabecular Microcracks and Broken Trabeculae 
168 
 
Independence of observations  
A second issue was the subjective nature of identifying and counting cracks. To check the inter-
observer variability of the protocol, two observers carried out the counting of cracks blinded in a BP-
treated specimen and in a FC specimen, respectively. The results are shown in Table 5.2 and Figure 
5.3. Comparing the results from two observers, it is seen that the results were highly consistent (less 
than 1% difference) for both microcrack and fully broken trabeculae counts.  
Table 5.2 Independence of observation testing for a BP-treated sample. 








Number of broken 
trabeculae 
1 7 1 6 1 
2 6 2 7 2 
3 7 0 7 0 
4 8 2 9 2 
5 7 1 8 2 
6 9 1 9 1 
7 6 3 6 3 
8 7 5 6 5 
9 6 3 7 3 
10 8 2 7 2 
11 8 2 8 2 
Average 7.1 2.0 7.2 2.1 




Table 5.3 Independent of observation testing for an fractured control (FC) sample 
During the Thesis write-up, an undergraduate project, at the Imperial College Medical School, was 
carried out for quantifying the number of microcracks and fully broken trabeculae. As their 
undergraduate projects, two medical students were counting microcracks using the same 
synchrotron radiation scanning images as this Thesis. For investigating the method of manual 
microcracks counting, 10 slices randomly chosen from one sample were counted first, and then 1000 
slices (one of every two adjacent slices) were also independently counted by the two medical 
students. Their results for the average number of microcracks and fully broken trabeculae per slice, 
based on 10 slices, were highly consistent (less than 1% difference) with the findings in this Thesis. 








Number of broken 
trabeculae 
1 6 2 6 2 
2 7 1 6 2 
3 7 2 7 2 
4 8 2 7 2 
5 6 0 7 0 
6 8 3 8 3 
7 7 2 8 2 
8 9 3 9 2 
9 10 2 9 2 
10 8 3 8 3 
11 7 3 8 3 
Average 7.5 2.1 7.5 2.1 
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Their results based on 1000 slices counting were also very close (less than 5% difference) to the 
findings from this Thesis. Because of copyright reasons, their results were not included in this Thesis. 
Based on the above two tests, 11 slices was decided as the number of slices counted for each 
specimen. All these 36 specimens were re-numbered randomly and blind counting was undertaken 
for each specimen.  
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5.3 Results  
All the microcracks and fully broken trabeculae counting results are summarized in Table 5.4. 
Statistical tests have been done for each parameter. 
Table 5.4 Microcracks and broken trabeculae counting results. 
  Microcracks Broken trabeculae 
  Unloaded loaded Increase % Unloaded  Loaded Increase % 
ALN 8.1± 1.2 12.0± 1.6 47% 2.3± 0.3 3.2± 0.6 39% 
FC 6.9 ± 0.9 8.9± 0.8 29% 1.9± 0.3 2.3± 0.3 24% 
ELD 5.3± 0.2 5.7± 0.2 8% 1.6± 0.1 1.8± 0.2 13% 
A one-way ANOVA was conducted to determine if the number of microcracks of the unloaded 
samples was different for different groups. There were no outliers, as assessed by boxplot; data was 
normally distributed for each group, as assessed by Shapiro-Wilk test (p> 0.05); and there was 
homogeneity of variances, as assessed by Levene's test of homogeneity of variances (p>0.05). Data is 
presented as mean ± standard deviation and listed below. The number of microcracks for unloaded 
samples was statistically significantly different among different groups, F(2, 13) = 13.754, p= 0.001, 
  = 0.61. The number of microcracks of unloaded samples was 8.1 ± 1.2 for the ALN group, 6.9 ± 0.9 
for the FC group and 5.3 ± 0.2 for the ELD group. Tukey’s post hoc analysis was also conducted.   
A one-way ANOVA was conducted to determine if the number of microcracks in the samples that 
had been loaded before scanning (‘pre-load’) was different for different groups. There were no 
outliers, as assessed by boxplot; data was normally distributed for each group, as assessed by 
Shapiro-Wilk test (p> 0.05); and there was homogeneity of variances, as assessed by Levene's test of 
homogeneity of variances (p>0.05). The number of microcracks for pre-loaded samples was 
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statistically significantly different among different groups, F(2, 10) = 29.557, p< 0.0005,  = 0.81. 
The number of microcracks of pre-loaded samples was 12.0 ± 1.6 for the ALN group, 8.9 ± 0.8 for the 
FC group and 5.7 ± 0.2 for the ELD group. Tukey’s post hoc analysis was also conducted to test if the 
difference was significant between two groups and the results were combined with apparent 
strength results and listed in Figure 5.12. 
 
Figure 5.12 Number of microcracks and apparent strength compared among groups. Tukey’s post hoc 
analysis was done to find if the result of every two groups were significantly different. The same letter 
marked on two groups indicates that the result was significantly different between them with a p 
value of less than 0.05. The same letter with the symbol of one star marked on two groups indicates 
that the result was significantly different between them with p value less than 0.001.  
Similarly, the number of fully broken trabeculae was also analysed and presented in the same way as 
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A one-way ANOVA was conducted to determine if the number of fully broken trabeculae in the 
unloaded samples was different for different groups. There were no outliers, as assessed by boxplot; 
data was normally distributed for each group, as assessed by Shapiro-Wilk test (p> 0.05); and there 
was homogeneity of variances, as assessed by Levene's test of homogeneity of variances (p>0.05). 
The number of fully broken trabeculae in the unloaded samples was statistically significantly 
different among different groups, F(2, 13) = 9.262, p= 0.003,  = 0.51. The number of fully broken 
trabeculae for the unloaded samples was 2.3 ± 0.3 for the ALN group, 1.9 ± 0.3 for the FC group and 
1.6 ± 0.1 for the ELD group. Tukey’s post hoc analysis was also conducted.  
A one-way ANOVA was conducted to determine if the number of fully broken trabeculae in the pre-
loaded samples was different for different groups. There were no outliers, as assessed by boxplot; 
data was normally distributed for each group, as assessed by Shapiro-Wilk test (p> 0.05); and there 
was homogeneity of variances, as assessed by Levene's test of homogeneity of variances (p>0.05).  
The number of fully broken trabeculae in the pre-loaded samples was statistically significantly 
different among different groups, F(2, 10) = 12.791, p= 0.002,  = 0.64. The number of fully broken 
trabeculae in the pre-loaded samples was 3.2 ± 0.6 for the ALN group, 2.3 ± 0.3 for the FC group and 
1.8 ± 0.2 for ELD group. Tukey’s post hoc analysis was also conducted.  
The statistics results for fully broken trabeculae were combined with apparent strength and shown 
in Figure 5.13.  
 
 





Figure 5.13 Number of broken trabeculae and apparent strength compared among groups. Tukey’s post 
hoc analysis was done to find if the result of every two groups were significantly different. The same letter 
marked on two groups indicates that the result was significantly different between them with a p value 
less than 0.05. The same letter with the symbol of one star marked on two groups indicates that the result 
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5.4 Discussions  
This is one of the first studies to quantify the number of microcracks and fully broken trabeculae in 
BP-treated human bones, and to combine this data with mechanical testing data. The most 
important finding of this chapter is that more microcracks and fully broken trabeculae were found in 
BP-treated bones compared with non-treated controls (FC group) and elderly controls (ELD group).  
The number of microcracks in the ALN group was 25% higher than that of the FC group and 52% 
higher than that of the ELD group. The differences were statistically significant. However, these 
differences were much larger in samples that had been loaded (pre-loaded) prior to scanning. For 
pre-loaded samples, the number of microcracks in the ALN group was 36% higher than the FC group, 
and 111% higher than the ELD group. Figure 5.14 shows a pair of slices for comparison, which were 
randomly selected from pre-loaded BP-treated and non-treated fracture control samples 
respectively. There was an obvious difference in the amount of microcracks and fully broken 
trabeculae observed between the two samples.  
 




Figure 5.14 Comparison between (a) BP-treated sample (a slice randomly selected from the ALN group) 
and (b) non-treated fracture control sample (a slice randomly selected from the FC group). Both 
samples had been pre-loaded.  
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When comparing the pre-loaded and unloaded samples within the same group, it was found that the 
loading process caused relatively more microcracks in the ALN group than in the FC and ELD groups. 
For the ELD group, the number of microcracks in the pre-loaded samples was 8% higher than that in 
the unloaded samples. However, this figure increased to 35% in the FC group and 47% in the ALN 
group. It appears that the BP-treated bones were more prone to load-induced microcracking 
suggesting that BP-treated bone was less tough.  
The findings for fully broken trabeculae were very similar to the findings for microcracks. Among the 
un-loaded samples, the number of fully broken trabeculae was 1.6 for the ELD group, 1.9 for the FC 
group and 2.2 for the ALN group. The number of broken trabeculae for ALN group was 16% more 
than that of FC group and 38% more than that of the ELD group. However, an even larger difference 
was found for the loaded samples: the ALN group was 39% higher than the FC group and 78% higher 
than the ELD group. As for microcracking, the loading process increased the number of broken 
trabeculae at different levels for different groups. Among the ELD samples group, the pre-loaded 
samples showed 13% more fully broken trabeculae compared with those unloaded samples. 
However, this figure increased to 24% for the FC group and 45% for the ALN group.  
The results showed more broken trabeculae among the BP-treated bones than among untreated 
fracture controls and elderly controls. Also importantly, much larger differences were observed 
when comparing the loaded samples across these three groups. It suggests that BP-treated bones 
are more brittle and microcracks may more easily grow into bigger microcracks and merge with 
adjacent microcracks. Two examples were chosen to illustrate this process in Figure 5.15. It shows 
two microcracks start from two edges of a single trabecula and develops toward the middle until the 
whole trabecula is broken.  
 





Figure 5.15 Two examples of microcracks starting from two sides and meeting in the middle. Microcracks further developing may cause the whole trabecular branch to break and 
separate into two parts.
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The results from this study have been firstly compared with other findings which were based on 
healthy cadavers reported from the current literatures both qualitatively and quantitatively. Two 
examples of microcracks from this Thesis were reconstructed for presentationin 3D. Figure 5.16 
shows these two trabecular bone cubes and the microcracks laid within the bones. The microcracks 
were found to fit well into an elliptical shape.  
 
Figure 5.16 3D models made to represent microcracks within trabecular bones based on the samples 
in this Thesis. Two 3D reconstruction models were made based on synchrotron radiation microCT 
slices. (a) A small cube of trabecular bone without any sign of microcracking. (b) the same but 
transparent model shows a hidden microcrack inside the trabeculae bone. (c) another small cube of 
trabecular bone. Two microcracks can be observed. (d) the transparent model shows the whole shape 
of these two microcracks and found they were merged into one. Only the bigger one was modelled 
and highlighted in red.  
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Larrue et al (Larrue, Rattner et al. 2011) also studied trabecular bone samples and modelled the 
microcrack, which is presented in Figure 5.17. The microcracks modelled in Figure 5.16 in this study 
were of a very similar shape compared with Larrue’s model. Mohsin et al. (Mohsin, O'Brien et al. 
2006) also presented a similar ellipsoid shape of a microcrack in Figure 5.18.  
 
Figure 5.17 3D reconstruction of a microcrack and fitting it into an ellipsoid shape. (Larrue, Rattner et 
al. 2011) 
 




Figure 5.18 A microcrack was reconstructed and shown at four different angles in (a)-(d). The standard 
cylindrical shape drill hole was also modelled to help understand the orientation of the microcrack 
rotating at different angles. (Mohsin, O'Brien et al. 2006) 
In terms of the total number of microcracks or microcrack density (the total amount of microcracks 
per unit area), there have been very few studies based on BP-treated human samples. The results of 
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this study were first compared with the studies based on human samples. The average number of 
microcracks per slice in this study was 8.1 for ALN group samples, 6.5 for FC group samples and 5.3 
for ELD group samples. The total area of each slice was 11   . Therefore, the microcrack densities 
in this study were 0.74/    for ALN group samples, 0.59/    for FC group, and 0.48/    for ELD 
group. Stepan (2007) reported the microcrack densities as 0.91/    for BP-treated samples and 
0.51/    for non-treated controls, based on the samples from bone biopsy surgery (Figure 5.19) 
(Stepan, Burr et al. 2007). The result of 0.91/    for BP-treated samples was slightly higher than 
the result of the BP-treated group in this study. The average BP treatment period for Stepan’s study 
was five years and longer than that of this study (average treatment period of 3 years and 4 months), 
which can partly explain the difference. The microcrack density for the ELD group seems to match 
the finding of Stepan’s study. Larrue et al (Larrue, Rattner et al. 2011) reported the microcrack 
density as 0.55/   to 0.76    from healthy cadaver samples, which seems consistent with the 
results for the FC and ELD groups in this study. It suggests the amount or density of microcracks 
detected in this study can be supported by other studies in the literature. 
 
Figure 5.19 Comparison of microcrack densities between treatment naïve and BP (alendronate) 
treated human samples (Stepan, Burr et al. 2007).  
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The microcrack density results have been proved to be correct for both BP-treated bones and non-
treated controls by comparing with the results reported from other studies. It was more important 
to this study that the significant difference in microcrack accumulation between BP-treated and non-
treated was also found in other studies. As it is not feasible to scan the bone samples in vivo at high 
resolution and measure microcrack density due to the high radiation dose, there have been only two 
studies using bone biopsy taken from the iliac crest of BP-treated women. The samples were stained 
and observed under Fluorescent microscopy. A control group of samples were taken from the same 
locations of cadavers. Stepan (Stepan, Burr et al. 2007) found a 79% higher microcrack density in 
their BP-treated sample group than that of the non-treated control group, which was shown in 
Figure 5.19 previously. Chapurlat also did a similar study but reported no significant difference 
between BP-treated and non-treated control groups (Chapurlat, Arlot et al. 2007). 
While there are few human sample-based studies investigating the effect of BP-treatment on 
microcracks, there are relatively more such studies using animal models. Rats and dogs are the two 
most common models. Allen et al. carried out two studies on female dogs and similar findings to this 
Thesis were reported (Allen, Iwata et al. 2006, Allen and Burr 2007). They treated one year old 
beagles with daily oral doses of BP for three years. The results (Figure 5.20) show that microcrack 
density in BP-treated groups (two different doses) was higher than that of non-treated group 
(although only the effect of the higher dose was significant). When it came to average microcrack 
length, it was found that microcracks were on average shorter in the BP-treated groups compared 
with non-treated controls. It suggests that BP treatment brought in some new but shorter 
microcracks. In their second study, they reported 233% more microcracks accumulated in 0.2 
mg/kg/day BP-treated group than those in the non-treated control group (Allen, Iwata et al. 2006). 
Hirano et al. also treated dogs (1 to 2 years old) with BP at clinical doses for one year and found 50% 
higher microcracks density compared with a non-treated control group (Hirano, Turner et al. 2000). 
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This chapter found BP-treated bones had 53% more microcracks compared with non-treated control 
group. This matches well with Hirano’s finding (50%), but is much lower than Allen’s results. Allen 
had treated samples with BP for three years prior to microcrack density measurement, while one-
year treatment was adopted by Hirano. The difference in the treatment period may explain the 
difference in microcrack accumulation.  
 
Figure 5.20 Microcrack density and length comparison between BP-treated with different doses 
(0.2mg and 1.0mg per kilogram per day) and non-treated controls.(a) Microcrack density comparison 
among three groups and the high does BP treatment group shown significantly higher level of 
microcracks accumulation. The microcrack number increased with the dose of BP treatment. High 
dose treatment group accumulated more microcracks than the lose-dose BP treatment group. (b) 
Average microcrack length comparison among groups. BP-treated bones were with shorter 
microcracks length, which suggested more smaller microcracks appeared after BP treatment. The 
daily dose of 0.2 mg/kg equalled the clinical treatment of OP patients. (Allen and Burr 2007). 
Although there have been no studies investigating the fracture mechanism and theory of how 
microcracks and other damage weaken trabecular bone strength quantitatively (Cowin 2009), some 
trends in the relationship between mechanical strength and microcrack accumulation are noticeable 
from this study. The mechanical strength was roughly inversely proportional with the number of 
microcracks and fully broken trabeculae. The results of average apparent strength and number of 
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microcracks of three groups for unloaded samples and pre-loaded samples are shown in Figure 5.21 
and Figure 5.22 respectively. It can be seen that very strong correlations are noticed between 
apparent strength and microcrack accumulation for both unloaded samples and pre-loaded samples. 
The result indicates that microcrack accumulation heavily affects trabecular bone’s compressive 
strength. The mechanisms behind this need to be further studied.  
 
Figure 5.21 Average apparent strength correlated with average number of microcracks in unloaded 
samples of three groups. Three date points represent the average strength and number of 
microcracks of three groups of ELD, FC and ALN from left to right respectively.  
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Figure 5.22 Average apparent strength correlated with average number of microcracks in loaded 
samples of three groups. Three date points represent the average strength and number of 
microcracks of three groups of ELD, FC and ALN from left to right respectively. 
The accuracy of the results in this chapter was limited by several issues. Firstly, the samples 
necessarily had to be dried out prior to synchrotron scanning; otherwise the beam energy would 
cause thermal expansions large enough that the bone would move during scanning, which would 
make image reconstruction impossible. The drying out of the specimens was a concern as the drying 
process is known to cause artificial ‘drying’ microcracks. However, the study was primarily a 
comparative study between BP treated and non-treated bones. Hence, it was viewed that the drying 
effect would affect all the groups equally and that a significant difference in results between groups 
would not be affected by the drying artefact. Also, one of the most important results of the Thesis 
relates to the increase in the number of microcracks as a result of loading, irrespective of how many 
cracks (including drying crack) existed before loading.  
Secondly, the microcracks and fully broken trabeculae were counted from 2D slices instead of from a 
3D reconsctruction of the specimen, which includs all the cracks contained within the specimen. The 
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reason for this approach was that large computer resources are needed to carry out a full 3D 
analysis (60 gigabyte image files for each sample). Related to this limitation, the number of cracks 
were presented as ‘number of cracks per square millimere’ as opposed to, perhaps more 
appropriate,  ‘number of cracks in the whole volume’ of the specimen. There were two reasons for 
this approach, both related to how many of the 2200 slices from a scanned specimen should be used 
to estimate the total number of cracks in the volume. If using a very large number of slices (i.e. 
closely spaced) two microcracks observed in the 2D slices (one in each slice) may in reality be just 
one (3D) microcrack spanning two slices and it would erronerously lead to an estimation of 2 
microcracks in the volume. Figure 5.23 shows an example of a set of adjacent slices spanned by one 
microcrack. It is clear from Figure 5.23 (a) and (b) that two small microcracks exist, but these two 
microcracks are actually just one (larger) 3D microcrack. Thus, using too many slices to estimate the 
number of microcracks in the volume would cause an overestimation (unless somehow tracking and 
excluding overlapping cracks which would have been very time consuming and subject to observer 
error). On the other hand, using too few slices (slices spaced far apart) clearly means that some 
microcracks, lying between slices, could be missed resulting in an underestimation of number of 
cracks per volume. As a compromise, this Thesis used slices sufficiently far apart that cracks were 
not counted multiple times but also so far apart that a reliable number of cracks per volume could 
be achieved, thus only the number of cracks per square millimere was reported. While this is a 
limitation it did enable comparison to other studies on microcracks in bone as the vast majority of 
these also report the number of cracks per square millimere. 




Figure 5.23 Observation from adjacent slices. A microcrack spanning to slices appears as two 
microcracks from adjacent slices (a) and (b) shows two single microcracks. (c) and (d) These two 
microcracks merge into a big one.  
Thirdly, this study reported only the number of microcraks (and fully broken trabeculae) but not any 
other features of the microcracks, notably not a very important parameter, such as the size of the 
microcracks. However, as just described the geometry of a microcrack is necessarily 3D and a 2D 
image is likely to be completely erroneous for estimating the size of a crack that spans several slices. 
Again this was a limitation due to the lack of  availability of  computer resources. 




Synchrotron radiation micro-CT scanning was able to visualise microcracks and fully broken 
trabeculae. The pixel size of 1.3 µm is a good balance between data size and the image quality. For 
better microcrack outline detail, 0.8-0.9 µm pixel size is recommended.  
More microcracks and fully broken trabeculae were found in BP-treated bones than in untreated 
fracture controls and elderly controls. Also, the BP-treated bones were more prone to further 
microcrack formation following loading indicating that the BP bone may be more brittle.  
Very obvious trends were observed that mechanical strength inversely correlated with the number 
of microcracks and fully broken trabeculae. Combining mechanical strength and microcrack 
accumulation data, strong correlations were found between apparent strength and microcrack 
accumulation for both unloaded samples and pre-loaded samples. These were stronger than 
apparent strength with other densities and microstructure parameters reported in previous chapters. 
This strong correlation indicates that microcrack accumulation can reduce trabecular bone’s 
compressive strength. It is highly recommended that further study investigating the link between 
microcrack accumulation and reduced bone strength for BP-treated trabecular bone is carried out. 
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   Chapter 6.               
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6.1 Overall discussion   
6.1.1 Mechanical testing  
The results from each chapter have been discussed and compared with other studies in depth. This 
overall discussion aims to discuss all these results within a more clinical background.  
BP is classified as “anti-remodelling agent” (O'Neal, Diab et al. 2010). It was found to significantly 
reduce bone remodelling in BP-treated postmenopausal women (Müller and Recker 2007). Positive 
effects of BP of improving BMD and reducing fracture risk have been reported for most patients 
(Bone, Hosking et al. 2004, Nowacka-Cieciura, Cieciura et al. 2006, Guo, Wu et al. 2013). However, 
concerns have been raised regarding possible adverse effects of BP (Abrahamsen 2010, Abrahamsen 
2010), particularly atypical hip fractures as well as many typical fractures in patients on long term BP 
therapy (more than 8 years). In these patients BP seems less effective and may even be the cause of 
the fractures. (Shane, Burr et al. 2010, Abrahamsen and Einhorn 2012, Warren, Gilchrist et al. 2012, 
Hermann and Abrahamsen 2013). Other studies have confirmed that the increase in strength was  
mainly due to an increase in bone mineral density (Müller and Recker 2007), as opposed to more 
fundamental improvement in bone quality. Therefore, the BP-treated samples from fracture patients 
of this study are crucial to study the adverse effects of BP. This is the first study focusing on those 
patients for whom BP did not prevent fracture and to compare the mechanical strength of these 
patients’ bone to that of the bone from non-treated controls.  
It was found that the apparent strength for the ALN group was 29% lower than that of the FC group, 
and 38% lower than that of the ELD control group. Statistical testing confirmed both comparisons 
were found to be significantly different. In terms of the outcomes (fracture) of BP treatment, BP was 
prescribed to these patients for the purpose of preventing fractures (Bone, Hosking et al. 2004). 
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However, the patients of the ALN group were all treated with BP but still fractured. BP treatment 
was supposed to prevent fractures by improving bone strength over non-treated bones. Reduced 
strength was observed from the BP-treated ALN group in this study. Based on this, it can be 
concluded that BP treatment was not successful in these patients neither in terms of preventing 
fracture nor in improving bone strength. The BP-treated patients included in this study were 
exclusively those who had suffered hip fractures and were scheduled for hip replacement as for 
practical reasons this allowed the collection of samples. In addition to this group of patients, there 
were many more BP-treated patients that do not fracture. Therefore, the BP-treated samples of this 
group are possibly not representative of the bone of all BP-treated patients, as they are, arguably, a 
sub-group of patients for whom BP did not work well. The findings from mechanical testing in this 
study should be interpreted in this way: BP medications did not work in some patients receiving this 
treatment and in these patients their bone strength was found to be associated with lower 
mechanical strength.  
It is conceivable that there is a confounding factor in this study: those BP-treated bones had reduced 
bone density (less bone) compared with controls, as only those patients more severely affected by 
OP tend to be treated with BP. In clinical practice, the loss of bone mass is typically diagnosed using 
DEXA scans to measure BMD, which captures the mineral content in a 2D area. The BP treatment 
group patients were believed to have been DEXA scanned prior to the treatment, but the data was 
not available for this study. Most of the non-treated fracture control group patients had not been 
classified as high-risk fracture patients and therefore, mostly, had not been DEXA scanned. It was not 
possible to compare the BMD results among groups. If the BP samples had lower mechanical 
strength than the untreated group because they were more osteoporotic, BP cores would be 
expected to have lower apparent density. The apparent density was measured in this study for each 
group and the average apparent density for ALN group was 2% higher than that of the non-treated 
control group, but this difference was not significant. The mechanical strength was further 
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normalized with bone apparent density. The result shows that apparent density-normalized strength 
was still significantly lower in BP-treated group compared with the non-treated fractured control 
group and elderly control group. This suggests that low density is not the cause of the low strength 
of the BP treated samples.  
Prior to this study, BP’s effect on human bones had only been studied based on the outcome 
(number of fracture cases after treatment of 5, or 10 years) of BP treatment. There have not been 
any studies on human bone that linked the mechanical strength and BP treatment. Some studies 
based on animal models had reported improvements in bone apparent strength or ultimate load 
following BP treatment (Ohnishi, Nakamura et al. 1997, Wang, Allen et al. 2008, Zimmermann, 
Schaible et al. 2016). However, none of these studies normalised bone strength with densities. 
Higher bone strength with BP treatment may be explained by the drug’s effect on bone density. 
Allen and Burr did a study on 1-year treated beagles and compared the mechanical strength-density 
relationship with non-treated controls. They found that the strength-density curves for the BP-
treated group and non-treated group were very similar (Allen and Burr 2011). This suggests that BP 
works mainly by improving bone density and other effects on strength are very limited. Possibly to 
relevance, these studies investigated the effect of BP on all the samples, which included most of the 
samples BP worked well in and also a small sub-group of samples BP might not work well in. When 
the average mechanical strength was calculated, the mechanical strength was improved compared 
with non-treated animal samples. Therefore, the conclusion from these animal studies is not in 
conflict with the findings from this study.  
Clinical studies following large groups of BP-treated patients have reported that BP reduces the 
number of fracture cases effectively. The age of patients included in these studies ranged from 55 to 
80 years old (Black 2006) and there was a notable number of patients under 70 years old. Bone 
remodeling is heavily affected by aging, especially microcracks were increasingly accumulated after 
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the age of 70 (Mori, Harruff et al. 1997). 70% of the samples in the BP-treated group in this Thesis 
were from patients older than 70, and the other 30% were quite close to 70 years old. Thus, the 
patients included in this study were much older than the patients of the mentioned clinical studies. 
BP’s adverse effect on bone remodelling might become more pronounced when combined with the 
lower remodelling rate in older patients, which may partly explain the difference between the 
findings of the clinical studies and this Thesis.  
Hence the BP-treated patients do not seem to exhibit weaker bone because they are associated with 
lower apparent density.  
6.1.2 Microstructure  
The microstructure study was carried out to realise two objectives. Firstly, it was to investigate if any 
differences in trabecular microstructure exist between BP-treated and non-treated groups. Secondly, 
it was to investigate if the reduced strength of BP-treated group could be partly or fully explained by 
trabecular microstructure. 
All the samples were microCT scanned and different microstructural parameters were measured. 
Bone volume fraction was a key determinant of trabecular bone strength as also shown in many 
studies (Stauber and Muller 2006, Follet, Viguet-Carrin et al. 2011, Melton, Riggs et al. 2011, 
Topolinski, Cichanski et al. 2011). Considering that all the samples of the same shape and size, bone 
apparent density represented the total amount of bone mass, while bone volume fraction 
represented the total amount of bone volume within the cylindrical specimen. Only 0.1% difference 
in bone volume fraction was observed between BP-treated and non-treated FC control groups, and 
this difference was not significant. Similar results were also found for trabecular thickness. There 
was a less than 1% observed difference in trabecular thickness between BP-treated and non-treated 
groups. Connectivity density for the ALN group was found to be 11% lower than that of non-treated 
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control FC group. When investigated for correlation with bone apparent strength, trabecular 
connectivity density was found to be highly correlated with apparent strength for the BP-treated 
group, but not for other groups. Even though BP-treated bone had a similar amount of bone mass 
and volume compared with the non-treated control FC group, the microstructure of the BP-treated 
bone was more poorly connected, which was associated with reduced mechanical strength. It can be 
concluded that no obvious differences besides connectivity were observed between BP-treated and 
non-treated control groups.  
On discussing this with an orthopaedic consultant, they confirmed that only obvious osteoporotic 
bones and high fracture risk patients were treated with BP medications. Had BP-treated patients had 
not been prescribed BP treatment, their microstructure would be expected to be poorer on average 
compared with those of non-treated controls as a result of being more severe OP (Hooven, Gehlbach 
et al. 2005). However, there were no obvious or significant differences between BP-treated and non-
treated controls for most of the microstructural parameters. This proves that BP can prevent more 
severe osteoporotic bone’s trabeculae from continuing to get thinner and BP can maintain the 
microstructure effectively. Among several microstructural parameters, connectivity density was the 
main one that showed an obvious difference between BP-treated and non-treated samples. It seems 
that BP-treated bone cannot repair or re-connect the broken trabeculae. As a parameter describing 
the degree to which a trabecular bone structure is multiply connected, it does not differentiate 
between thick and thin trabeculae, nor between rod–like and plate-like structures (Odgaard and 
Gundersen 1993). It makes sense that BP-treated bones were found to be of a similar level of 
trabecular thicknesses and structure model index as those of non-treated controls while connectivity 
differed.  
Because of the unavailability of samples, BP’s effect of protecting and maintaining trabecular 
microstructure had not been studied in human bones prior to this Thesis, but has been studied 
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widely using animal models. Several studies have reported an increase of trabecular thickness after 
BP treatment using rat models. BP was shown to increase the trabecular thickness and reduce the 
trabecular space to a level similar to rats on sham treatment (i.e. not ovariectomised) (Brouwers, 
Lambers et al. 2008, Shahnazari, Yao et al. 2010, Wu, Adeeb et al. 2013). As well as rat models, 
canine models are frequently used to model BP’s effect on bones. Ding (Ding, Day et al. 2003) 
reported that high-dose BP treatment on canines slightly increased (6%) trabecular thickness. Allen 
(Allen, Iwata et al. 2006) also reported canine vertebral bones showing greater cortical thickness 
after BP treatment, but no obvious difference was found when investigating different doses of the 
treatment. There are contradictory studies reporting thinner trabecular thickness among BP-treated 
animals. An early study by Bourrin et al. (Bourrin, Ammann et al. 2002) found that BP treated rats 
had thinner trabecular thickness than non-treated ovariectomised rats (32% thinner). In Muller’s 
study (Müller and Recker 2007), a thinner trabecular thickness was also found in rats with BP 
treatment. In Camargos’s (Camargos, Bhattacharya et al. 2015) very recent study, it was also found 
that BP-treated bones had thinner trabecular thickness compared with those of both non-treated 
ovariectomised and non-ovariectomised controls. The reason for this difference might be the 
different daily activities and treatment period between animals and humans. For connectivity 
density, similar results to this Thesis were also found from animal studies. Ding (Ding, Day et al. 2003) 
treated canines with high-dose (0.5 mg/kg daily) BP for one year and did not observe differences 
between BP-treated and control groups. This showed that even high doses of BP did not improve the 
connectivity density in dogs. Shahnazari (Shahnazari, Yao et al. 2010) tested trabecular bone samples 
from rats and found the connectivity density of BP-treated ovariectomised rats was still lower than 
that of controls. The results for other parameters were also found to be highly consistent with 
animal studies. The microstructural parameter results from this study support and are supported by 
studies based on animal models.  
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It suggests that BP treatment reduces connectivity density. Overall, connectivity density is one of the 
causes of reduced mechanical strength. Apart from connectivity density, BP-treated bones do not 
seem to exhibit weaker bone because of the trabecular microstructure. 
6.1.3 Microcracking 
As introduced previously, BP has been  called an “anti-remodelling agent” (O'Neal, Diab et al. 2010) 
and a few studies have reported BP as suppressing bone turnover (Yoshida, Moriya et al. 1998, 
Mashiba, Turner et al. 2001, Qiu, Phipps et al. 2010, Allen and Burr 2011). In animal studies, it has 
been well established that microcrack accumulation is increased in BP-treated animals as a result of 
suppression of bone remodelling (Mashiba, Hirano et al. 2000, Mashiba, Turner et al. 2001, Allen and 
Burr 2007, Allen and Burr 2008). This study investigated diffidence in microcrack accumulation in BP-
treated and non-treated control human samples.  
The number of microcracks in the BP-treated group was found to be 25% higher than that of the 
non-treated control group and 52% higher than that of the elderly control group. These differences 
were statistically significant. However, these differences were much larger in samples that had been 
loaded (pre-loaded) prior to scanning. For pre-loaded samples, the number of microcracks in the 
ALN group was 36% higher than that in the FC group, and 111% higher than that in the ELD group. 
When comparing the pre-loaded and unloaded samples of the same group, it was found that the 
loading process caused relatively more microcracks in the ALN group (47%) than in the FC (35%) and 
the ELD (4%) groups. It appears that the BP-treated bones were more prone to load-induced 
microcracking suggesting that the BP-treated bone was less tough.  
The findings for fully broken trabeculae were very similar to the findings for microcracks. The 
number of broken trabeculae in the BP-treated ALN group was 16% more than that of the FC group 
and 38% higher than that of the ELD group. As for microcracking, the difference between pre-loaded 
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and non-loaded samples in each group was larger in the BP-treated ALN group (45%) compared with 
that of the non-treated FC (24%) and the ELD groups (13%). The results showed more broken 
trabeculae in the BP-treated bones than in the untreated fracture and elderly controls. Importantly, 
much larger differences were observed when comparing the loaded samples across these three 
groups. It suggests that BP-treated bones are more brittle and microcracks may more easily grow.  
The difference in microcrack accumulation between the BP-treated and non-treated controls has 
been studied in both human samples and animal models. Studies on humans used bone biopsies 
taken from the iliac crest of BP-treated women and compared these with samples from the same 
location from cadavers. Stepan found a 79% higher microcrack density in the BP-treated group 
relative to non-treated control group. Meanwhile, Chapurlat reported no significant difference 
between these two groups (Chapurlat, Arlot et al. 2007). Many more studies have been performed 
using animal models. Allen et al. carried out two studies on female dogs and both studies found 
higher microcrack density in BP-treated groups (Allen, Iwata et al. 2006, Allen and Burr 2007). Hirano 
et al. also treated dogs (1 to 2 years old) with BP at clinical doses for one year and found a 50% 
higher microcrack density compared with the non-treated control group (Hirano, Turner et al. 2000). 
The animal studies also evaluated the influence of the length and dose of BP treatment on 
microcrack accumulation. No significant difference in microcrack density between one year 
treatment and three years treatment was found (Allen and Burr 2007). It suggests that most of the 
microcracks initiate during the early stage of treatment. It was also found that high-dose BP 
treatment caused significantly more microcracks than low-dose treatment (Allen and Burr 2007).  
An obstacle for the study of BP’s effect on bone is the availability of human bone samples, which 
limited the accuracy of previous studies. Referring to the studies that did use human samples, only a 
very thin slice of bone (from bone biopsy) was tested and cannot accurately represent the 3D bone 
microstructure. For animal based studies, there were two main shortcomings that affected the 
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interpretation of the results. Firstly, the animals were young (usually 1 to 2 years old), for whom 
bone growth and microcracking mechanism were quite different from those of elderly humans. Mori 
(Mori, Harruff et al. 1997)  found that the average microcrack density in a group of elderly women 
(more than 70 years old) was twice that of a group of younger women (less than 70 years old). 
Secondly, microcracks occur from daily activities. The animals in these studies were kept in the lab or 
other limited space with a very restricted range of daily activities that would lead to microcrack 
initiation and development, which diminishes the adverse effects of BP. 
The mechanical strength was inversely proportional to the number of microcracks and fully broken 
trabeculae. This result indicates that a strong correlation between apparent strength and microcrack 
accumulation. It suggests that microcrack accumulation strongly affects the compressive strength of 
trabecular bone. Currey (Currey, Brear et al. 1996) also found that the increased level of microcrack 
accumulation reduced bone strength and even more bone toughness. BP treatment does increase 
microcrack accumulation, but it also increases bone volume and mineralisation. These effects offset 
each other resulting in no impairment of mechanical properties (Allen, Iwata et al. 2006). In terms of 
the influence of microcrack accumulation on fatigue resistance of bone, two key factors need to be 
considered:  microdamage initiation and microdamage growth. It has been suggested that if the 
material and structure of bone is prone to allow microcracks to grow,  this has a  more detrimental 
effect on bone’s ability to resist fracture than if the bone contained more but stable microcracks 
(Chapurlat and Delmas 2009). In a review paper, Allen and Burr also concluded that microcracking is 
a parameter that affects bone material biomechanical properties and material biomechanical 
properties are strongly linked with bone structural biomechanical properties and fracture risk (Allen 
and Burr 2007).  
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6.2 Main limitations  
The limitations specific to the topic of each chapter have been discussed in the relevant chapters. 
The limitations of samples and methodology that are common for the whole study are discussed in 
this section. 
6.2.1 Samples  
Firstly, this study was limited by the number of samples, especially the medium term (3 to 5 years) 
and long-term (5 to 10 years) BP-treated samples. This study investigates the effect of BP treatment 
on bone. However, the effect of different BP-treatment periods (short term, medium term and long 
term) can only be investigated and compared if enough samples in each treatment period are 
available.  
Secondly, the bone conditions of these samples prior to BP-treatment are unknown. Although 
parameters of microstructure and microcracking are not possible to measure in vivo, clinical 
information such as the BMD value from DEXA scans and previous fracture information would be 
very valuable.  
Finally, BP patients in this study may only represent a subset of all the patients that have been 
treated with BP and the conclusion of this study may only be applicable for such patients and not for 
all patients treated with BP. The bone samples from this study are from patients treated with BP but 
who had still fractured; otherwise it was not possible to obtain the bone samples. This study 
investigated if in this sub-group of patients, for whom BP evidently was not effective, the BP 
treatment was associated with reduced mechanical strength and to further explore the causes for 
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this. The results and conclusions of this study are possibly only applicable to this subgroup of 
patients and may not represent the effect of BP on patients in general.  
6.2.2 Methodology 
Firstly, the samples were only tested in compression due to practical issues related to manufacturing 
specimens of appropriate size and shape for mechanical testing. As has been shown in this study, 
microcracking is a crucial factor for mechanical strength. The effect of microcracks  during tensile 
testing is expected to be even more severe. However, in the femoral head, single trabeculae are 
usually short and curved and are very difficult to machine into a regular shape for tensile testing. The 
femoral head samples of this study were collected from trauma patients and usually contained no 
cortical bone as generally only the femoral head was available with no femoral neck. Hense, in this 
study it was not possible to do tensile testing on either trabecular or cortical bone.  
Secondly, the accuracy achieved when counting microcracks and fully broken trabeculae was limited 
by two factors. There was no commercial software available to automatically count the number of 
microcracks and fully broken trabeculae. Manual counting might cause inaccuracy. Also, the 
counting was based on 2D images rather than 3D volumes. This was a limitation due to the available 
computer resources; 3D models reconstruction from the very big data file size of synchrotron 
radiation scanning requires large computer resources. Considering the microcracks and fully broken 
trabeculae in reality are 3D objects, assessing these objects from 2D images will cause inaccuracy. 
However, the accuracy of the quantitative assessment of microcrack is probably less important than 
the qualitative difference in number of microcracks and fully broken trabeculae between BP and 
control groups.  
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6.3 Concluding remarks  
This study found that BP-treated bone was associated with reduced mechanical strength. The 
difference in mechanical strength between BP-treated bones and non-treated controls was 
statistically significant.  The cause of the reduced strength in BP-treated bone was investigated in 
terms of bone density, bone microstructure and microcracking. There were no large and significant 
differences observed in bone apparent density and bone volume fraction. The apparent strength 
was normalised for bone apparent density and bone volume fraction, but BP-treated bone was also 
associated with lower normalised strength. Thus the reduced strength of BP-treated bone cannot be 
explained simply as an effect of this bone being more osteoporotic.  
There was no large (less than 5%) difference found between BP-treated and non-treated controls for 
all the microstructural parameters apart from connectivity density. It was found that the 
connectivity density for the BP-treated group was 11% lower than that of the non-treated control 
group. Trabecular microstructure for the BP-treated group was poorly connected and can partly 
explain the reduced strength of the BP-treated samples. The study measured microcracking at the 
sub-micro level with a pixel size of 1.3 µm. A larger number of microcracks and fully broken 
trabeculae were found in BP-treated bones than in untreated fracture controls. Also, the BP-treated 
bones were more brittle, allowing further microcrack to develop. It was observed that mechanical 
strength was inversely correlated with the number of microcracks and fully broken trabeculae. 
Furthermore, strong correlations were found between apparent strength and microcracks 
accumulation for both unloaded samples and pre-loaded samples. This indicates that microcrack 
accumulation did reduce the strength of trabecular bone.  
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6.4 Significance and clinical relevance 
This is the first study that has physically tested BP-treated human samples to investigate BP’s effect 
on bone strength. Previous studies with a similar aim were based on animal samples, and it is 
questionable how such studies reflect the behaviour of elderly human bone.  
As this study was based on bone from ‘normal’ or typical fractures, the findings of this study suggest 
that adverse effects of BP are not limited to atypical hip fractures, but rather are systemic and may 
predispose patients towards fractures whether ‘typical’ or ‘atypical’. In patients who suffered typical 
fractures after taking BP, the bone was weaker than the bone from patients with a fragility fracture 
who had not taken BP and from bones of non-fracture control patients. Paradoxically, BP may have 
impaired bone strength, and even increased the risk of a typical fragility fractures. Current 
estimations of BP-induced stress fractures (whether atypical or typical) probably underestimate the 
true incidence. This study suggests that, in addition, typical fractures may be associated with BP 
treatment, so follow-up testing after five years of BP treatment for predicting typical fractures is 
highly recommended.  
The identification of patients who are at risk of BP-induced fractures is of crucial importance to 
reduce this complication in the future. The FDA (FDA 2013) has suggested that patients need to be 
monitored to determine whether they are at risk of a BP-induced fracture, recommends that 
patients on BP with increasing pain should be screened radiographically to identify potential 
subtrochanteric stress fractures. Moreover, this assessment should not be just limited to assessment 
using DEXA scans, as BMD measurement alone cannot predict the potential increasing fracture risk 
(Hollick and Reid 2011).  
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6.5 Recommendation and future works 
Previous clinical studies investigating the effects of BP were mostly long-term (10 years) follow-up 
studies. A follow-up study involving a large group of BP-treatment receivers and non-treated elderly 
persons, all age and sex matched, is highly recommended. The status of the bones of the 
participants should be recorded at initiation of BP treatment and at regular intervals thereafter. 
When any of these patients suffer a hip fracture and need a hip replacement operation, the femoral 
head should be collected for further studies with the consent of patients. The engineering study 
results can then be combined with the clinical records prior-to-fracture.  
Mechanisms of microcracking and the relationship between mechanical strength and fracture risk 
are much less known and highly recommended for further investigation. Microcracking was 
considered as a parameter that affects bone material biomechanical properties together with 
mineralisation and the condition of the organic matrix. Furthermore, material biomechanical 
properties were strongly linked with bone structural biomechanical properties and fracture risk, 
together with bone mass and bone geometry parameters (Allen and Burr 2007). It is not a simple link 
between microcracking and material biomechanical properties, nor between material biomechanical 
properties and fracture risk. A study of microcrack initiation and progression can prompt an 
improved understanding of trabecular failure mechanisms and establish trabecular local failure 
criteria. Investigations of how BP affects bone at the sub-micron level and at the level of collagen 
fibrils are urgently recommended for further study. It is hypothesised that the improvement on 
microstructure of BP is partially offset by adverse effects on the bone material (Allen and Burr 2011). 
A study at the level of the collagen fibrils may help understand how microcrack initiation and 
progression in BP-treated bone differ from non-treated controls. Such understanding may lead to 
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contributions towards the understanding of fracture the whole structure and towards the 
development of a diagnostic tool for predicting fracture risk.  
Caution is recommended when extrapolating findings from BP studies of animals to humans. Animal 
models are performed as it is a more practically feasible way to address many of the questions 
relating to the effects of BP. However, there are several issues that need to be considered. Firstly, 
such studies are usually on young animals. Bone growth is heavily affected by age, especially 
microcracks are intensively accumulated after the age of 70 (Mori, Harruff et al. 1997). Secondly, the 
animals are treated with BP over only a short time interval, typically 1 to 12 months. This treatment 
period may be too short to show BP’s adverse effects, and so the positive effect of BP on bone 
strength are emphasised with the negative effects becoming more prominent in the longer term. 
Thirdly, BP is reported to suppress bone turnover and further affect bone’s microcrack self-repair 
function (Mashiba, Turner et al. 2001). These microcracks occur as a result of daily activities. 
However, the animal in these studies are typically kept in the lab with limited space for movement 
and daily activities. This reduces the risk of microcracks initiation and progression resulting in such 
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There are two appendices in this part.  
All the result parameters have been tested for normality for choosing the most suitable and accurate 
statistics tests to determine the statistics different among groups. The normality tests results for all 
the parameters in this thesis were included in appendix A.  
A questionnaire has been sent to GP for each femoral head sample to request patient information. 




A. Normality tests for all parameters  
a. Apparent strength 
Table A 1 Test of normality for bone apparent strength. 
Groups Kolmogorov-Smirnov Shapiro-Wilk 
 
Statistic df Sig. Statistic df Sig. 
ALN 0.107300561 20.00 .200
*
 0.97 20 0.785423 
ELD 0.197994866 10.00 .200
*
 0.87 10 0.11236 
OA 0.152029527 20.00 .200
*
 0.96 20 0.470311 
FC 0.113056543 26.00 .200
*
 0.96 26 0.402593 
 
 
Table A 2 Skewness and Kurtosis test for bone apparent strength. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 0.13 0.51 0.25 
 
Kurtosis -0.55 0.99 -0.56 
FC Skewness 0.20 0.46 2.84 
 
Kurtosis -0.77 0.89 -0.87 
OA Skewness -0.20 0.51 -0.38 
 
Kurtosis 0.91 0.99 0.92 
ELD Skewness 0.33 0.69 0.48 
 






























b. Elastic modulus 
Table A 3 Test of normality for elastic modulus. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.181801 17.00 0.14 0.93 17 0.251 
ELD 0.295966 10.00 0.01 0.85 10 0.066 
OA 0.138806 20.00 .200
*
 0.96 20 0.631 
FC 0.151452 23.00 0.19 0.90 23 0.030 
 
 
Table A 4 Skewness and Kurtosis test for elastic modulus. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 0.82 0.55 1.49 
 
Kurtosis 0.03 1.06 0.03 
FC Skewness 0.92 0.48 1.90 
 
Kurtosis -0.04 0.93 -0.04 
OA Skewness 0.29 0.51 0.57 
 
Kurtosis -0.64 0.99 -0.65 
ELD Skewness 0.99 0.69 1.45 
 






























c. Plastic deformation strain range 
Table A 5 Test of normality for plastic deformation strain range. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.211531 17.00 0.04 0.92 17 0.154 
ELD 0.100239 10.00 .200* 0.97 10 0.892 
OA 0.091555 19.00 .200* 0.96 19 0.484 




Table A 6 Skewness and Kurtosis test for plastic deformation strain range. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.49 0.55 -0.89 
 
Kurtosis 1.50 1.06 1.41 
FC Skewness 4.38 0.50 8.74 
 
Kurtosis 19.67 0.97 20.24 
OA Skewness 0.21 0.52 0.40 
 
Kurtosis -1.01 1.01 -0.99 
ELD Skewness 0.07 0.69 0.10 
 






























d. Apparent density 
Table A 7 Test of normality for bone apparent density. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.14 20.00 .200* 0.96 20 0.453 
ELD 0.16 10.00 .200* 0.93 10 0.448 
OA 0.14 20.00 .200* 0.93 20 0.191 
FC 0.10 26.00 .200* 0.98 26 0.796 
 
 
Table A 8 Skewness and Kurtosis test for bone apparent density. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.48 0.51 -0.93 
 Kurtosis -0.55 0.99 -0.55 
FC Skewness -0.07 0.46 -0.16 
 Kurtosis 0.04 0.89 0.05 
OA Skewness 0.51 0.51 0.99 
 Kurtosis -0.79 0.99 -0.79 
ELD Skewness -0.34 0.69 -0.49 


























e. Bone volume fraction 
Table A 9 Test of normality for bone volume fraction. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.19 19.00 0.06 0.92 19 0.099 
ELD 0.17 9.00 .200* 0.89 9 0.184 
OA 0.16 20.00 .200* 0.97 20 0.650 




Table A 10 Skewness and Kurtosis test for bone volume fraction. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 1.70 0.52 3.24 
 Kurtosis 3.62 1.01 3.57 
FC Skewness 0.72 0.52 1.38 
 Kurtosis 0.69 1.01 0.68 
OA Skewness 0.17 0.51 0.34 
 Kurtosis -0.27 0.99 -0.27 
ELD Skewness 0.16 0.72 0.22 




























f. Bone material density 
Table A 11 Test of normality for bone material density. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.14 16 .200* 0.96 16 0.674 
ELD 0.17 9 .200* 0.93 9 0.478 
OA 0.24 20 0.00 0.76 20 0.000 




Table A 12 Skewness and Kurtosis test for bone material density. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 0.24 0.52 0.45 
 Kurtosis 0.01 1.01 0.00 
FC Skewness -0.20 0.52 -0.39 
 Kurtosis -0.31 1.01 -0.30 
OA Skewness 2.24 0.51 4.37 
 Kurtosis 5.92 0.99 5.97 
ELD Skewness 0.28 0.72 0.39 

























g. Apparent strength normalized with apparent density 
Table A 13 Test of normality for apparent strength normalized with apparent density. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.23 20 0.01 0.87 20 0.010 
ELD 0.17 10 .200* 0.91 10 0.295 
OA 0.19 20 0.06 0.90 20 0.037 




Table A 14 Skewness and Kurtosis test for apparent strength/ bone apparent density. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 1.40 0.51 2.74 
 
Kurtosis 2.06 0.99 2.07 
FC Skewness 0.68 0.46 1.49 
 
Kurtosis -0.19 0.89 -0.21 
OA Skewness 0.51 0.51 0.99 
 
Kurtosis -1.23 0.99 -1.24 
ELD Skewness 0.94 0.69 1.37 
 



























h. Apparent strength normalized with bone volume fraction 
Table A 15 Test of normality for bone apparent strength normalized with bone volume fraction. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.16 19 .200* 0.94 19 0.264 
ELD 0.17 9 .200* 0.94 9 0.575 
OA 0.22 20 0.01 0.91 20 0.059 




Table A 16 Skewness and Kurtosis test for apparent strength/ bone volume fraction. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 0.51 0.52 0.97 
 
Kurtosis 1.33 1.01 1.31 
FC Skewness 0.18 0.55 0.33 
 
Kurtosis -1.45 1.06 -1.36 
OA Skewness 0.88 0.51 1.71 
 
Kurtosis -0.10 0.99 -0.10 
ELD Skewness 0.47 0.72 0.66 
 



























i. Connectivity density 
Table A 17 Test of normality for trabecular connectivity density. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.13 19 .200* 0.96 19 0.658 
ELD 0.17 9 .200* 0.93 9 0.521 
OA 0.15 20 .200* 0.96 20 0.587 




Table A 18 Skewness and Kurtosis test for trabecular connectivity density. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.29 0.52 -0.55 
 
Kurtosis -0.85 1.01 -0.84 
FC Skewness 0.63 0.52 1.20 
 
Kurtosis -0.35 1.01 -0.34 
OA Skewness 0.96 0.51 1.88 
 
Kurtosis 0.75 0.99 0.75 
ELD Skewness 0.78 0.72 1.09 
 



























j. Trabecular structure anisotropy 
Table A 19 Test of normality for trabecular structure anisotropy. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.15 19 .200* 0.96 19 0.509 
ELD 0.21 9 .200* 0.94 9 0.622 
OA 0.08 20 .200* 0.98 20 0.918 




Table A 20 Skewness and Kurtosis test for trabecular structure anisotropy. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.67 0.52 -1.27 
 
Kurtosis 1.30 1.01 1.28 
FC Skewness -0.12 0.52 -0.22 
 
Kurtosis -0.08 1.01 -0.07 
OA Skewness 0.00 0.51 0.00 
 
Kurtosis -0.68 0.99 -0.69 
ELD Skewness -0.47 0.72 -0.65 
 




























k. Fractal dimension  
Table A 21 Test of normality for fractal dimension. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.12 19 .200* 0.94 19 0.265 
ELD 0.18 9 .200* 0.95 9 0.649 
OA 0.12 19 .200* 0.97 19 0.794 




Table A 22 Skewness and Kurtosis test for fractal dimension. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.44 0.52 -0.84 
 
Kurtosis 0.39 1.01 0.38 
FC Skewness -0.73 0.52 -1.39 
 
Kurtosis 1.21 1.01 1.19 
OA Skewness -2.83 0.51 -5.53 
 
Kurtosis 10.37 0.99 10.45 
ELD Skewness 0.77 0.72 1.08 
 
























l. Mean trabecular thickness 
Table A 23 Test of normality for average trabecular thickness. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.13 19 .200* 0.94 19 0.293 
ELD 0.12 9 .200* 0.98 9 0.940 
OA 0.17 20 0.16 0.94 20 0.205 




Table A 24 Skewness and Kurtosis test for average trabecular thickness. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.28 0.52 -0.54 
 
Kurtosis -0.86 1.01 -0.85 
FC Skewness 0.70 0.52 1.33 
 
Kurtosis -0.19 1.01 -0.19 
OA Skewness 0.67 0.51 1.30 
 
Kurtosis 1.61 0.99 1.62 
ELD Skewness 0.43 0.72 0.60 
 




























m. Mean trabecular space 
Table A 25 Test of normality for average trabecular space. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.16 18 .200* 0.93 18 0.237 
ELD 0.26 9 0.07 0.88 9 0.143 
OA 0.11 20 .200* 0.98 20 0.918 




Table A 26 Skewness and Kurtosis test for average trabecular space. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 1.67 0.52 3.19 
 
Kurtosis 3.49 1.01 3.44 
FC Skewness 0.70 0.52 1.33 
 
Kurtosis -0.54 1.01 -0.54 
OA Skewness -0.20 0.51 -0.40 
 
Kurtosis -0.22 0.99 -0.22 
ELD Skewness -1.37 0.72 -1.91 
 



















Figure A 51 Q-Q Plot of average trabecular space for OA group. 
 
 






n. Structure model index 
Table A 27 Test of normality for structure model index. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.13 18 .200* 0.96 18 0.697 
ELD 0.17 9 .200* 0.94 9 0.625 
OA 0.15 17 .200* 0.96 17 0.686 




Table A 28 Skewness and Kurtosis test for structure model index. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness -0.41 0.54 -0.76 
 
Kurtosis 1.63 1.04 1.57 
FC Skewness -0.70 0.52 -1.33 
 
Kurtosis -0.67 1.01 -0.66 
OA Skewness 0.59 0.55 1.08 
 
Kurtosis 0.32 1.06 0.30 
ELD Skewness -0.23 0.72 -0.32 
 



























o. Number of microcracks unloaded 
Table A 29 Test of normality for the number of microcracks unloaded. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.24 6 .200* 0.90 6 0.375 
ELD 0.29 5 .200* 0.91 5 0.490 




Table A 30 Skewness and Kurtosis test for the number of microcracks unloaded. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 1.06 0.85 1.25 
 
Kurtosis 0.63 1.74 0.36 
FC Skewness 0.56 0.91 0.61 
 
Kurtosis -3.22 2.00 -1.61 
ELD Skewness 0.52 0.91 0.57 
 


































p. Number of microcracks loaded 
Table A 31 Test of normality for the number of microcracks loaded. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.22 4   0.93 4 0.568 
ELD 0.17 3 
 
1.00 3 1.000 




Table A 32 Skewness and Kurtosis test for the number of microcracks loaded. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 1.03 1.01 1.02 
 
Kurtosis 0.19 2.62 0.07 
FC Skewness -1.02 0.85 -1.21 
 
Kurtosis 0.04 1.74 0.02 
ELD Skewness 0.78 0.72 1.09 
 































q. Number of fully broken trabeculae unloaded  
Table A 33 Test of normality for the number of fully broken trabeculae unloaded. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.17 6 .200* 0.96 6 0.804 
ELD 0.36 5 0.03 0.77 5 0.042 




Table A 34 Skewness and Kurtosis test for the number of fully broken trabeculae unloaded. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 0.64 0.85 0.76 
 
Kurtosis -0.30 1.74 -0.17 
FC Skewness -0.54 0.91 -0.59 
 
Kurtosis -1.49 2.00 -0.74 
ELD Skewness 0.88 0.91 0.97 
 

































r. Number of fully broken trabeculae pre-loaded  
Table A 35 Test of normality for the number of fully broken trabeculae pre-loaded. 
Groups 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ALN 0.27 4   0.90 4 0.416 
ELD 0.25 3 
 
0.96 3 0.637 




Table A 36 Skewness and Kurtosis test for the number of fully broken trabeculae pre-loaded. 
Groups Tests Statistic Std.Dev z value 
ALN Skewness 0.38 1.01 0.37 
 
Kurtosis -3.60 2.62 -1.37 
FC Skewness -1.19 0.85 -1.41 
 
Kurtosis 1.67 1.74 0.96 
ELD Skewness 0.78 0.72 1.09 
 























































Imperial College London 
Faculty of Medicine 
Room 7L21, Floor 7, Laboratory Block 
St Dunstan’s Road, Charing Cross Campus 
London, W6 8RP.  
E: richard.abel@imperial.ac.uk 
07760 168 197/020 3313 4489 
14
th
 November 2014 
Dear XXX 
Request for patient information on bone health 
We are writing to ask you for help with your patient named below who underwent hip 
surgery at St Mary’s Hospital. With the patients consent we have collected the femoral head 
for a study into the effect of long-term bisphosphonate use on fracture risk, which has been 
ethically approved (Imperial College Tissue Bank application number R11030). 
Name:  XXX  
Date of Birth: XXX 
Hospital Number: XXX 
The majority of patients who take bisphosphonates show improved bone strength and 
reduced fracture risk during the first 3-5 years of treatment. However, a small proportion (1-
2%) exhibit rare stress fractures in the lateral proximal femur, often referred to as ‘a-typical’. 
This may occur because bisphosphonates reduce the rate of natural bone repair (i.e. 
remodelling), which prevents the bone wastage associated with osteoporosis but may also 
cause unrepaired micro-cracks to accumulate and coalesce into a brittle fracture. 
Accordingly we are comparing bone collected from patients prescribed bisphosphonate 
therapy and naïve controls. We aim to determine whether bisphosphonates can increase the 
risk of rare stress fractures in some patients? 
We are fully aware of the substantial demands upon your time and apologise for the 
inconvenience but we would like to request some patient info for the project. Please could 
you fill out the attached form and return it in the enclosed stamped addressed envelope.  




Dr. Richard Abel 
Lecturer in musculoskeletal science 
 
 
Prof. Justin Cobb 




Research Sample ID: SM XX 
 
1. Is the patient known to suffer from any of the following conditions?   
               Osteoporosis                                                                                      Yes ⃝ No ⃝ 
               Osteopenia                                                                                         Yes ⃝ No ⃝ 
               Hip osteoarthritis                                                                              Yes ⃝ No ⃝ 
               Other major illness (es): ___________________________ 
2. Has the patient taken / been taking bisphosphonates?                     Yes ⃝ No ⃝ 
                If yes, Indication for treatment: _____________________ 
                Type of bisphosphonate: __________________________ 
   Dosage: _______________________________________ 
   The date treatment started: _MM__/__Y Y Y Y_ 
   The date treatment discontinued: _MM__/__Y Y Y Y_ 
   Reason for discontinuation:___________________ 
3. Has the patient had a previous fracture?            Yes ⃝ No ⃝ 
    If yes, Site(s) of fracture(s): _______________________ 
    Date of fracture(s): _MM__/__Y Y Y Y_ 
4. Has the patient received / been receiving hormone replacement therapy?    Yes ⃝ No ⃝ 
     If yes, Type of HRT: ______________________________ 
                  Dosage: _______________________________________ 
    The date treatment started: _MM__/__Y Y Y Y_ 
    The date treatment discontinued: _MM__/__Y Y Y Y_ 
     Reason for discontinuation:____________________ 
5. Has the patient taken / been taking calcium supplementation?          Yes ⃝ No ⃝ 
6. Has the patient taken / been taking Vitamin D supplementation?        Yes ⃝ No ⃝ 
7. Is the patient known to have cancer?             Yes ⃝ No ⃝ 
    If yes, Type of cancer: _____________________________ 
    Treatment received: _____________________________  
8. Has the patient had a history of smoking:             Yes ⃝ No ⃝ 
    If yes, current smoker: Yes ⃝ No ⃝; Or Time since quitting: _________ 
 
